{"id":40964,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/credit-agreement-healthsouth-corp-and-nationsbank-na.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"credit-agreement-healthsouth-corp-and-nationsbank-na","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/finance\/credit-agreement-healthsouth-corp-and-nationsbank-na.html","title":{"rendered":"Credit Agreement &#8211; HealthSouth Corp. and NationsBank NA"},"content":{"rendered":"<pre>\n--------------------------------------------------------------------------------\n\n\n\n\n\n                                      THIRD\n                              AMENDED AND RESTATED\n                                CREDIT AGREEMENT\n\n\n\n                                  by and among\n\n\n\n                            HEALTHSOUTH CORPORATION,\n                                  as Borrower,\n\n\n                       NATIONSBANK, NATIONAL ASSOCIATION,\n                                    as Agent\n\n                                       and\n\n                   THE LENDERS PARTY HERETO FROM TIME TO TIME\n\n\n\n\n                                 April 18, 1996\n\n\n\n\n\n\n\n--------------------------------------------------------------------------------\n\n\n\n                                TABLE OF CONTENTS\n<\/pre>\n<table>\n<caption>\n<p>                                                                                                               Page<\/p>\n<p>                                    ARTICLE I<\/p>\n<p>                              Definitions and Terms<\/p>\n<p><s>  <c>                                                                                                      <c><br \/>\n1.1.  Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  2<br \/>\n1.2.  Rules of Interpretation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 30<br \/>\n1.3.  Classes and Types of Loans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 31<\/p>\n<p>                                   ARTICLE II<\/p>\n<p>                                    The Loans<\/p>\n<p>2.1.  Syndicated Loans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 32<br \/>\n2.2.  Competitive Bid Loans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 35<br \/>\n2.3.  Payment of Interest&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 40<br \/>\n2.4.  Payment of Principal&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 40<br \/>\n2.5.  Non-Conforming Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 41<br \/>\n2.6.  Notes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 41<br \/>\n2.7.  Pro Rata Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 42<br \/>\n2.8.  Reductions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 42<br \/>\n2.9.  Conversions and Elections of Subsequent Interest<br \/>\n      Periods&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 43<br \/>\n2.10. Increase and Decrease in Amounts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 44<br \/>\n2.11. Unused Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 44<br \/>\n2.12. Deficiency Advances&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 44<br \/>\n2.13. Use of Proceeds&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 45<br \/>\n2.14. Extension of Stated Termination Date&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 45<\/p>\n<p>                                   ARTICLE III<\/p>\n<p>                                Letters of Credit<\/p>\n<p>3.1.  Letters of Credit&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 48<br \/>\n3.2.  Reimbursement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 48<br \/>\n3.3.  Letter of Credit Facility Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 52<br \/>\n3.4.  Administrative Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 52<\/p>\n<p>                                   ARTICLE IV<\/p>\n<p>               Termination of Eurodollar Rate and Yield Protection<\/p>\n<p>4.1.  Suspension of Loans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 53<br \/>\n4.2.  Compensation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 54<br \/>\n4.3.  Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 55<\/p>\n<p>                                    ARTICLE V<\/p>\n<p>     Conditions to Making Loans and Issuing Letters of Credit<\/p>\n<p>5.1.  Conditions of Initial Advance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 57<br \/>\n5.2.  Conditions of Loans and Letters of Credit&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 59<\/p>\n<caption>\n<p>                                   ARTICLE VI<\/p>\n<p>                         Representations and Warranties<\/p>\n<p><s>   <c>                                                                                                      <c><br \/>\n6.1.  Organization and Authority&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 61<br \/>\n6.2.  Loan Documents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 61<br \/>\n6.3.  Solvency&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 62<br \/>\n6.4.  Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 62<br \/>\n6.5.  Ownership Interests&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 62<br \/>\n6.6.  Financial Condition&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 62<br \/>\n6.7.  Title to Properties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 63<br \/>\n6.8.  Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 63<br \/>\n6.9.  Other Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 63<br \/>\n6.10. Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 64<br \/>\n6.11. Margin Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 64<br \/>\n6.12. Investment Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 65<br \/>\n6.13. Patents, Etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 65<br \/>\n6.14. No Untrue Statement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 65<br \/>\n6.15. No Consents, Etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 65<br \/>\n6.16. ERISA Requirement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 66<br \/>\n6.17. No Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 66<br \/>\n6.18. Hazardous Materials&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 66<br \/>\n6.19. Employment Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 66<br \/>\n6.20. RICO&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 67<br \/>\n6.21. Reimbursement from Third Party Payors&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 67<\/p>\n<p>                                   ARTICLE VII<\/p>\n<p>                              Affirmative Covenants<\/p>\n<p>7.1.  Financial Statements, Reports, Etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 68<br \/>\n7.2.  Maintain Properties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 70<br \/>\n7.3.  Existence, Qualification, Etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 70<br \/>\n7.4.  Regulations and Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 70<br \/>\n7.5.  Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 70<br \/>\n7.6.  True Books&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 70<br \/>\n7.7.  Right of Inspection&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 71<br \/>\n7.8.  Observe all Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 71<br \/>\n7.9.  Governmental Licenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 71<br \/>\n7.10. Covenants Extending to Other Persons&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 71<br \/>\n7.11. Officer&#8217;s Knowledge of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 71<br \/>\n7.12. Suits or Other Proceedings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 71<br \/>\n7.13. Notice of Discharge of Hazardous Material or<br \/>\n      Environmental Complaint&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 72<br \/>\n7.14. Environmental Compliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 72<br \/>\n7.15. Continuation of Current Business&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 73<br \/>\n7.16. Management Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 73<\/p>\n<p>                                  ARTICLE VIII<\/p>\n<p>                               Negative Covenants<br \/>\n8.1.  Financial Covenants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 74<br \/>\n8.2.  Investments and Loans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 74<\/p>\n<p>                                       ii<\/p>\n<caption>\n<p><s>  <c>                                                                                                        <c><br \/>\n8.3.  Indebtedness&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 74<br \/>\n8.4.  Disposition of Assets&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 75<br \/>\n8.5.  Consolidation or Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 75<br \/>\n8.6.  Liens&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 75<br \/>\n8.7.  Dividends and Distributions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 75<br \/>\n8.8.  Acquisitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 75<br \/>\n8.9.  Restricted Payments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 75<br \/>\n8.10. Compliance with ERISA&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 76<br \/>\n8.11. Fiscal Year&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 76<br \/>\n8.12. Dissolution, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 76<\/p>\n<p>                                   ARTICLE IX<\/p>\n<p>                       Events of Default and Acceleration<\/p>\n<p>9.1.  Events of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 78<br \/>\n9.2.  Agent to Act&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 81<br \/>\n9.3.  Cumulative Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 81<br \/>\n9.4.  No Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 81<br \/>\n9.5.  Allocation of Proceeds&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 81<\/p>\n<p>                                    ARTICLE X<\/p>\n<p>                                    The Agent<\/p>\n<p>10.1.  Appointment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 83<br \/>\n10.2.  Attorneys-in-fact&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 83<br \/>\n10.3.  Limitation on Liability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 83<br \/>\n10.4.  Reliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 83<br \/>\n10.5.  Notice of Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 84<br \/>\n10.6.  No Representations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 84<br \/>\n10.7.  Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 85<br \/>\n10.8.  Lender&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 85<br \/>\n10.9.  Resignation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 85<br \/>\n10.10. Sharing of Payments, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 86<br \/>\n10.11. Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 87<br \/>\n10.12. Independent Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 87<\/p>\n<p>                                   ARTICLE XI<\/p>\n<p>                                  Miscellaneous<\/p>\n<p>11.1.  Assignments and Participations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 88<br \/>\n11.2.  Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 90<br \/>\n11.3.  No Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 91<br \/>\n11.4.  Setoff&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 92<br \/>\n11.5.  Survival&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 92<br \/>\n11.6.  Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 92<br \/>\n11.7.  Amendments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 93<br \/>\n11.8.  Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 94<br \/>\n11.9.  Waivers by Borrower&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 94<br \/>\n11.10. Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 95<br \/>\n11.11. Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 96<\/p>\n<p>                                       iii<\/p>\n<caption>\n<p><s>    <c>                                                                                                     <c><br \/>\n11.12. Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 96<br \/>\n11.13. Agreement Controls&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 97<br \/>\n11.14. Integration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 97<br \/>\n11.15. Successors and Assigns&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 97<br \/>\n11.16. Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 97<br \/>\n11.17. Usury Savings Clause&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 97<\/p>\n<p>EXHIBIT A   Applicable Commitment Percentages&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.A-1<br \/>\nEXHIBIT B   Form of Assignment and Acceptance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.B-1<br \/>\nEXHIBIT C   Notice of Appointment (or Revocation)<br \/>\n            of Authorized Representative&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;C-1<br \/>\nEXHIBIT D   Form of Borrowing Notice&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.D-1<br \/>\nEXHIBIT E   Form of Competitive Bid Note&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;E-1<br \/>\nEXHIBIT F   Form of Interest Rate Selection Notice&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..F-1<br \/>\nEXHIBIT G   Form of Line of Credit Note&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.G-1<br \/>\nEXHIBIT H   Investments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..H-1<br \/>\nEXHIBIT I   Form of Revolving Note&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;I-1<br \/>\nEXHIBIT J   Form of Competitive Bid Quote Request&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;J-1<br \/>\nEXHIBIT K   Form of Competitive Bid Quote&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..K-1<br \/>\nEXHIBIT L   Form of Opinion of Borrower&#8217;s Counsel&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;L-1<br \/>\nEXHIBIT M   Compliance Certificate&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;M-1<br \/>\nEXHIBIT N   Executive Officers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.N-1<\/p>\n<p>Schedule 6.4   Subsidiaries<br \/>\nSchedule 6.19  Employment Matters<br \/>\nSchedule 8.3   Existing Subsidiary Indebtedness<\/p>\n<p><\/c><\/c><\/s><\/caption>\n<p><\/c><\/c><\/s><\/caption>\n<p><\/c><\/c><\/s><\/caption>\n<p><\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                                    iv<\/p>\n<p>                   THIRD AMENDED AND RESTATED CREDIT AGREEMENT<\/p>\n<p>         THIS THIRD AMENDED AND RESTATED CREDIT  AGREEMENT dated as of April 18,<br \/>\n1996 (this &#8220;Agreement&#8221;) is entered into by and among HEALTHSOUTH CORPORATION,  a<br \/>\nDelaware  corporation  (the  &#8220;Borrower&#8221;),  the Lenders  signatories  hereto (the<br \/>\n&#8220;Lenders&#8221;) and NATIONSBANK,  N.A., a national banking association,  as agent for<br \/>\nthe Lenders (the &#8220;Agent&#8221;).<\/p>\n<p>                                    RECITAL:<br \/>\n                                    &#8212;&#8212;&#8211;<\/p>\n<p>         Pursuant to a Credit Agreement dated as of November 20, 1992 as amended<br \/>\nby  Amendments  No. 1 and No. 2 (the  &#8220;Original  Agreement&#8221;),  the lenders party<br \/>\nthereto  (the  &#8220;Original  Lenders&#8221;)  agreed to make loans and cause to be issued<br \/>\nletters  of  credit  all in an  aggregate  outstanding  amount  of not to exceed<br \/>\n$390,000,000.  Pursuant to the terms of the Original Agreement all Participating<br \/>\nSubsidiaries  and  Participating  Partnerships  (each as defined in the Original<br \/>\nAgreement)  guaranteed  payment of all  Credit  Obligations  (as  defined in the<br \/>\nOriginal Agreement).  In addition, the Borrower and certain of the Participating<br \/>\nSubsidiaries  executed  and  delivered  to the  Agent,  for the  benefit  of the<br \/>\nLenders,  Pledge Agreements conveying the property described therein as security<br \/>\nfor the Credit  Obligations.  At the  request of the  Borrower,  by Amended  and<br \/>\nRestated Credit  Agreement  dated June 7, 1994 (the &#8220;First Restated  Agreement&#8221;)<br \/>\nthe  Borrower,  the Agent and  certain of the  Original  Lenders  together  with<br \/>\nadditional  lenders (the &#8220;First  Restatement  Lenders&#8221;) amended and restated the<br \/>\nOriginal  Agreement  thereby  increasing  the amount of the credit  facility  to<br \/>\n$550,000,000,   changing  certain  provisions  of  the  Original  Agreement  and<br \/>\nresulting in the addition of certain Participating Subsidiaries.  At the request<br \/>\nof the Borrower, by Second Amended and Restated Credit Agreement dated April 11,<br \/>\n1995, as amended by Amendment  No. 1 and  Amendment No. 2 (the &#8220;Second  Restated<br \/>\nAgreement&#8221;),  the Borrower, the Agent and the First Restatement Lenders together<br \/>\nwith additional lenders (the &#8220;Second Restated Lenders&#8221;) amended and restated the<br \/>\nFirst Restated Agreement thereby increasing the amount of the credit facility to<br \/>\n$1,000,000,000,  changing certain provisions of the First Restated Agreement and<br \/>\nresulting   in  the   addition  of  certain   Participating   Subsidiaries   and<br \/>\nParticipating Partnerships.  The Borrower has requested that the Second Restated<br \/>\nAgreement  be further  amended and restated in its entirety in order to increase<br \/>\nthe  amount  of  the  credit  facility  and to  further  change  certain  of the<br \/>\nprovisions contained therein and to change certain of the lenders  participating<br \/>\ntherein.  Accordingly,  the  Borrower,  the Lenders and the Agent agree that the<br \/>\nSecond  Restated  Agreement  is hereby  amended and  restated in its entirety as<br \/>\nfollows, effective as of the Closing Date:<\/p>\n<p>                                    ARTICLE I<\/p>\n<p>                              Definitions and Terms<br \/>\n                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>         1.1.     Definitions.  For the purposes of  this Agreement, in addition<br \/>\nto the  definitions  set  forth  above,  the  following  terms  shall  have  the<br \/>\nrespective meanings set forth below:<\/p>\n<p>                  &#8220;Absolute  Rate&#8221; shall have the meaning  assigned to such term<br \/>\n         in Section 2.2(c)(ii)(D).<\/p>\n<p>                  &#8220;Absolute  Rate  Auction&#8221;   shall  mean  a   solicitation   of<br \/>\n         Competitive Bid Quotes setting forth Absolute Rates pursuant<br \/>\n         to Section 2.2.<\/p>\n<p>                  &#8220;Absolute Rate Loans&#8221; shall mean the Competitive Bid Loans the<br \/>\n         interest  rates on which are  determined on the basis of Absolute Rates<br \/>\n         set at Absolute Rate Auctions.<\/p>\n<p>                  &#8220;Acquisition&#8221;  means  the  acquisition,   whether  with  cash,<br \/>\n         property, stock or promise to pay, of all or a portion of a Person or a<br \/>\n         Facility  or  Facilities  of a Person,  permitted  under  Section  8.8;<br \/>\n         provided such Person or Facilities is in substantially the same line of<br \/>\n         business engaged in by Borrower or its Consolidated Entities.<\/p>\n<p>                  &#8220;Actual\/360  Basis&#8221; shall mean a method of computing  interest<br \/>\n         or other charges  hereunder on the basis of an assumed year of 360 days<br \/>\n         for actual  number of days  elapsed,  meaning  that  interest  or other<br \/>\n         charges  accrued for each day will be computed by multiplying  the rate<br \/>\n         applicable  on that  day by the  unpaid  principal  balance  (or  other<br \/>\n         relevant sum) on that day and dividing the result by 360.<\/p>\n<p>                  &#8220;Advance&#8221;  means  a  borrowing  under  the  Revolving   Credit<br \/>\n         Facility  or  Line  of  Credit  Facility  consisting  of the  aggregate<br \/>\n         principal amount of a Syndicated Loan or a Competitive Bid Loan.<\/p>\n<p>                  &#8220;Affiliate&#8221; of any specified Person means any other Person (i)<br \/>\n         which  directly  or  indirectly  through  one  or  more  intermediaries<br \/>\n         controls,  or is controlled by, or is under common  control with,  such<br \/>\n         specified Person;  or (ii) which  beneficially owns or holds 5% or more<br \/>\n         of any  class  of the  outstanding  voting  stock  (or in the case of a<br \/>\n         Person which is not a corporation,  5% or more of the equity  interest)<br \/>\n         of such specified Person; or 5% or more of any class of the outstanding<br \/>\n         voting stock (or in the case of a Person which is not a corporation, 5%<br \/>\n         or more of the equity interest) of which is beneficially  owned or held<br \/>\n         by such  specified  Person.  The term &#8220;control&#8221;  means the  possession,<br \/>\n         directly or  indirectly,  of the power to direct or cause the direction<br \/>\n         of the<\/p>\n<p>                                        2<\/p>\n<p>         management  and  policies of a Person,  whether  through  ownership  of<br \/>\n         voting stock, by contract or otherwise.<\/p>\n<p>                  &#8220;Applicable Commitment Percentage&#8221; means, with respect to each<br \/>\n         Lender,  that portion of the Total Line of Credit  Commitment and Total<br \/>\n         Revolving Credit  Commitment  allocable to such Lender (a) with respect<br \/>\n         to Lenders as of the Closing  Date,  as set forth on Exhibit A, and (b)<br \/>\n         with  respect  to any  Person  who  becomes  a  Lender  thereafter,  as<br \/>\n         reflected in each  Assignment  and Acceptance to which such Lender is a<br \/>\n         party assignee;  provided that the Applicable  Commitment Percentage of<br \/>\n         each Lender shall be increased or decreased to reflect any  assignments<br \/>\n         to or by such Lender effected in accordance with Section 11.1.<\/p>\n<p>                  &#8220;Applicable  Margin&#8221;  means  that  number of basis  points per<br \/>\n         annum set forth  below  determined  based  upon the more  favorable  of<br \/>\n         either  (i)  the  highest  Rating  of  outstanding   senior   unsecured<br \/>\n         Indebtedness  of the  Borrower  from  time to time or (ii) the ratio of<br \/>\n         Consolidated   EBITDA  to   Consolidated   Interest   Expense  for  the<br \/>\n         Four-Quarter Period most recently ended as specified below:<\/p>\n<p>                                                    Rating<br \/>\n                                                    &#8212;&#8212;<br \/>\n             Ratio of Consolidated                                    Applicable<br \/>\n         EBITDA to Consolidated Interest        S&amp;P or Moody&#8217;s          Margin<br \/>\n         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-        &#8212;&#8212;&#8212;&#8212;&#8211;          &#8212;&#8212;<\/p>\n<p>         a) Greater than 7.50 to 1.00           A-         A3            25 b.p.<\/p>\n<p>         b) Equal to or Less than 7.50<br \/>\n            to 1.00 but Greater than<br \/>\n            6.50 to 1.00                        BBB+       Baa1          30<\/p>\n<p>         c) Equal to or Less than 6.50<br \/>\n            to 1.00 but Greater than<br \/>\n            5.50 to 1.00                        BBB        Baa2          35<\/p>\n<p>         d) Equal to or Less than 5.50<br \/>\n            to 1.00 but Greater than<br \/>\n            4.50 to 1.00                        BBB-       Baa3          45<\/p>\n<p>         e) Equal to or Less than 4.50<br \/>\n            to 1.00 but Greater than<br \/>\n            3.50 to 1.00                        BB+        Ba1           55<\/p>\n<p>         f) Equal to or Less than 3.50<br \/>\n            to 1.00 but Greater than<br \/>\n            3.00 to 1.00                        BB         Ba2           62.5<\/p>\n<p>         g) Equal to or Less than 3.00<br \/>\n            to 1.00 but Greater than            BB-        Ba3<br \/>\n            2.50 to 1.00                         or Lower                75<\/p>\n<p>                                        3<\/p>\n<p>         The Applicable Margin shall be established in the case of a Rating from<br \/>\n         time to time based upon the Rating  then in effect  and, in the case of<br \/>\n         the  ratio,  at the end of each  fiscal  quarter of the  Borrower  (the<br \/>\n         &#8220;Ratio  Determination  Date&#8221;).  Any  change  in the  Applicable  Margin<br \/>\n         following each Ratio  Determination Date shall be determined based upon<br \/>\n         the  computations set forth in the Compliance  Certificate,  subject to<br \/>\n         review and  approval of such  computations  by the Agent,  and shall be<br \/>\n         effective commencing on the date following the date such certificate is<br \/>\n         received  until the date  following the date on which a new  Compliance<br \/>\n         Certificate  is  delivered  or is required to be  delivered,  whichever<br \/>\n         shall first occur;  provided  however,  if the  Borrower  shall fail to<br \/>\n         deliver any such certificate within the time period required by Section<br \/>\n         7.1,  then the  Applicable  Margin  shall be 2% until  the  appropriate<br \/>\n         certificate  is so delivered.  From the Closing Date to the first Ratio<br \/>\n         Determination  Date,  the  Applicable  Margin  shall be 45 basis points<br \/>\n         unless there is an  improvement in the Rating from the Rating in effect<br \/>\n         at the Closing Date.<\/p>\n<p>                  &#8220;Applicable  Unused Fee&#8221; means that number of basis points per<br \/>\n         annum set forth below,  which shall be  determined  based upon the more<br \/>\n         favorable  of  either  (i) the  highest  Rating of  outstanding  senior<br \/>\n         unsecured  Indebtedness  of the Borrower  from time to time or (ii) the<br \/>\n         ratio of Consolidated  EBITDA to Consolidated  Interest Expense for the<br \/>\n         Four-Quarter Period most recently ended as specified below:<\/p>\n<table>\n<caption>\n<p>                                             Rating           Applicable Unused Fee<br \/>\n                                             &#8212;&#8212;           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n              Ratio of Consolidated                         Line of        Revolving<br \/>\n         EBITDA to Consolidated Interest  S&amp;P or Moody&#8217;s Credit Facility Credit Facility<br \/>\n         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-  &#8212;&#8212;&#8212;&#8212;&#8211; &#8212;&#8212;&#8212;&#8212;&#8212; &#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>          <s>                           <c>    <c>       <c>          <c><br \/>\n         a) Greater than 7.50 to 1.00     A-    A3           8 b.p.        9 b.p.<\/p>\n<p>         b) Equal to or Less than 7.50<br \/>\n            to 1.00 but Greater than<br \/>\n            6.50 to 1.00                  BBB+  Baa1         9            10<\/p>\n<p>         c) Equal to or Less than 6.50<br \/>\n            to 1.00 but Greater than<br \/>\n            5.50 to 1.00                  BBB   Baa2        10            12.5<\/p>\n<p>         d) Equal to or Less than 5.50<br \/>\n            to 1.00 but Greater than<br \/>\n            4.50 to 1.00                  BBB-  Baa3        12.5          15<\/p>\n<p>         e) Equal to or Less than 4.50<br \/>\n            to 1.00 but Greater than<br \/>\n            3.50 to 1.00                  BB+   Ba1         15            17.5<\/p>\n<p>         f) Equal to or Less than 3.50<br \/>\n            to 1.00 but Greater than<br \/>\n            3.00 to 1.00                  BB    Ba2         17.5          20<\/p>\n<p>         g) Equal to or Less than 3.00<br \/>\n            to 1.00 but Greater than      BB-   Ba3<br \/>\n            2.50 to 1.00                   or Lower         22.5          25<\/p>\n<p><\/c><\/c><\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                        4<\/p>\n<p>         The Applicable  Unused Fee shall be established in the case of a Rating<br \/>\n         from time to time based upon the Rating then in effect, and in the case<br \/>\n         of the ratio,  at the end of each fiscal  quarter of the Borrower  (the<br \/>\n         &#8220;Ratio  Determination  Date&#8221;).  Any change in the Applicable Unused Fee<br \/>\n         following each Ratio  Determination Date shall be determined based upon<br \/>\n         the  computations set forth in the Compliance  Certificate,  subject to<br \/>\n         review  and  approval  of such  computations  by the Agent and shall be<br \/>\n         effective commencing on the date following the date such certificate is<br \/>\n         received  until the date  following the date on which a new  Compliance<br \/>\n         Certificate  is  delivered  or is required to be  delivered,  whichever<br \/>\n         shall first occur;  provided  however,  if the  Borrower  shall fail to<br \/>\n         deliver any such certificate within the time period required by Section<br \/>\n         7.1, then the Applicable  Unused Fee shall be 2%. From the Closing Date<br \/>\n         to the first Ratio  Determination Date, the Applicable Unused Fee shall<br \/>\n         be 15 basis  points on the  Revolving  Credit  Facility  and 12.5 basis<br \/>\n         points on the Line of Credit Facility unless there is an improvement in<br \/>\n         the Rating from the Rating in effect at the Closing Date.<\/p>\n<p>                  &#8220;Applications  and  Agreements  for Letters of Credit&#8221;  means,<br \/>\n         collectively, the Applications and Agreements for Letters of Credit, or<br \/>\n         similar  documentation,  executed by the Borrower from time to time and<br \/>\n         delivered  to the Issuing  Bank to support  the  issuance of Letters of<br \/>\n         Credit.<\/p>\n<p>                  &#8220;Assignment  and  Acceptance&#8221;  shall  mean an  Assignment  and<br \/>\n         Acceptance in the form of Exhibit B (with blanks  appropriately  filled<br \/>\n         in)  delivered  to the  Agent in  connection  with an  assignment  of a<br \/>\n         Lender&#8217;s interest under this Agreement pursuant to Section 11.1.<\/p>\n<p>                  &#8220;Authorized   Representative&#8221;   means  any  of  the  Executive<br \/>\n         Officers of the Borrower or, with  respect to  financial  matters,  the<br \/>\n         Treasurer or the chief financial officer of the Borrower,  or any other<br \/>\n         Person  expressly  designated by the Board of Directors of the Borrower<br \/>\n         (or the appropriate committee thereof) as an Authorized  Representative<br \/>\n         of the Borrower, as set forth from time to time in a certificate in the<br \/>\n         form of Exhibit C.<\/p>\n<p>                  &#8220;Base Rate&#8221; means the per annum rate of interest  equal to the<br \/>\n         greater of (i) the Prime Rate or (ii) the Federal Funds  Effective Rate<br \/>\n         plus  one-half  of one  percent  (1\/2%).  Any  change  in the Base Rate<br \/>\n         resulting  from a  change  in the  Prime  Rate  or  the  Federal  Funds<br \/>\n         Effective Rate shall become  effective as of 12:01 A.M. of the Business<br \/>\n         Day on which each such change occurs. The Base Rate is a reference rate<br \/>\n         used by the Agent in determining interest rates on certain loans and is<br \/>\n         not intended to be the lowest rate of interest charged on any extension<br \/>\n         of credit to any debtor.<\/p>\n<p>                                        5<\/p>\n<p>                  &#8220;Base Rate Loan&#8221;  means a Loan for which the rate of  interest<br \/>\n         is determined by reference to the Base Rate.<\/p>\n<p>                  &#8220;Base Rate  Segment&#8221;  means a Segment  bearing  interest or to<br \/>\n         bear interest at the Base Rate.<\/p>\n<p>                  &#8220;Base  Rate  Refunding   Loan&#8221;  means  an  Advance  under  the<br \/>\n         Revolving  Credit  Facility which bears interest at a Base Rate made to<br \/>\n         satisfy Reimbursement Obligations arising from a drawing under a Letter<br \/>\n         of Credit.<\/p>\n<p>                  &#8220;Board&#8221;  means the Board of Governors  of the Federal  Reserve<br \/>\n         System (or any successor body).<\/p>\n<p>                  &#8220;Borrowing Notice&#8221; means the notice delivered by an Authorized<br \/>\n         Representative in connection with an Advance under the Revolving Credit<br \/>\n         Facility or Line of Credit Facility, in the form of Exhibit D.<\/p>\n<p>                  &#8220;Business  Day&#8221; means,  (i) except in the case of a Eurodollar<br \/>\n         Loan,  any day which is not a Saturday,  Sunday or a day on which banks<br \/>\n         in the  States  of New  York  and  North  Carolina  are  authorized  or<br \/>\n         obligated by law,  executive order or governmental  decree to be closed<br \/>\n         and, (ii) with respect to any Eurodollar  Rate Loan, any day which is a<br \/>\n         Business   Day,  as  described   above,   and  on  which  the  relevant<br \/>\n         international  financial  markets  are  open  for  the  transaction  of<br \/>\n         business  contemplated by this Agreement in London,  England, New York,<br \/>\n         New York and Charlotte, North Carolina.<\/p>\n<p>                  &#8220;Capital Leases&#8221; means all leases which have been or should be<br \/>\n         capitalized  in  accordance  with GAAP as in  effect  from time to time<br \/>\n         including Statement No. 13 of the Financial  Accounting Standards Board<br \/>\n         and any successor thereof.<\/p>\n<p>                  &#8220;Capital Stock&#8221; of any Person means any and all shares, rights<br \/>\n         to   purchase,   warrants  or  options   (whether   or  not   currently<br \/>\n         exercisable),  participation  or other  equivalents  of or  interest in<br \/>\n         (however  designated) the equity (including  without  limitation common<br \/>\n         stock,  preferred stock and partnership and joint venture interests) of<br \/>\n         such Person  (excluding any debt securities that are convertible  into,<br \/>\n         or exchangeable for, such equity).<\/p>\n<p>                  &#8220;Change of Control&#8221; means, at any time:<\/p>\n<p>                     (i) any  &#8220;person&#8221;  or  &#8220;group&#8221;  (each  as used in  Sections<br \/>\n                  13(d)(3) and 14(d)(2) of the Exchange  Act), who are not as of<br \/>\n                  the Closing  Date  owners of one  percent  (1%) or more of the<br \/>\n                  Voting  Stock  of  the   Borrower,   either  (A)  becomes  the<br \/>\n                  &#8220;beneficial  owner&#8221; (as defined in Rule 13d-3 of the  Exchange<br \/>\n                  Act), directly or indirectly,  of Voting Stock of the Borrower<br \/>\n                  (or securities convertible into or<\/p>\n<p>                                        6<\/p>\n<p>                  exchangeable  for such Voting Stock)  representing 15% or more<br \/>\n                  of the  combined  voting  power  of all  Voting  Stock  of the<br \/>\n                  Borrower (on a fully  diluted  basis) or (B) otherwise has the<br \/>\n                  ability,  directly or  indirectly,  to elect a majority of the<br \/>\n                  board of directors of the Borrower;<\/p>\n<p>                     (ii)  during  any  period of up to 24  consecutive  months,<br \/>\n                  commencing  on  the  Closing  Date,  individuals  who  at  the<br \/>\n                  beginning of such period were  directors of the Borrower shall<br \/>\n                  cease for any  reason  (other  than the death,  disability  or<br \/>\n                  retirement  of an officer of the Borrower that is serving as a<br \/>\n                  director  at  such  time so long  as  another  officer  of the<br \/>\n                  Borrower  replaces  such Person as a director) to constitute a<br \/>\n                  majority of the board of directors of the Borrower; or<\/p>\n<p>                     (iii) any Person or two or more  Persons  acting in concert<br \/>\n                  shall have  acquired by contract or  otherwise,  or shall have<br \/>\n                  entered into a contract or arrangement that, upon consummation<br \/>\n                  thereof, will result in its or their acquisition, of the power<br \/>\n                  to exercise,  directly or indirectly,  a controlling influence<br \/>\n                  on the management or policies of the Borrower.<\/p>\n<p>                  &#8220;Closing  Date&#8221; means the date as of which this  Agreement  is<br \/>\n         executed  by the  Borrower,  the Lenders and the Agent and on which the<br \/>\n         conditions set forth in Section 5.1 have been satisfied.<\/p>\n<p>                  &#8220;Code&#8221;  means the Internal  Revenue Code of 1986,  as amended,<br \/>\n         and any regulations promulgated thereunder.<\/p>\n<p>                  &#8220;Commitment&#8221;  shall mean, as to each Lender, the obligation of<br \/>\n         such  Lender to make  Loans  pursuant  to Section  2.1 in an  aggregate<br \/>\n         amount at any one time  outstanding  up to but not exceeding the amount<br \/>\n         set opposite such Lender&#8217;s name on the signature pages hereof under the<br \/>\n         caption &#8220;Commitment&#8221; (as the same may be limited or reduced at any time<br \/>\n         or from  time to time  pursuant  to  Section  2.8);  provided  that the<br \/>\n         Commitment  of each Lender  shall be  increased or decreased to reflect<br \/>\n         any  assignments  to or by such  Lender  effected  in  accordance  with<br \/>\n         Section 11.1.<\/p>\n<p>                  &#8220;Common  Stock&#8221;  means the  common  stock,  par value $.01 per<br \/>\n         share, of the Borrower.<\/p>\n<p>                  &#8220;Competitive Bid Borrowing&#8221; shall have the meaning assigned to<br \/>\n         such term in Section 2.2(b).<\/p>\n<p>                  &#8220;Competitive  Bid Loans&#8221; shall mean the Loans  provided for by<br \/>\n         Section 2.2.<\/p>\n<p>                                        7<\/p>\n<p>                  &#8220;Competitive  Bid  Notes&#8221;  shall  mean  the  promissory  notes<br \/>\n         provided for by Section 2.6(c)  substantially  in the form of Exhibit E<br \/>\n         and  all  promissory   notes  delivered  in  substitution  or  exchange<br \/>\n         therefor,  in each case as the same shall be modified and  supplemented<br \/>\n         and in effect from time to time.<\/p>\n<p>                  &#8220;Competitive Bid Quote&#8221; shall mean an offer in accordance with<br \/>\n         Section  2.2(c)  by a Lender  to make a  Competitive  Bid Loan with one<br \/>\n         single specified interest rate.<\/p>\n<p>                  &#8220;Competitive   Bid  Quote  Request&#8221;  shall  have  the  meaning<br \/>\n         assigned to such term in Section 2.2(b).<\/p>\n<p>                  &#8220;Compliance  Certificate&#8221; shall have the meaning attributed to<br \/>\n         that term in Section 7.1(c).<\/p>\n<p>                  &#8220;Consistent  Basis&#8221; in  reference to the  application  of GAAP<br \/>\n         means the accounting  principles observed in the period referred to are<br \/>\n         comparable in all material respects to those applied in the preparation<br \/>\n         of the audited  financial  statements  of the  Borrower  referred to in<br \/>\n         Section 6.6(a).<\/p>\n<p>                  &#8220;Consolidated  Amortization  Expense&#8221; of the  Borrower for any<br \/>\n         period  means  the  amortization   expense  of  the  Borrower  and  its<br \/>\n         Consolidated  Entities  for such period (to the extent  included in the<br \/>\n         computation of Consolidated  Net Income),  determined on a consolidated<br \/>\n         basis in accordance with GAAP.<\/p>\n<p>                  &#8220;Consolidated  Depreciation Expense&#8221; of the Borrower means the<br \/>\n         depreciation expense of the Borrower and its Consolidated  Entities for<br \/>\n         such period (to the extent  included in the computation of Consolidated<br \/>\n         Net Income of the  Borrower),  determined  on a  consolidated  basis in<br \/>\n         accordance with GAAP.<\/p>\n<p>                  &#8220;Consolidated  EBITDA&#8221; means, with respect to the Borrower and<br \/>\n         its  Consolidated  Entities for any  Four-Quarter  Period ending on the<br \/>\n         date of  computation  thereof,  the sum of,  without  duplication,  (i)<br \/>\n         Consolidated Net Income,  (ii)  Consolidated  Interest  Expense,  (iii)<br \/>\n         Consolidated  Income  Tax  Expense,   (iv)  Consolidated   Amortization<br \/>\n         Expense,  (v) Consolidated  Depreciation  Expense and (vi) the minority<br \/>\n         interest  of any  Person  or  Persons  in  Consolidated  Entities,  all<br \/>\n         determined on a consolidated basis in accordance with GAAP applied on a<br \/>\n         Consistent Basis.<\/p>\n<p>                  &#8220;Consolidated  Entity&#8221;  shall mean any Person whose  financial<br \/>\n         statements are appropriately consolidated with the Borrower&#8217;s financial<br \/>\n         statements under GAAP.<\/p>\n<p>                  &#8220;Consolidated  Indebtedness&#8221;  means  all  Indebtedness  of the<br \/>\n         Borrower  and  its   Consolidated   Entities,   all   determined  on  a<br \/>\n         consolidated basis.<\/p>\n<p>                                        8<\/p>\n<p>                  &#8220;Consolidated  Interest  Expense&#8221;  means,  with respect to any<br \/>\n         Four-Quarter  Period  ending on the date of  computation  thereof,  the<br \/>\n         gross interest expense of the Borrower and its  Consolidated  Entities,<br \/>\n         including without  limitation (i) the current amortized portion of debt<br \/>\n         discounts to the extent  included in gross interest  expense,  (ii) the<br \/>\n         current  amortized  portion  of all fees  (including  fees  payable  in<br \/>\n         respect of any Rate Hedging  Obligation) payable in connection with the<br \/>\n         incurrence of  Indebtedness  to the extent  included in gross  interest<br \/>\n         expense,  (iii) the portion of any  payments  made in  connection  with<br \/>\n         Capital Leases allocable to interest expense,  and (iv) lease payments,<br \/>\n         other  than  the  Headquarters   Obligations,   made  pursuant  to  the<br \/>\n         Headquarters   Lease,  all  determined  on  a  consolidated   basis  in<br \/>\n         accordance with GAAP applied on a Consistent Basis.<\/p>\n<p>                  &#8220;Consolidated Net Income&#8221; of the Borrower for any period means<br \/>\n         the net income (or loss) of the Borrower and its Consolidated  Entities<br \/>\n         for such period  determined on a consolidated  basis in accordance with<br \/>\n         GAAP,  without  giving  effect to  dividends on any series of preferred<br \/>\n         stock of any Consolidated Entity, whether or not in cash, to the extent<br \/>\n         such  consolidated net income was reduced thereby;  provided that there<br \/>\n         shall be excluded  from such net income (for all  purposes,  other than<br \/>\n         compliance  with  Section  8.1(a),  to the  extent  otherwise  included<br \/>\n         therein), without duplication,  (i) the net income of any Person (other<br \/>\n         than a Consolidated  Entity) to the extent that any such income has not<br \/>\n         actually been received by the Borrower or a Consolidated  Entity in the<br \/>\n         form of dividends  or similar  distributions  during such  period,  but<br \/>\n         including,  in any  event,  net  income  of any  Person  who  becomes a<br \/>\n         Consolidated Entity whose Acquisition is accounted for on a &#8220;pooling of<br \/>\n         interests&#8221;   basis;  (ii)  except  to  the  extent  includable  in  the<br \/>\n         consolidated  net  income  of the  Borrower  or a  Consolidated  Entity<br \/>\n         pursuant to the foregoing clause (i), the net income of any Person that<br \/>\n         accrued prior to the date that (a) such Person  becomes a  Consolidated<br \/>\n         Entity or is merged into or consolidated with a Consolidated  Entity or<br \/>\n         (b) the  assets  of such  Person  are  acquired  by the  Borrower  or a<br \/>\n         Consolidated Entity; (iii) the net income of any Consolidated Entity to<br \/>\n         the extent  that the  declaration  or payment of  dividends  or similar<br \/>\n         distributions  by  such  Consolidated  Entity  of  that  income  is not<br \/>\n         permitted by  operation  of the terms of its charter or any  agreement,<br \/>\n         instrument,  judgment,  decree,  order,  statute,  rule or governmental<br \/>\n         regulation  applicable to that Consolidated  Entity during such period;<br \/>\n         (iv) any gain (or loss), together with any related provisions for taxes<br \/>\n         on any such gain,  realized  during such period by the  Borrower or its<br \/>\n         Consolidated  Entities upon (a) the acquisition of any  securities,  or<br \/>\n         the  extinguishment  of  any  Indebtedness,  of  the  Borrower  or  its<br \/>\n         Consolidated  Entities or (b) any asset sale by the referent  person or<br \/>\n         any of its Subsidiaries; (v) any extraordinary gain (or<\/p>\n<p>                                        9<\/p>\n<p>         extraordinary  loss),  together with any related provision for taxes or<br \/>\n         tax  benefit  resulting  from  any  such  extraordinary  gain or  loss,<br \/>\n         realized  by the  Borrower  or its  Consolidated  Entities  during such<br \/>\n         period;  and  (vi)  in  the  case  of a  successor  to  any  Person  by<br \/>\n         consolidation,  merger or transfer of its assets,  any  earnings of the<br \/>\n         successor  prior to such merger,  consolidation  or transfer of assets;<br \/>\n         provided,  further,  however,  that  there  shall be added  back to net<br \/>\n         income  non-recurring,  non-cash  expenses and cash  transaction  costs<br \/>\n         relating  to   professional   fees  arising  in  conjunction   with  an<br \/>\n         Acquisition  provided  such  expenses  do not exceed 10% of the Cost of<br \/>\n         Acquisition.<\/p>\n<p>                  &#8220;Consolidated  Net Worth&#8221; of the Borrower as of any date means<br \/>\n         the Consolidated  Stockholders&#8217;  Equity  (including any preferred stock<br \/>\n         that is classified as equity under GAAP, other than Disqualified Stock)<br \/>\n         of the Borrower and its  Consolidated  Entities  (excluding  any equity<br \/>\n         adjustment for foreign currency  translation for any period  subsequent<br \/>\n         to  the  Closing  Date)  on a  consolidated  basis  at  such  date,  as<br \/>\n         determined in accordance  with GAAP,  less all write-ups  subsequent to<br \/>\n         the Closing  Date in the book value of any asset owned by the  Borrower<br \/>\n         or any of its Consolidated Entities.<\/p>\n<p>                  &#8220;Consolidated  Stockholders&#8217; Equity&#8221; shall mean at any time as<br \/>\n         at  which  the  amount  thereof  is to be  determined,  the  sum of the<br \/>\n         following  amounts  in  respect of the  Borrower  and the  Consolidated<br \/>\n         Entities:  (i) the par or  stated  value  of all  Capital  Stock of the<br \/>\n         Borrower,  (ii) retained  earnings,  (iii)  additional paid in capital,<br \/>\n         (iv) capital surplus and (v) earned surplus minus treasury stock.<\/p>\n<p>                  &#8220;Consolidated  Tangible  Net Worth&#8221;  means,  as of any date on<br \/>\n         which  the   amount   thereof   is  to  be   determined,   Consolidated<br \/>\n         Stockholders&#8217;  Equity  minus  (without  duplication  of  deductions  in<br \/>\n         respect of items  already  deducted in arriving at surplus and retained<br \/>\n         earnings)  (i)  all  reserves  (other  than  contingency  reserves  not<br \/>\n         allocated to any  particular  purpose),  including  without  limitation<br \/>\n         reserves  for  depreciation,  depletion,  amortization,   obsolescence,<br \/>\n         deferred income taxes,  insurance and inventory  valuation and (ii) the<br \/>\n         net book value of all  assets  which  would be  treated  as  intangible<br \/>\n         assets, such as (without limitation) goodwill (whether representing the<br \/>\n         excess of cost  over  book  value of  assets  acquired  or  otherwise),<br \/>\n         capitalized   expenses,   unamortized   debt   discount   and  expense,<br \/>\n         consignment  inventory  rights,  patents,   trademarks,   trade  names,<br \/>\n         copyrights,   franchises   and   licenses,   all  as  determined  on  a<br \/>\n         consolidated  basis in  accordance  with GAAP  applied on a  Consistent<br \/>\n         Basis.<\/p>\n<p>                  &#8220;Consolidated Total Assets&#8221; means, as of any date on which the<br \/>\n         amount thereof is to be determined, the net book value of all assets of<br \/>\n         the Borrower and its Consolidated<\/p>\n<p>                                       10<\/p>\n<p>         Entities as determined on a consolidated  basis in accordance with GAAP<br \/>\n         applied on a Consistent Basis.<\/p>\n<p>                  &#8220;Consolidated  Total Capital&#8221;  means,  as of any date on which<br \/>\n         the  amount  thereof  is to be  determined,  the  sum  of  Consolidated<br \/>\n         Indebtedness plus Consolidated Shareholders&#8217; Equity of the Borrower and<br \/>\n         its Consolidated Entities.<\/p>\n<p>                  &#8220;Contract Provider&#8221; means any Person who provides professional<br \/>\n         health  care  services  under  or  pursuant  to any  contract  with the<br \/>\n         Borrower or any Subsidiary.<\/p>\n<p>                  &#8220;Controlled  Partnership&#8221; shall mean a general  partnership of<br \/>\n         which  the  Borrower  or a  Subsidiary  is a general  partner  (but not<br \/>\n         including  Alabama  World  Football),  or a limited  partnership  whose<br \/>\n         general  partners  include  the  Borrower  or  a  Subsidiary  (but  not<br \/>\n         including  Vanderbilt),  or a limited  liability  company whose members<br \/>\n         include the Borrower or a Subsidiary or another Controlled Partnership,<br \/>\n         which  partnership,  whether general or limited,  or limited  liability<br \/>\n         company  has  assets  with a value in  excess  of  $2,000.00,  and with<br \/>\n         respect to which  partnership or limited liability company the Borrower<br \/>\n         or a  Subsidiary  is  entitled  to  receive  not  less  than 50% of any<br \/>\n         distributions  of cash made to the partners or members  thereof,  other<br \/>\n         than any preferred  cash  distribution  arrangement in existence at the<br \/>\n         Closing Date or approved by the Required  Lenders in writing,  or which<br \/>\n         is otherwise a Consolidated Entity.<\/p>\n<p>                  &#8220;Cost of Acquisition&#8221;  means,  in respect of any  Acquisition,<br \/>\n         the  sum of (i)  the  amount  of  cash  paid  by the  Borrower  and its<br \/>\n         Consolidated  Entities in connection  with such  Acquisition,  (ii) the<br \/>\n         Fair Market Value of all Capital Stock or other ownership  interests of<br \/>\n         the Borrower or any  Consolidated  Entity issued or given in connection<br \/>\n         with such Acquisition,  (iii) the amount  (determined by using the face<br \/>\n         amount or the amount payable at maturity,  whichever is greater) of all<br \/>\n         Indebtedness  incurred,  assumed or  acquired in  connection  with such<br \/>\n         Acquisition,  (iv) all additional purchase price amounts in the form of<br \/>\n         earnouts and other  contingent  obligations  that should be recorded on<br \/>\n         the financial statements of the Borrower and its Consolidated  Entities<br \/>\n         in connection with Generally Accepted  Accounting  Principles,  (v) all<br \/>\n         amounts  paid  in  respect  of  covenants  not to  compete,  consulting<br \/>\n         agreements  and other  affiliated  contracts  in  connection  with such<br \/>\n         Acquisition  and (vi) the  aggregate  fair  market  value of all  other<br \/>\n         consideration  given by the Borrower and its  Consolidated  Entities in<br \/>\n         connection with such Acquisition.<\/p>\n<p>                                       11<\/p>\n<p>                  &#8220;Default&#8221; means any event or condition which,  with the giving<br \/>\n         or  receipt  of notice or lapse of time or both,  would  constitute  an<br \/>\n         Event of Default.<\/p>\n<p>                  &#8220;Default Rate&#8221; means (i) with respect to each  Eurodollar Rate<br \/>\n         Loan and Eurodollar Rate Segment,  until the end of the Interest Period<br \/>\n         applicable thereto, a rate of two percent (2%) plus the Eurodollar Rate<br \/>\n         applicable  to  such  Loan  or  Segment,  and  thereafter  at a rate of<br \/>\n         interest  per annum which shall be two percent (2%) plus the Base Rate,<br \/>\n         (ii) with respect to Base Rate Loans and Base Rate Segments,  at a rate<br \/>\n         of interest  per annum  which  shall be two percent  (2%) plus the Base<br \/>\n         Rate and (iii) in any case,  the maximum rate  permitted by  applicable<br \/>\n         law, if lower.<\/p>\n<p>                  &#8220;Disqualified  Stock&#8221;  means any Capital  Stock  that,  by its<br \/>\n         terms (or by the terms of any security into which it is  convertible or<br \/>\n         for which it is  exchangeable),  or upon the  happening  of any  event,<br \/>\n         matures  or is  mandatorily  redeemable,  pursuant  to a  sinking  fund<br \/>\n         obligation or  otherwise,  or is redeemable at the option of the holder<br \/>\n         thereof,  in  whole or in part,  on or  prior to the  Revolving  Credit<br \/>\n         Termination Date.<\/p>\n<p>                  &#8220;Dollars&#8221; and the symbol &#8220;$&#8221; mean dollars  constituting  legal<br \/>\n         tender for the payment of public and private debts in the United States<br \/>\n         of America.<\/p>\n<p>                  &#8220;Employee Benefit Plan&#8221; means any employee benefit plan within<br \/>\n         the  meaning  of  Section  3(3) of ERISA  which (i) is  maintained  for<br \/>\n         employees of the Borrower or any of its ERISA  Affiliates or is assumed<br \/>\n         by the Borrower or any of its ERISA  Affiliates in connection  with any<br \/>\n         Acquisition  or (ii) has at any time been  maintained for the employees<br \/>\n         of the Borrower or any current or former ERISA Affiliate.<\/p>\n<p>                  &#8220;Environmental  Laws&#8221; means,  collectively,  the Comprehensive<br \/>\n         Environmental  Response,  Compensation  and  Liability  Act of 1980, as<br \/>\n         amended,  the Superfund Amendments and Reauthorization Act of 1986, the<br \/>\n         Resource   Conservation  and  Recovery  Act,  as  amended,   the  Toxic<br \/>\n         Substances Control Act, as amended,  the Clean Air Act, as amended, the<br \/>\n         Clean Water Act, as amended,  any other  &#8220;Superfund&#8221; or &#8220;Superlien&#8221; law<br \/>\n         or any  other  federal,  or  applicable  state or local  statute,  law,<br \/>\n         ordinance, code, rule, regulation, order or decree regulating, relating<br \/>\n         to, or imposing  liability  or  standards  of conduct  concerning,  any<br \/>\n         Hazardous Material.<\/p>\n<p>              &#8220;ERISA&#8221; means the Employee Retirement Income Security Act of 1974,<br \/>\n         as amended from time to time,  and any successor  statute and all rules<br \/>\n         and regulations promulgated thereunder.<\/p>\n<p>                  &#8220;ERISA  Affiliate&#8221;,  as  applied  to the  Borrower,  means any<br \/>\n         Person or trade or business which is a member of a group which<\/p>\n<p>                                       12<\/p>\n<p>         is under  common  control  with the  Borrower,  who  together  with the<br \/>\n         Borrower, is treated as a single employer within the meaning of Section<br \/>\n         414(b) and (c) of the Code.<\/p>\n<p>                  &#8220;Eurodollar  Auction&#8221; shall mean a solicitation of Competitive<br \/>\n         Bid Quotes  setting  forth  Eurodollar  Margins  based on the Interbank<br \/>\n         Offered Rate pursuant to Section 2.2.<\/p>\n<p>                  &#8220;Eurodollar  Margin&#8221;  shall have the meaning  assigned to such<br \/>\n         term in Section 2.2(c)(ii)(C).<\/p>\n<p>                  &#8220;Eurodollar  Market  Loans&#8221; shall mean  Competitive  Bid Loans<br \/>\n         interest  rates on  which  are  determined  on the  basis of  Interbank<br \/>\n         Offered Rate pursuant to a Eurodollar Auction.<\/p>\n<p>                  &#8220;Eurodollar Rate&#8221; means the interest rate per annum calculated<br \/>\n         according to the following formula:<\/p>\n<p>         Eurodollar =        Interbank Offered Rate        +    Applicable<br \/>\n                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n            Rate       1- Eurodollar Reserve Percentage      Margin<\/p>\n<p>                  &#8220;Eurodollar  Rate Loan&#8221;  means a Loan or Segment of a Loan for<br \/>\n         which the rate of interest is determined by reference to the Eurodollar<br \/>\n         Rate.<\/p>\n<p>                  &#8220;Eurodollar  Rate Segment&#8221; means a Segment bearing interest or<br \/>\n         to bear interest at the Eurodollar Rate.<\/p>\n<p>                  &#8220;Eurodollar  Reserve  Percentage&#8221;  means,  for any  day,  that<br \/>\n         percentage  (expressed  as a decimal)  which is in effect  from time to<br \/>\n         time under  Regulation D or any  successor  regulation,  as the maximum<br \/>\n         reserve  requirement  (including  any basic,  supplemental,  emergency,<br \/>\n         special, or marginal reserves)  applicable with respect to Eurocurrency<br \/>\n         liabilities  as that term is defined in  Regulation  D (or  against any<br \/>\n         other  category of liabilities  that includes  deposits by reference to<br \/>\n         which  the  interest  rate on  Eurodollar  Rate  Loans is  determined),<br \/>\n         whether or not the Agent or any Lender has any Eurocurrency liabilities<br \/>\n         subject to such requirements, without benefits of credits or proration,<br \/>\n         exceptions  or offsets that may be  available  from time to time to the<br \/>\n         Agent  or  any   Lender.   The   Eurodollar   Rate  shall  be  adjusted<br \/>\n         automatically  on and as of the  effective  date of any  change  in the<br \/>\n         Eurodollar Reserve Percentage.<\/p>\n<p>                  &#8220;Event of Default&#8221; means any of the  occurrences  set forth as<br \/>\n         such in Section 9.1.<\/p>\n<p>                  &#8220;Exchange Act&#8221; means the  Securities  Exchange Act of 1934, as<br \/>\n         amended, and the regulations promulgated thereunder.<\/p>\n<p>                  &#8220;Executive  Officer&#8221;  means any  Person  who from time to time<br \/>\n         holds the offices with Borrower listed on Exhibit N.<\/p>\n<p>                                       13<\/p>\n<p>                  &#8220;Facility&#8221;    shall   mean   an   inpatient   or    outpatient<br \/>\n         rehabilitation facility,  certified outpatient rehabilitation facility,<br \/>\n         skilled  nursing   facility,   specialty   medical  center,   specialty<br \/>\n         orthopedic   hospital  or  acute  care  hospital,   subacute  inpatient<br \/>\n         facility,   transitional   living  center,   medical  office  building,<br \/>\n         outpatient  surgery  center or  outpatient  diagnostic  center with all<br \/>\n         buildings  and  improvements  associated  therewith,  that is  owned or<br \/>\n         leased,  in whole or  part,  by the  Borrower  or a  Subsidiary  or any<br \/>\n         partnership controlled directly or indirectly by the Borrower.<\/p>\n<p>                  &#8220;Facility  Termination  Date&#8221; means the date on which both the<br \/>\n         Revolving Credit  Termination  Date and the Line of Credit  Termination<br \/>\n         Date shall have occurred, no Letters of Credit shall remain outstanding<br \/>\n         and the Borrower  shall have fully,  finally and  irrevocably  paid and<br \/>\n         satisfied all Obligations.<\/p>\n<p>                  &#8220;Fair Market  Value&#8221;  shall mean,  with respect to any capital<br \/>\n         stock or other ownership  interests  issued or given by the Borrower or<br \/>\n         any Consolidated  Entity in connection with an Acquisition,  (i) in the<br \/>\n         case of capital  stock that is Common  Stock and such  Common  Stock is<br \/>\n         then  designated as a national  market system  security by the National<br \/>\n         Association  of  Securities  Dealers,  Inc.  (&#8220;NASD&#8221;) or is listed on a<br \/>\n         national securities exchange,  the average of the last reported bid and<br \/>\n         ask  quotations  or prices  reported  thereon for Common  Stock or such<br \/>\n         other  value as may be  ascribed  to the Common  Stock in a  definitive<br \/>\n         merger or  acquisition  agreement  provided  such  value is  determined<br \/>\n         according to customary  methods for like  transactions  and is approved<br \/>\n         (to the  extent  required  by  Borrower&#8217;s  charter  or  bylaws)  by the<br \/>\n         Borrower&#8217;s Board of Directors or (ii) in the case of capital stock that<br \/>\n         is not  Common  Stock  or in the  event  that  Common  Stock  is not so<br \/>\n         designated by NASD or listed on such national exchange,  or in the case<br \/>\n         of any other ownership interests,  the determination of the fair market<br \/>\n         value thereof in good faith by a majority of  disinterested  members of<br \/>\n         the board of directors of the Borrower or such Consolidated  Entity, in<br \/>\n         each case  effective  as of the close of business on the  Business  Day<br \/>\n         immediately preceding the closing date of such Acquisition.<\/p>\n<p>                  &#8220;Federal Funds  Effective  Rate&#8221; means,  for any day, the rate<br \/>\n         per annum  (rounded  upward to the nearest  1\/100th of 1%) equal to the<br \/>\n         weighted average of the rates on overnight  Federal funds  transactions<br \/>\n         with members of the Federal  Reserve  System  arranged by Federal funds<br \/>\n         brokers on such day, as  published  by the Federal  Reserve Bank of New<br \/>\n         York on the Business Day next succeeding such day, provided that (a) if<br \/>\n         such day is not a Business  Day, the Federal Funds  Effective  Rate for<br \/>\n         such day shall be such rate on such  transactions on the next preceding<br \/>\n         Business  Day,  and (b) if no such  rate is so  published  on such next<br \/>\n         succeeding  Business Day, the Federal Funds Effective Rate for such day<br \/>\n         shall be the average rate<\/p>\n<p>                                       14<\/p>\n<p>         quoted to the Agent on such day on such  transaction  as  determined by<br \/>\n         the Agent.<\/p>\n<p>                  &#8220;Fiscal  Year&#8221;  means the twelve  month  fiscal  period of the<br \/>\n         Borrower  commencing  on January 1 of each  calendar year and ending on<br \/>\n         December 31 of each calendar year.<\/p>\n<p>                  &#8220;Fixed  Rate&#8221; shall mean the  Absolute  Rate or the  Interbank<br \/>\n         Offered Rate plus the Applicable  Margin or the Eurodollar  Margin,  as<br \/>\n         the case may be.<\/p>\n<p>                  &#8220;Fixed  Rate Loan&#8221; means a Loan for which the rate of interest<br \/>\n         is determined by reference to the Fixed Rate.<\/p>\n<p>                  &#8220;Fixed  Rate  Segment&#8221;  shall  mean a Segment to which a Fixed<br \/>\n         Rate is (or is proposed to be) applicable.<\/p>\n<p>                  &#8220;Four-Quarter  Period&#8221; means a period of four full consecutive<br \/>\n         fiscal quarters of the Borrower and its Subsidiaries, taken together as<br \/>\n         one  accounting  period;  provided,   however,  for  purposes  of  this<br \/>\n         Agreement,  for  periods  prior to  December  31,  1996 the  results of<br \/>\n         operations  shall be determined for the  Four-Quarter  Period ending on<br \/>\n         the  last  day  of (i)  the  first  quarter  of  Fiscal  Year  1996  by<br \/>\n         multiplying  the results of  operations  for the first  quarter by four<br \/>\n         (4),  (ii) the second  quarter of Fiscal Year 1996 by  multiplying  the<br \/>\n         results of operations for the first and second quarters by two (2), and<br \/>\n         (iii) for the third  quarter  of Fiscal  Year 1996 by  multiplying  the<br \/>\n         results  of  operations  of the  sum of the  first,  second  and  third<br \/>\n         quarters by four-thirds (4\/3&#8217;s).<\/p>\n<p>                  &#8220;GAAP&#8221; or &#8220;Generally  Accepted  Accounting  Principles&#8221;  means<br \/>\n         generally  accepted  accounting  principles,  being those principles of<br \/>\n         accounting  set forth in  pronouncements  of the  Financial  Accounting<br \/>\n         Standards  Board  or  the  American   Institute  of  Certified   Public<br \/>\n         Accountants or which have other substantial  authoritative  support and<br \/>\n         are applicable in the circumstances as of the date of a report.<\/p>\n<p>                  &#8220;Governmental   Authority&#8221;  shall  mean  any  Federal,  state,<br \/>\n         municipal,  national  or  other  governmental  department,  commission,<br \/>\n         board,   bureau,   court,   agency  or   instrumentality  or  political<br \/>\n         subdivision  thereof  or any entity or  officer  exercising  executive,<br \/>\n         legislative,  judicial,  regulatory or  administrative  functions of or<br \/>\n         pertaining  to any  government  or any  court,  in  each  case  whether<br \/>\n         associated with a state of the United States,  the United States,  or a<br \/>\n         foreign entity or government.<\/p>\n<p>                  &#8220;Guaranteed   Obligations&#8221;   of  any  person  shall  mean  all<br \/>\n         guaranties  (including  guaranties  of  guaranties  and  guaranties  of<br \/>\n         dividends and other monetary  obligations),  endorsements,  assumptions<br \/>\n         and other contingent obligations with respect to,<\/p>\n<p>                                       15<\/p>\n<p>         or to purchase or to otherwise pay or acquire,  Indebtedness of others;<br \/>\n         provided,  however,  that such term shall not include obligations under<br \/>\n         leases  and other  contracts  initially  incurred  directly  by another<br \/>\n         Person and subsequently directly assumed by the Person in question, but<br \/>\n         such  term  shall  include  obligations  that,  if the  same  had  been<br \/>\n         initially  incurred  directly  by the  Person in  question,  would have<br \/>\n         constituted Guaranteed Obligations.<\/p>\n<p>                  &#8220;Hazardous  Material&#8221; means and includes any hazardous,  toxic<br \/>\n         or dangerous waste,  substance or material,  the generation,  handling,<br \/>\n         storage,  disposal,  treatment  or  emission of which is subject to any<br \/>\n         Environmental Law.<\/p>\n<p>                  &#8220;HCFA&#8221;  means  the  United   States   Health  Care   Financing<br \/>\n         Administration and any successor thereto.<\/p>\n<p>                  &#8220;Headquarters   Lease&#8221;  means  the  Lease  Agreement   between<br \/>\n         HEALTHSOUTH Holdings, Inc., as Lessee, and First Security Bank of Utah,<br \/>\n         N.A., as Lessor,  dated as of November 16, 1995 providing for the lease<br \/>\n         to  HEALTHSOUTH  Holdings,  Inc. of the land and  improvements  thereon<br \/>\n         located on the property described therein,  as such Lease Agreement may<br \/>\n         be amended, modified or supplemented from time to time.<\/p>\n<p>                  &#8220;Headquarters  Obligations&#8221;  means all of the Holder  Advances<br \/>\n         and Loans, as each such term is defined in the Participation Agreement.<\/p>\n<p>                  &#8220;Indebtedness&#8221;  of any  Person  at  any  date  means,  without<br \/>\n         duplication:  (i) all  indebtedness  of such Person for borrowed  money<br \/>\n         (whether  or not the  recourse  of the  lender  is to the  whole of the<br \/>\n         assets  of  such  Person  or  only  to a  portion  thereof);  (ii)  all<br \/>\n         obligations  of such Person  evidenced by bonds,  debentures,  notes or<br \/>\n         other  similar  instruments;   (iii)  all  obligations  (contingent  or<br \/>\n         otherwise)  of such  Person in  respect  of  letters of credit or other<br \/>\n         similar   instruments  (or   reimbursement   obligations  with  respect<br \/>\n         thereto);  (iv) all  obligations  of such Person  with  respect to Rate<br \/>\n         Hedging  Obligations  (other than those that fix the  interest  rate on<br \/>\n         variable  rate  indebtedness  otherwise  permitted  hereunder  or  that<br \/>\n         protect the Borrower and or its  Consolidated  Entities against changes<br \/>\n         in foreign exchange  rates);  (v) obligations of such Person to pay the<br \/>\n         deferred  and unpaid  purchase  price of property or  services,  except<br \/>\n         trade payables and accrued expenses  incurred in the ordinary course of<br \/>\n         business;  (vi) all Capitalized Lease Obligations of such Person; (vii)<br \/>\n         all  indebtedness  of others  secured  by a Lien on any  assets of such<br \/>\n         Person,  whether or not such  indebtedness  is assumed by such  Person;<br \/>\n         (viii) all Guaranteed Obligations;  (ix) the Headquarters  Obligations;<br \/>\n         and (x) all  obligations of a like nature to those described in clauses<br \/>\n         (i)  through  (ix) above of a  partnership  of which  such  Person is a<br \/>\n         general partner. The<\/p>\n<p>                                       16<\/p>\n<p>         amount  of  Indebtedness  of  any  Person  at  any  date  shall  be the<br \/>\n         outstanding  balance at such date of all  unconditional  obligations as<br \/>\n         described  above,  the  maximum  liability  of such Person for any such<br \/>\n         contingent  obligations  at such date and, in the case of clause (vii),<br \/>\n         the amount of the Indebtedness secured.<\/p>\n<p>                  &#8220;Interbank Offered Rate&#8221; means, with respect to any Eurodollar<br \/>\n         Rate Loan or Eurodollar Rate Segment or Eurodollar Market Loans for the<br \/>\n         Interest Period applicable thereto,  the average (rounded upward to the<br \/>\n         nearest one-sixteenth (1\/16) of one percent) per annum rate of interest<br \/>\n         determined by the Agent (each such  determination  to be conclusive and<br \/>\n         binding  absent  manifest  error) as of two Business  Days prior to the<br \/>\n         first  day of such  Interest  Period,  as the  effective  rate at which<br \/>\n         deposits in  immediately  available  funds in Dollars  are being,  have<br \/>\n         been,  or would be offered or quoted by the Agent to major banks in the<br \/>\n         applicable  interbank market for Eurodollar deposits at any time during<br \/>\n         the Business Day which is the second Business Day immediately preceding<br \/>\n         the first day of such Interest  Period,  for a term  comparable to such<br \/>\n         Interest  Period  and in the  amount  of such  Eurodollar  Rate Loan or<br \/>\n         Eurodollar Rate Segment or Eurodollar Market Loan. If no such offers or<br \/>\n         quotes are generally available for such amount, then the Agent shall be<br \/>\n         entitled  to  determine  the  Eurodollar  Rate  by  estimating  in  its<br \/>\n         reasonable  judgment the per annum rate (as described above) that would<br \/>\n         be applicable if such quote or offers were generally available.<\/p>\n<p>                  &#8220;Interest Period&#8221; shall mean:<\/p>\n<p>                  (i) with  respect to any  Eurodollar  Rate Loan,  each  period<br \/>\n         commencing on the date such  Eurodollar  Rate Loan is made or converted<br \/>\n         from a Loan of  another  Type or the  last  day of the  next  preceding<br \/>\n         Interest   Period  for  such  Loan  and   ending  on  the   numerically<br \/>\n         corresponding day in the first,  second,  third or sixth calendar month<br \/>\n         thereafter,  as the  Borrower  may select as provided  in Section  2.3,<br \/>\n         except that each  Interest  Period that  commences on the last Business<br \/>\n         Day  of a  calendar  month  (or  on  any  day  for  which  there  is no<br \/>\n         numerically  corresponding day in the appropriate  subsequent  calendar<br \/>\n         month) shall end on the last Business Day of the appropriate subsequent<br \/>\n         calendar month;<\/p>\n<p>                  (ii) with  respect  to any  Absolute  Rate  Loan,  the  period<br \/>\n         commencing  on the date such  Absolute  Rate Loan is made and ending on<br \/>\n         any Business Day up to 180 days thereafter,  as the Borrower may select<br \/>\n         as provided in Section 2.2(b); and<\/p>\n<p>                  (iii) with respect to any  Eurodollar  Market Loan, the period<br \/>\n         commencing on the date such  Eurodollar  Market Loan is made and ending<br \/>\n         on the numerically  corresponding  day in the first,  second,  third or<br \/>\n         sixth calendar month thereafter, as<\/p>\n<p>                                       17<\/p>\n<p>         the Borrower may select as provided in Section 2.2(b), except that each<br \/>\n         Interest  Period that  commences on the last Business Day of a calendar<br \/>\n         month (or any day for which there is no numerically  corresponding  day<br \/>\n         in the  appropriate  subsequent  calendar  month) shall end on the last<br \/>\n         Business Day of the appropriate subsequent calendar month.<\/p>\n<p>         Notwithstanding  the  foregoing:  (i) if any  Interest  Period  for any<br \/>\n         Competitive  Bid Loan would  otherwise end after the  Revolving  Credit<br \/>\n         Termination  Date,  such  Interest  Period  shall end on the  Revolving<br \/>\n         Credit Termination Date; (ii) if any Interest Period for any Eurodollar<br \/>\n         Rate Loan would  otherwise end after the Revolving  Credit  Termination<br \/>\n         Date or Line of Credit Termination Date, such Interest Period shall end<br \/>\n         on the Revolving Credit  Termination Date or Line of Credit Termination<br \/>\n         Date, respectively; (iii) each Interest Period that would otherwise end<br \/>\n         on a day which is not a Business  Day shall end on the next  succeeding<br \/>\n         Business  Day (or, in the case of an Interest  Period for a  Eurodollar<br \/>\n         Rate Loan or a Eurodollar Market Loan, if such next succeeding Business<br \/>\n         Day falls in the next succeeding  calendar month, on the next preceding<br \/>\n         Business  Day);  and (iv)  notwithstanding  clauses (i), (ii) and (iii)<br \/>\n         above,  no Interest  Period for any Loan  (other than an Absolute  Rate<br \/>\n         Loan)  shall have a  duration  of less than one month (in the case of a<br \/>\n         Eurodollar Rate Loan or a Eurodollar  Market Loan) and, if the Interest<br \/>\n         Period for any  Eurodollar  Rate Loan or  Eurodollar  Market Loan would<br \/>\n         otherwise  be a  shorter  period,  such  Loan  shall  not be  available<br \/>\n         hereunder for such period.<\/p>\n<p>                  &#8220;Interest  Rate  Selection  Notice&#8221;  means the written  notice<br \/>\n         delivered  by an  Authorized  Representative  in  connection  with  the<br \/>\n         election of a subsequent  Interest  Period for any Eurodollar Rate Loan<br \/>\n         or Eurodollar  Rate Segment or the  conversion of any  Eurodollar  Rate<br \/>\n         Loan or  Eurodollar  Rate  Segment  into a Base  Rate Loan or Base Rate<br \/>\n         Segment or the  conversion  of any Base Rate Loan or Base Rate  Segment<br \/>\n         into a Eurodollar Rate Loan or Eurodollar Rate Segment,  in the form of<br \/>\n         Exhibit F.<\/p>\n<p>                  &#8220;Issuing  Bank&#8221;  means  NationsBank  as issuer of  Letters  of<br \/>\n         Credit under Article III.<\/p>\n<p>                  &#8220;LC Account Agreement&#8221; means the LC Account Agreement dated as<br \/>\n         of the date  hereof  between the  Borrower  and the  Issuing  Bank,  as<br \/>\n         amended, modified or supplemented from time to time.<\/p>\n<p>                  &#8220;Lending Office&#8221; means, as to each Lender and for each Type of<br \/>\n         Loan,  the  Lending  Office of such  Lender  (or an  Affiliate  of such<br \/>\n         Lender)  designated for such Type of Loan on the signature pages hereof<br \/>\n         or in an Assignment  and Acceptance or such other office of such Lender<br \/>\n         (or of an affiliate of<\/p>\n<p>                                       18<\/p>\n<p>         such  Lender)  as such  Lender  may  from  time to time  specify  to an<br \/>\n         Authorized  Representative  and the  Agent as the  office  by which its<br \/>\n         Loans are to be made and maintained.<\/p>\n<p>                  &#8220;Letter of Credit&#8221; means a standby  letter of credit issued by<br \/>\n         the  Issuing  Bank  pursuant  to  Article  III for the  account  of the<br \/>\n         Borrower  in  favor  of  a  Person  advancing  credit  or  securing  an<br \/>\n         obligation on behalf of the Borrower.<\/p>\n<p>                  &#8220;Letter  of Credit  Commitment&#8221;  means,  with  respect to each<br \/>\n         Lender,  the  obligation  of such Lender to acquire  Participations  in<br \/>\n         respect of Letters of Credit  and  Reimbursement  Obligations  up to an<br \/>\n         aggregate  amount at any one time  outstanding  equal to such  Lender&#8217;s<br \/>\n         Applicable   Commitment  Percentage  of  the  Total  Letter  of  Credit<br \/>\n         Commitment as the same may be increased or decreased  from time to time<br \/>\n         pursuant to this Agreement.<\/p>\n<p>                  &#8220;Letter of Credit  Facility&#8221;  means the facility  described in<br \/>\n         Article III  providing  for the  issuance  by the Issuing  Bank for the<br \/>\n         account of the  Borrower  of Letters of Credit in an  aggregate  stated<br \/>\n         amount  at any  time  outstanding  not  exceeding,  together  with  all<br \/>\n         Reimbursement Obligations, the Total Letter of Credit Commitment.<\/p>\n<p>                  &#8220;Letter  of  Credit  Outstandings&#8221;  means,  as of any  date of<br \/>\n         determination, the aggregate amount remaining undrawn under all Letters<br \/>\n         of Credit plus Reimbursement Obligations then outstanding.<\/p>\n<p>                  &#8220;Lien&#8221; means any interest in property  securing any obligation<br \/>\n         owed to, or a claim by, a Person other than the owner of the  property,<br \/>\n         whether such interest is based on the common law,  statute or contract,<br \/>\n         and including but not limited to the lien or security  interest arising<br \/>\n         from a mortgage, encumbrance,  pledge, security agreement,  conditional<br \/>\n         sale or trust receipt or a lease,  consignment or bailment for security<br \/>\n         purposes.  For the  purposes of this  Agreement,  the  Borrower and any<br \/>\n         Subsidiary shall be deemed to be the owner of any property which it has<br \/>\n         acquired or holds subject to a conditional  sale  agreement,  financing<br \/>\n         lease, or other arrangement pursuant to which title to the property has<br \/>\n         been retained by or vested in some other Person for security purposes.<\/p>\n<p>                  &#8220;Line  of  Credit  Commitment&#8221;  means,  with  respect  to each<br \/>\n         Lender,  the  obligation of such Lender to make Line of Credit Loans to<br \/>\n         the Borrower in a principal  amount equal to such  Lender&#8217;s  Applicable<br \/>\n         Commitment Percentage of the Total Line of<br \/>\n         Credit Commitment.<\/p>\n<p>                  &#8220;Line of Credit  Facility&#8221;  means the  facility  described  in<br \/>\n         Section 2.1(b) providing for Line of Credit Loans to the<\/p>\n<p>                                       19<\/p>\n<p>Borrower by the Lenders in the  original  principal  amount of the Total Line of<br \/>\nCredit Commitment.<\/p>\n<p>                  &#8220;Line of Credit  Loan&#8221; means a loan made  pursuant to the Line<br \/>\n         of Credit Facility in accordance with Section 2.1(b).<\/p>\n<p>                  &#8220;Line of Credit Notes&#8221;  means,  collectively,  the  promissory<br \/>\n         notes of the  Borrower  evidencing  Line of Credit  Loans  executed and<br \/>\n         delivered to the Lenders as provided in Section 2.6(b) substantially in<br \/>\n         the form of Exhibit G, with appropriate insertions as to amounts, dates<br \/>\n         and names of Lenders.<\/p>\n<p>                  &#8220;Line  of  Credit  Outstandings&#8221;  means,  as of  any  date  of<br \/>\n         determination,  the aggregate  principal amount of Line of Credit Loans<br \/>\n         then outstanding and all interest accrued thereon.<\/p>\n<p>                  &#8220;Line  of  Credit  Termination  Date&#8221;  means  (i)  the  Stated<br \/>\n         Termination  Date or (ii) such earlier date of  termination of Lenders&#8217;<br \/>\n         obligations  pursuant to Section 9.1 upon the occurrence of an Event of<br \/>\n         Default,  or  (iii)  such  date as the  Borrower  may  voluntarily  and<br \/>\n         permanently terminate the Line of Credit Facility by payment in full of<br \/>\n         all Line of Credit Outstandings.<\/p>\n<p>                  &#8220;Loan&#8221; or &#8220;Loans&#8221; means any Syndicated Loans,  Competitive Bid<br \/>\n         Loans,  Reimbursement Obligations and Letter of Credit Outstandings and<br \/>\n         all extensions and renewals thereof.<\/p>\n<p>                  &#8220;Loan  Documents&#8221;  means this  Agreement,  the  Notes,  the LC<br \/>\n         Account  Agreement,  the  Applications  and  Agreements  for  Letter of<br \/>\n         Credit, and all other instruments and documents heretofore or hereafter<br \/>\n         executed  or  delivered  to or in favor of any  Lender  or the Agent in<br \/>\n         connection   with  the  Loans  made,   Letters  of  Credit  issued  and<br \/>\n         transactions  contemplated  under  this  Agreement,  as the same may be<br \/>\n         amended, supplemented or replaced from time to time.<\/p>\n<p>                  &#8220;Material  Adverse Effect&#8221; means a material  adverse effect on<br \/>\n         (i) the business,  properties,  operations  or condition,  financial or<br \/>\n         otherwise,  of the Borrower and its Consolidated  Entities,  taken as a<br \/>\n         whole,  (ii)  the  ability  of  the  Borrower  to pay  or  perform  its<br \/>\n         obligations,  liabilities and indebtedness  under the Loan Documents as<br \/>\n         such payment or  performance  becomes due in accordance  with the terms<br \/>\n         thereof,  or (iii) the rights,  powers and remedies of the Agent or any<br \/>\n         Lender  under  any  Loan   Document  or  the   validity,   legality  or<br \/>\n         enforceability  thereof  (including  for  purposes of clauses  (ii) and<br \/>\n         (iii) the imposition of burdensome conditions thereon).<\/p>\n<p>                  &#8220;Material  Group&#8221; shall mean, at any time, any group,  whether<br \/>\n         one or more, or combination of Consolidated Entities<\/p>\n<p>                                       20<\/p>\n<p>         (a) whose assets, in the aggregate, constitute 5% or more of the assets<br \/>\n         of the Borrower and the Consolidated  Entities on a consolidated  basis<br \/>\n         or (b) whose net revenues,  in the aggregate,  constitute 5% or more of<br \/>\n         the net  revenues of the Borrower  and the  Consolidated  Entities on a<br \/>\n         consolidated basis.<\/p>\n<p>                  &#8220;Medicaid  Certification&#8221;  means  certification  by  HCFA or a<br \/>\n         state  agency or entity  under  contract  with HCFA that a health  care<br \/>\n         operation is in compliance with all the conditions of participation set<br \/>\n         forth in the Medicaid Regulations.<\/p>\n<p>                  &#8220;Medicaid Provider  Agreement&#8221; means an agreement entered into<br \/>\n         between  a state  agency or other  entity  administering  the  Medicaid<br \/>\n         program  and a health  care  operation  under  which  the  health  care<br \/>\n         operation  agrees  to  provide   services  for  Medicaid   patients  in<br \/>\n         accordance with the terms of the agreement and Medicaid Regulations.<\/p>\n<p>                  &#8220;Medicaid  Regulations&#8221; means,  collectively,  (i) all federal<br \/>\n         statutes  (whether set forth in Title XIX of the Social Security Act or<br \/>\n         elsewhere)  affecting the medical  assistance  program  established  by<br \/>\n         Title  XIX of the  Social  Security  Act  and any  statutes  succeeding<br \/>\n         thereto;   (ii)  all  applicable   provisions  of  all  federal  rules,<br \/>\n         regulations,   manuals  and  orders  of  all  Governmental  Authorities<br \/>\n         promulgated pursuant to or in connection with the statutes described in<br \/>\n         clause  (i) above and all  federal  administrative,  reimbursement  and<br \/>\n         other  guidelines of all Governmental  Authorities  having the force of<br \/>\n         law  promulgated  pursuant  to  or  in  connection  with  the  statutes<br \/>\n         described in clause (i) above;  (iii) all state  statutes and plans for<br \/>\n         medical   assistance  enacted  in  connection  with  the  statutes  and<br \/>\n         provisions  described  in  clauses  (i) and  (ii)  above;  and (iv) all<br \/>\n         applicable provisions of all rules, regulations,  manuals and orders of<br \/>\n         all Governmental  Authorities  promulgated pursuant to or in connection<br \/>\n         with the  statutes  described  in  clause  (iii)  above  and all  state<br \/>\n         administrative,  reimbursement and other guidelines of all Governmental<br \/>\n         Authorities  having  the  force of law  promulgated  pursuant  to or in<br \/>\n         connection  with the statutes  described in clause (ii) above,  in each<br \/>\n         case as may be amended, supplemented or otherwise modified from time to<br \/>\n         time.<\/p>\n<p>                  &#8220;Medicare  Certification&#8221;  means  certification  by  HCFA or a<br \/>\n         state  agency or entity  under  contract  with HCFA that a health  care<br \/>\n         operation is in compliance with all the conditions of participation set<br \/>\n         forth in the Medicare Regulations.<\/p>\n<p>                  &#8220;Medicare Provider  Agreement&#8221; means an agreement entered into<br \/>\n         between  a state  agency or other  entity  administering  the  Medicare<br \/>\n         program  and a health  care  operation  under  which  the  health  care<br \/>\n         operation agrees to provide services for Medicare<\/p>\n<p>                                       21<\/p>\n<p>         patients in  accordance  with the terms of the  agreement  and Medicare<br \/>\n         Regulations.<\/p>\n<p>                  &#8220;Medicare  Regulations&#8221;  means,   collectively,   all  federal<br \/>\n         statutes  (whether set forth in Title XVIII of the Social  Security Act<br \/>\n         or elsewhere)  affecting the health insurance  program for the aged and<br \/>\n         disabled  established by Title XVIII of the Social Security Act and any<br \/>\n         statutes succeeding thereto; together with all applicable provisions of<br \/>\n         all  rules,   regulations,   manuals  and  orders  and  administrative,<br \/>\n         reimbursement  and  other  guidelines  having  the  force of law of all<br \/>\n         Governmental  Authorities  (including  without  limitation,  Health and<br \/>\n         Human Services  (&#8220;HHS&#8221;),  HCFA, the Office of the Inspector General for<br \/>\n         HHS, or any Person succeeding to the functions of any of the foregoing)<br \/>\n         promulgated  pursuant  to or in  connection  with any of the  foregoing<br \/>\n         having  the  force of law,  as each  may be  amended,  supplemented  or<br \/>\n         otherwise modified from time to time.<\/p>\n<p>                  &#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service, Inc.<\/p>\n<p>                  &#8220;Multiemployer  Plan&#8221; means a &#8220;multiemployer  plan&#8221; as defined<br \/>\n         in  Section  4001(a)(3)  of ERISA to which  the  Borrower  or any ERISA<br \/>\n         Affiliate   is  making,   or  is  accruing  an   obligation   to  make,<br \/>\n         contributions  or has made,  or been  obligated to make,  contributions<br \/>\n         within the preceding six (6) Fiscal Years.<\/p>\n<p>                  &#8220;NationsBank&#8221; means NationsBank, National Association.<\/p>\n<p>                  &#8220;Notes&#8221; means, collectively,  the Line of Credit Notes and the<br \/>\n         Revolving Notes and the Competitive Bid Notes.<\/p>\n<p>                  &#8220;Obligations&#8221;   means   the   obligations,   liabilities   and<br \/>\n         Indebtedness  of the  Borrower  with respect to (i) the  principal  and<br \/>\n         interest on the Loans as evidenced by the Notes, (ii) the Reimbursement<br \/>\n         Obligations  and  otherwise  in respect of the  Letters of Credit,  and<br \/>\n         (iii) the payment and performance of all other obligations, liabilities<br \/>\n         and Indebtedness of the Borrower to the Lenders or the Agent hereunder,<br \/>\n         under any one or more of the other Loan  Documents  or with  respect to<br \/>\n         the Loans.<\/p>\n<p>                  &#8220;Participation&#8221;  means, with respect to any Lender (other than<br \/>\n         the  Issuing  Bank) and a Letter of  Credit,  the  extension  of credit<br \/>\n         represented  by the  participation  of  such  Lender  hereunder  in the<br \/>\n         liability of the Issuing  Bank in respect of a Letter of Credit  issued<br \/>\n         by the Issuing Bank in accordance with the terms hereof.<\/p>\n<p>                  &#8220;Participation  Agreement&#8221; means the  Participation  Agreement<br \/>\n         dated November 16, 1995 among HEALTHSOUTH Corporation,  as Construction<br \/>\n         Agent,  HEALTHSOUTH  Holdings,  Inc., as Lessee, First Security Bank of<br \/>\n         Utah, N.A., as<\/p>\n<p>                                       22<\/p>\n<p>         Trustee,   the  Holders  identified  therein,  the  Lenders  identified<br \/>\n         therein, and NationsBank, National Association, as Agent.<\/p>\n<p>                  &#8220;PBGC&#8221; means the Pension Benefit Guaranty  Corporation and any<br \/>\n         successor thereto.<\/p>\n<p>              &#8220;Pension Plan&#8221; means any employee  pension benefit plan within the<br \/>\n         meaning of Section  3(2) of ERISA,  other  than a  Multiemployer  Plan,<br \/>\n         which is subject to the  provisions of Title IV of ERISA or Section 412<br \/>\n         of the Code and which (i) is  maintained  for employees of the Borrower<br \/>\n         or any of its ERISA  Affiliates or is assumed by the Borrower or any of<br \/>\n         its ERISA  Affiliates in connection with any Acquisition or (ii) has at<br \/>\n         any time been  maintained  for the  employees  of the  Borrower  or any<br \/>\n         current or former ERISA Affiliate.<\/p>\n<p>                  &#8220;Permitted Encumbrances&#8221; shall mean:<\/p>\n<p>                  (1)  liens  for  taxes,  assessments  and  other  governmental<br \/>\n                  charges that are not delinquent or that are being contested in<br \/>\n                  good faith by appropriate proceedings duly pursued;<\/p>\n<p>                  (2)  mechanics&#8217;,  materialmen&#8217;s,  contractor&#8217;s,  landlord&#8217;s or<br \/>\n                  other  similar  liens  arising  in  the  ordinary   course  of<br \/>\n                  business, securing obligations that are not delinquent or that<br \/>\n                  are being  contested in good faith by appropriate  proceedings<br \/>\n                  duly pursued;<\/p>\n<p>                  (3)   restrictions,   exceptions,   reservations,   easements,<br \/>\n                  conditions, limitations and other matters of record other than<br \/>\n                  Liens  that do not  materially  adversely  affect the value or<br \/>\n                  utility of the affected property;<\/p>\n<p>                  (4)   Liens  on  assets securing  Indebtedness the proceeds of<br \/>\n                  which are used to acquire such assets;<\/p>\n<p>                  (5)      Liens  and  other  matters approved in writing by the<br \/>\n                  Required Lenders; and<\/p>\n<p>                  (6) Liens in favor of landlords,  the amount  secured by which<br \/>\n                  landlords&#8217;  Liens,  in the  aggregate,  would  not  materially<br \/>\n                  adversely affect the Borrower or a Material Group.<\/p>\n<p>                  &#8220;Permitted Investments&#8221; shall mean:<\/p>\n<p>                  (1) direct obligations of, or obligations the payment of which<br \/>\n                  is guaranteed  by, the United States of America or an interest<br \/>\n                  in any trust or fund that invests  solely in such  obligations<br \/>\n                  or repurchase  agreements,  properly secured,  with respect to<br \/>\n                  such obligations.<\/p>\n<p>                                       23<\/p>\n<p>                  (2) direct obligations of agencies or instrumentalities of the<br \/>\n                  United States of America having a rating of A or higher by S&amp;P<br \/>\n                  or A2 or higher by Moody&#8217;s;<\/p>\n<p>                  (3)  a   certificate   of   deposit   issued   by,   or  other<br \/>\n                  interest-bearing  deposits  with, a bank having its  principal<br \/>\n                  place of business  in the United  States of America and having<br \/>\n                  equity capital of not less than $250,000,000;<\/p>\n<p>                  (4)  a   certificate   of   deposit   issued   by,   or  other<br \/>\n                  interest-bearing deposits with, any other bank organized under<br \/>\n                  the laws of the United States of America or any state thereof,<br \/>\n                  provided  that such  deposit  is  either  (i)  insured  by the<br \/>\n                  Federal Deposit Insurance Corporation or (ii) properly secured<br \/>\n                  by such bank by  pledging  direct  obligations  of the  United<br \/>\n                  States of America having a market value not less than the face<br \/>\n                  amount of such deposits;<\/p>\n<p>                  (5) the capital  stock of and  partnership  interests  in, and<br \/>\n                  loans made by the Borrower  to,  Controlled  Partnerships  and<br \/>\n                  Subsidiaries;<\/p>\n<p>                  (6) prime  commercial  paper  maturing  within 270 days of the<br \/>\n                  acquisition thereof and, at the time of acquisition,  having a<br \/>\n                  rating of A-1 or higher by S&amp;P, or P-1 or higher by Moody&#8217;s;<\/p>\n<p>                  (7) eligible banker&#8217;s  acceptances,  repurchase agreements and<br \/>\n                  tax-exempt  municipal bonds having a maturity of less than one<br \/>\n                  year,  in each  case  having  a  rating,  or that is the  full<br \/>\n                  recourse  obligation of a person whose senior debt is rated, A<br \/>\n                  or higher by S&amp;P or A2 or higher by Moody&#8217;s;<\/p>\n<p>                  (8) loans made by the Borrower or a Consolidated  Entity in an<br \/>\n                  aggregate  amount of  $2,000,000  or less to  employees of the<br \/>\n                  Borrower or of a Consolidated Entity;<\/p>\n<p>                  (9) loans made by the Borrower or a Controlled  Partnership in<br \/>\n                  an aggregate  amount of $1,000,000 or less to limited partners<br \/>\n                  (or potential limited partners) of Controlled Partnerships for<br \/>\n                  the  purpose of  enabling  such  limited  partners  to acquire<br \/>\n                  limited partnership interests in Controlled  Partnerships,  to<br \/>\n                  operate  their   practices  or  to   restructure   partnership<br \/>\n                  interests;<\/p>\n<p>                  (10) loans in an aggregate amount of up to $20,000,000 made by<br \/>\n                  the Borrower to the HEALTHSOUTH Employee Stock Benefit Plan;<\/p>\n<p>                                       24<\/p>\n<p>                  (11)  scholarship  loans made by the  Borrower in an aggregate<br \/>\n                  amount  not  exceeding  $1,000,000  to  individuals  who  meet<br \/>\n                  certain   eligibility   requirements  as  established  by  the<br \/>\n                  Borrower from time to time;<\/p>\n<p>                  (12)  up to  100%  of  the  outstanding  shares  of  stock  of<br \/>\n                  Caretenders  Healthcorp  (formerly  known as Senior  Services,<br \/>\n                  Inc.) provided that aggregate  costs incurred to purchase such<br \/>\n                  shares shall not exceed $12,000,000;<\/p>\n<p>                  (13)  other   investments  of  less  than  $5,000,000  in  the<br \/>\n                  aggregate  expressly  approved  in  writing  by the  Agent and<br \/>\n                  investments  of  $5,000,000 or greater  expressly  approved in<br \/>\n                  writing by the Required Lenders;<\/p>\n<p>                  (14)     any other investment having a rating of A or higher<br \/>\n                  or A-1 or higher by S&amp;P or A2 or higher or P-1 or higher<br \/>\n                  by Moody&#8217;s;<\/p>\n<p>                  (15) loans to health care  practitioners and other persons not<br \/>\n                  to exceed in the aggregate $5,000,000;<\/p>\n<p>                  (16)  investments  in  Acacia  Venture   Partners,   Wellmark,<br \/>\n                  HEALTHSMART,  MedPartners  and Austin Medical Office  Building<br \/>\n                  which in the aggregate do not exceed $5,000,000; and<\/p>\n<p>                  (17)     additional investments existing on the Closing Date<br \/>\n                  and described in Exhibit H.<\/p>\n<p>                  &#8220;Person&#8221;  means  an  individual,   partnership,   corporation,<br \/>\n         limited  liability   company,   trust,   unincorporated   organization,<br \/>\n         association,  joint  venture  or a  government  or agency or  political<br \/>\n         subdivision thereof.<\/p>\n<p>                  &#8220;Prime  Rate&#8221; means the rate of interest  per annum  announced<br \/>\n         publicly by the Agent as its prime rate from time to time.<\/p>\n<p>                  &#8220;Principal   Office&#8221;   means  the   office  of  the  Agent  at<br \/>\n         NationsBank, National Association, Independence Center, 15th Floor, NC1<br \/>\n         001-15-04, Charlotte, North Carolina 28255, Attention: Agency Services,<br \/>\n         or such  other  office  and  address as the Agent may from time to time<br \/>\n         designate.<\/p>\n<p>                  &#8220;Rate Hedging  Obligations&#8221;  means any and all  obligations of<br \/>\n         the Borrower or any Consolidated Entity, whether absolute or contingent<br \/>\n         and howsoever and whensoever  created,  arising,  evidenced or acquired<br \/>\n         (including  all  renewals,  extensions  and  modifications  thereof and<br \/>\n         substitutions therefor),  under (i) any and all agreements,  devices or<br \/>\n         arrangements  designed to protect at least one of the  parties  thereto<br \/>\n         from the fluctuations of interest rates, exchange rates or forward<\/p>\n<p>                                       25<\/p>\n<p>         rates  applicable  to such  party&#8217;s  assets,  liabilities  or  exchange<br \/>\n         transactions,  including,  but not limited to,  Dollar-  denominated or<br \/>\n         cross-currency  interest rate  exchange  agreements,  forward  currency<br \/>\n         exchange agreements, interest rate cap or collar protection agreements,<br \/>\n         forward rate  currency or interest  rate  options,  puts,  warrants and<br \/>\n         those commonly known as interest rate &#8220;swap&#8221;  agreements;  and (ii) any<br \/>\n         and all cancellations, buybacks, reversals, terminations or assignments<br \/>\n         of any of the foregoing.<\/p>\n<p>                  &#8220;Rating&#8221; means the rating of senior unsecured  Indebtedness of<br \/>\n         the  Borrower  in effect at any time which  rating is made by either of<br \/>\n         Moody&#8217;s or S&amp;P.<\/p>\n<p>                  &#8220;Regulation D&#8221; means Regulation D of the Board as the same may<br \/>\n         be amended or supplemented from time to time.<\/p>\n<p>                  &#8220;Reimbursement  Obligation&#8221;  shall  mean,  at  any  time,  the<br \/>\n         obligation  of the  Borrower  with  respect  to any Letter of Credit to<br \/>\n         reimburse  the  Issuing  Bank and the  Lenders  to the  extent of their<br \/>\n         respective Participations (including by the receipt by the Issuing Bank<br \/>\n         of proceeds of Loans  pursuant to Section 3.2) for amounts  theretofore<br \/>\n         paid by the Issuing  Bank  pursuant  to a drawing  under such Letter of<br \/>\n         Credit.<\/p>\n<p>                  &#8220;Required Lenders&#8221; means, as of any date, Lenders on such date<br \/>\n         having Credit Exposures (as defined below)  aggregating at least 51% of<br \/>\n         the  aggregate  Credit  Exposures of all the Lenders on such date.  For<br \/>\n         purposes of the preceding sentence, the amount of the &#8220;Credit Exposure&#8221;<br \/>\n         of each Lender shall be equal to the aggregate  principal amount of the<br \/>\n         Loans  without  regard to any  Competitive  Bid Loan,  so long as there<br \/>\n         exists no Event of Default,  owing to such  Lender  plus the  aggregate<br \/>\n         unutilized  amounts  of such  Lender&#8217;s  Line of Credit  Commitment  and<br \/>\n         Revolving Credit Commitment plus the amount of such Lender&#8217;s Applicable<br \/>\n         Commitment Percentage of Letter of Credit Outstandings;  provided that,<br \/>\n         if any  Lender  shall  have  failed  to pay to  the  Issuing  Bank  its<br \/>\n         Applicable  Commitment  Percentage  of any drawing  under any Letter of<br \/>\n         Credit  resulting  in an  outstanding  Reimbursement  Obligation,  such<br \/>\n         Lender&#8217;s  Credit  Exposure   attributable  to  Letters  of  Credit  and<br \/>\n         Reimbursement  Obligations  shall be deemed  to be held by the  Issuing<br \/>\n         Bank for purposes of this definition.<\/p>\n<p>              &#8220;Restricted Payment&#8221; means (a) any dividend or other distribution,<br \/>\n         direct or  indirect,  on account of any shares of any class of stock of<br \/>\n         Borrower or any of its Consolidated  Entities (other than those payable<br \/>\n         or distributable solely to the Borrower) now or hereafter  outstanding,<br \/>\n         except a dividend  payable  solely in shares of a class of stock to the<br \/>\n         holders  of that  class;  (b)  any  redemption,  conversion,  exchange,<br \/>\n         retirement or similar payment, purchase or other acquisition for value,<br \/>\n         direct or indirect, of any shares of any class of<\/p>\n<p>                                       26<\/p>\n<p>         stock of the Borrower or any of its  Consolidated  Entities (other than<br \/>\n         those payable or distributable solely to the Borrower) now or hereafter<br \/>\n         outstanding; (c) any payment made to retire, or to obtain the surrender<br \/>\n         of, any outstanding warrants, options or other rights to acquire shares<br \/>\n         of any  class  of  stock  of the  Borrower  or any of its  Consolidated<br \/>\n         Entities now or hereafter outstanding; and (d) any issuance and sale of<br \/>\n         capital  stock  of any  Consolidated  Entity  of the  Borrower  (or any<br \/>\n         option,  warrant  or right to  acquire  such  stock)  other than to the<br \/>\n         Borrower.<\/p>\n<p>                  &#8220;Revolving  Credit  Commitment&#8221;  means,  with  respect to each<br \/>\n         Lender,  the obligation of such Lender to make  Revolving  Loans to the<br \/>\n         Borrower  up  to  an  aggregate   principal  amount  at  any  one  time<br \/>\n         outstanding equal to such Lender&#8217;s Applicable  Commitment Percentage of<br \/>\n         the Total Revolving Credit Commitment.<\/p>\n<p>                  &#8220;Revolving  Credit  Facility&#8221; means the facility  described in<br \/>\n         Section  2.1(a)  providing  for Loans to the Borrower by the Lenders in<br \/>\n         the  aggregate   principal   amount  of  the  Total  Revolving   Credit<br \/>\n         Commitment.<\/p>\n<p>                  &#8220;Revolving  Credit  Outstandings&#8221;  means,  as of any  date  of<br \/>\n         determination,  the aggregate  principal  amount of all Revolving Loans<br \/>\n         then outstanding and all interest accrued thereon.<\/p>\n<p>                  &#8220;Revolving  Credit  Termination Date&#8221; means (i) March 31, 2001<br \/>\n         or (ii)  such  earlier  date of  termination  of  Lenders&#8217;  obligations<br \/>\n         pursuant to Section 9.1 upon the occurrence of an Event of Default,  or<br \/>\n         (iii)  such  date  as the  Borrower  may  voluntarily  and  permanently<br \/>\n         terminate  the  Revolving  Credit  Facility  by  payment in full of all<br \/>\n         Revolving  Credit  Outstandings,  Competitive  Bid Loans and  Letter of<br \/>\n         Credit Outstandings and cancellation of all Letters of Credit.<\/p>\n<p>                  &#8220;Revolving  Loan&#8221; means any  borrowing  pursuant to an Advance<br \/>\n         under the Revolving Credit Facility in accordance with Section 2.1(a).<\/p>\n<p>                  &#8220;Revolving Notes&#8221; means, collectively, the promissory notes of<br \/>\n         the Borrower  evidencing  Revolving Loans executed and delivered to the<br \/>\n         Lenders as  provided  in Section  2.6(a)  substantially  in the form of<br \/>\n         Exhibit I, with appropriate  insertions as to amounts,  dates and names<br \/>\n         of Lenders.<\/p>\n<p>                  &#8220;S&amp;P&#8221; means  Standard &amp; Poor&#8217;s,  a division of The McGraw Hill<br \/>\n         Companies.<\/p>\n<p>                  &#8220;Segment&#8221;  means a  portion  of a Loan (or all  thereof)  with<br \/>\n         respect to which a particular  interest  rate is (or is proposed to be)<br \/>\n         applicable.<\/p>\n<p>                                       27<\/p>\n<p>                  &#8220;Single Employer Plan&#8221; means any employee pension benefit plan<br \/>\n         covered by Title IV of ERISA in respect  of which the  Borrower  or any<br \/>\n         Subsidiary is an  &#8220;employer&#8221;  as described in Section  4001(b) of ERISA<br \/>\n         and which is not a Multiemployer Plan.<\/p>\n<p>                  &#8220;Solvent&#8221; means, when used with respect to any Person, that at<br \/>\n         the time of determination:<\/p>\n<p>                              (i) the  fair  value of its  assets  (both at fair<br \/>\n                  valuation  and at present  fair  saleable  value on an orderly<br \/>\n                  basis) is in excess  of the total  amount of its  liabilities,<br \/>\n                  including contingent obligations; and<\/p>\n<p>                             (ii)  it is then able and expects to be able to pay<br \/>\n                  its debts as they mature; and<\/p>\n<p>                            (iii)    it  has  capital sufficient to carry on its<br \/>\n                  business as conducted and as proposed to be conducted.<\/p>\n<p>                  &#8220;Stated  Termination  Date&#8221; means March 31, 1997 or such later<br \/>\n         date as the parties may agree pursuant to Section 2.14.<\/p>\n<p>                  &#8220;Subordinated  Debt&#8221; means any unsecured  Indebtedness  of the<br \/>\n         Borrower  or  any   Consolidated   Entity  (other  than   inter-company<br \/>\n         Indebtedness) which is subordinated in right of payment in all respects<br \/>\n         to the Obligations in a manner reasonably acceptable to the Agent.<\/p>\n<p>                  &#8220;Subsidiary&#8221;  means any  corporation  or other entity in which<br \/>\n         more than 50% of its  outstanding  voting stock or more than 50% of all<br \/>\n         equity interests is owned directly or indirectly by the Borrower and\/or<br \/>\n         by one or more of the Borrower&#8217;s Subsidiaries.<\/p>\n<p>                  &#8220;Swap  Agreement&#8221;  means one or more  agreements  between  the<br \/>\n         Borrower and any Person with respect to  Indebtedness  evidenced by any<br \/>\n         or all of the Notes, on terms mutually  acceptable to Borrower and such<br \/>\n         Person and approved by each of the  Lenders,  which  agreements  create<br \/>\n         Rate Hedging Obligations;  provided,  however, that no such approval of<br \/>\n         the Lenders shall be required to the extent such agreements are entered<br \/>\n         into between the Borrower and any Lender.<\/p>\n<p>                  &#8220;Syndicated  Loans&#8221; shall mean the Revolving Loans and Line of<br \/>\n         Credit Loans  provided for by Section 2.1, which may be Base Rate Loans<br \/>\n         or Eurodollar Rate Loans.<\/p>\n<p>              &#8220;Termination  Event&#8221; means: (i) a &#8220;Reportable  Event&#8221; described in<br \/>\n         Section 4043 of ERISA and the regulations issued thereunder (unless the<br \/>\n         notice requirement has been waived by applicable  regulation);  or (ii)<br \/>\n         the  withdrawal of the Borrower or any ERISA  Affiliate  from a Pension<br \/>\n         Plan during a plan year<\/p>\n<p>                                       28<\/p>\n<p>         in  which  it  was a  &#8220;substantial  employer&#8221;  as  defined  in  Section<br \/>\n         4001(a)(2) of ERISA or was deemed such under Section  4068(f) of ERISA;<br \/>\n         or (iii) the  termination  of a Pension Plan, the filing of a notice of<br \/>\n         intent to terminate a Pension  Plan or the  treatment of a Pension Plan<br \/>\n         amendment as a  termination  under  Section 4041 of ERISA;  or (iv) the<br \/>\n         institution  of proceedings to terminate a Pension Plan by the PBGC; or<br \/>\n         (v) any other event or condition which would  constitute  grounds under<br \/>\n         Section  4042(a) of ERISA for the termination of, or the appointment of<br \/>\n         a trustee to  administer,  any  Pension  Plan;  or (vi) the  partial or<br \/>\n         complete  withdrawal  of the  Borrower  or any ERISA  Affiliate  from a<br \/>\n         Multiemployer  Plan;  or (vii) the  imposition  of a Lien  pursuant  to<br \/>\n         Section 412 of the Code or Section 302 of ERISA; or (viii) any event or<br \/>\n         condition  which  results  in the  reorganization  or  insolvency  of a<br \/>\n         Multiemployer  Plan  under  Section  4241 or  Section  4245  of  ERISA,<br \/>\n         respectively;  or (ix) any  event or  condition  which  results  in the<br \/>\n         termination of a Multiemployer Plan under Section 4041A of ERISA or the<br \/>\n         institution  by the PBGC of  proceedings  to terminate a  Multiemployer<br \/>\n         Plan under Section 4042 of ERISA.<\/p>\n<p>              &#8220;Total Letter of Credit  Commitment&#8221; means an amount not to exceed<br \/>\n         $75,000,000.<\/p>\n<p>                  &#8220;Total Line of Credit  Commitment&#8221;  means a  principal  amount<br \/>\n         equal to $350,000,000,  as reduced from time to time in accordance with<br \/>\n         Section 2.1(b) and Section 2.8.<\/p>\n<p>                  &#8220;Total Revolving Credit  Commitment&#8221;  means a principal amount<br \/>\n         equal to $900,000,000,  as reduced from time to time in accordance with<br \/>\n         Section 2.1(a) and Section 2.8.<\/p>\n<p>              &#8220;Type&#8221;  shall have the  meaning  assigned  to such term in Section<br \/>\n         1.3.<\/p>\n<p>                  &#8220;Unused  Amount&#8221;  shall mean with respect to each Lender,  (a)<br \/>\n         the Revolving  Credit  Commitment of such Lender less (b) such Lender&#8217;s<br \/>\n         pro rata  share of  outstanding  Revolving  Loans and  Letter of Credit<br \/>\n         Outstandings   less  (c)  the  outstanding   principal  amount  of  all<br \/>\n         Competitive  Bid Loans then held by such Lender;  provided,  that in no<br \/>\n         event shall such amount be a negative number.<\/p>\n<p>                  &#8220;Vanderbilt&#8221; shall mean Vanderbilt  Stallworth  Rehabilitation<br \/>\n         Hospital,  L.P.,  the  partners of which are the  Borrower,  Vanderbilt<br \/>\n         University and Vanderbilt Health Services.<\/p>\n<p>                  &#8220;Voting  Stock&#8221;  means  shares of  Capital  Stock  issued by a<br \/>\n         corporation,  or equivalent  interests in any other Person, the holders<br \/>\n         of which are ordinarily,  in the absence of contingencies,  entitled to<br \/>\n         vote for the  election  of  directors  (or persons  performing  similar<br \/>\n         functions) of such Person, even<\/p>\n<p>                                       29<\/p>\n<p>         if  the  right so to vote has been suspended by the happening of such a<br \/>\n         contingency.<\/p>\n<p>         1.2        Rules of Interpretation.<br \/>\n                    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                    (a) All  accounting  terms not  specifically  defined herein<br \/>\n         shall have the meanings assigned to such terms and shall be interpreted<br \/>\n         in accordance with GAAP applied on a Consistent Basis.<\/p>\n<p>                    (b) The  headings,  subheadings  and table of contents  used<br \/>\n         herein or in any other Loan  Document  are solely  for  convenience  of<br \/>\n         reference  and  shall not  constitute  a part of any such  document  or<br \/>\n         affect the meaning, construction or effect of any provision thereof.<\/p>\n<p>                    (c)  Except  as  otherwise  expressly  provided,  references<br \/>\n         herein to articles, sections, paragraphs, clauses, annexes, appendices,<br \/>\n         exhibits  and   schedules  are   references   to  articles,   sections,<br \/>\n         paragraphs,  clauses, annexes, appendices, exhibits and schedules in or<br \/>\n         to this Agreement.<\/p>\n<p>                    (d) All  definitions  set forth  herein or in any other Loan<br \/>\n         Document shall apply to the singular as well as the plural form of such<br \/>\n         defined term, and all references to the masculine  gender shall include<br \/>\n         reference  to the  feminine or neuter  gender,  and vice versa,  as the<br \/>\n         context may require.<\/p>\n<p>                    (e) When used  herein or in any other Loan  Document,  words<br \/>\n         such as &#8220;hereunder&#8221;, &#8220;hereto&#8221;, &#8220;hereof&#8221; and &#8220;herein&#8221; and other words of<br \/>\n         like  import  shall,  unless  the  context  clearly  indicates  to  the<br \/>\n         contrary,  refer to the whole of the applicable document and not to any<br \/>\n         particular article, section, subsection, paragraph or clause thereof.<\/p>\n<p>                    (f)  References  to  &#8220;including&#8221;   means  including  without<br \/>\n         limiting the generality of any description preceding such term, and for<br \/>\n         purposes  hereof the rule of ejusdem generis shall not be applicable to<br \/>\n         limit a general  statement,  followed by or referable to an enumeration<br \/>\n         of  specific  matters,   to  matters  similar  to  those   specifically<br \/>\n         mentioned.<\/p>\n<p>                    (g) All dates and times of day specified  herein shall refer<br \/>\n         to such dates and times at Charlotte, North Carolina.<\/p>\n<p>                    (h) Each of the  parties  to the Loan  Documents  and  their<br \/>\n         counsel have reviewed and revised, or requested (or had the opportunity<br \/>\n         to  request)  revisions  to,  the  Loan  Documents,  and  any  rule  of<br \/>\n         construction  that  ambiguities are to be resolved against the drafting<br \/>\n         party shall be inapplicable in the construing and interpretation of the<br \/>\n         Loan Documents and all exhibits, schedules and appendices thereto.<\/p>\n<p>                                       30<\/p>\n<p>                    (i)    Any  reference  to an officer of the  Borrower or any<br \/>\n         other Person by reference to the title of such officer  shall be deemed<br \/>\n         to  refer  to each  other  officer  of  such  Person,  however  titled,<br \/>\n         exercising the same or substantially similar functions.<\/p>\n<p>                    (j)    All  references  to  any  agreement  or  document  as<br \/>\n         amended,  modified or supplemented,  or words of similar effect,  shall<br \/>\n         mean  such  document  or  agreement,  as the case may be,  as  amended,<br \/>\n         modified  or  supplemented  from time to time only as and to the extent<br \/>\n         permitted therein and in the Loan Documents.<\/p>\n<p>         1.3.     Classes and Types of Loans.  Loans hereunder are distinguished<br \/>\nby &#8220;Class&#8221; and by &#8220;Type&#8221;. The &#8220;Class&#8221; of a Loan refers to whether such Loan is a<br \/>\nCompetitive Bid Loan or a Syndicated Loan (and if a Syndicated Loan, a Revolving<br \/>\nLoan or Line of Credit Loan), each of which constitutes a Class. The &#8220;Type&#8221; of a<br \/>\nLoan refers to whether such Loan is a Base Rate Loan, a Eurodollar Rate Loan, an<br \/>\nAbsolute  Rate Loan or a Eurodollar  Market Loan,  each of which  constitutes  a<br \/>\nType. Loans may be identified by both Class and Type.<\/p>\n<p>                                       31<\/p>\n<p>                                   ARTICLE II<\/p>\n<p>                                    The Loans<br \/>\n                                    &#8212;&#8212;&#8212;<\/p>\n<p>         2.1.       Syndicated Loans.<br \/>\n                    &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                    (a)     Revolving Credit Facility.  Subject to the terms and<br \/>\nconditions of this Agreement,  each Lender  severally agrees to make Advances to<br \/>\nthe Borrower  under the  Revolving  Credit  Facility  from time to time from the<br \/>\nClosing Date until the Revolving Credit  Termination Date on a pro rata basis as<br \/>\nto the total  borrowing  requested by the Borrower on any day determined by such<br \/>\nLender&#8217;s Applicable  Commitment Percentage up to but not exceeding the Revolving<br \/>\nCredit Commitment of such Lender,  provided,  however, that the Lenders will not<br \/>\nbe required and shall have no obligation to make any such Advance (i) so long as<br \/>\na Default or an Event of Default has occurred and is  continuing  or (ii) if the<br \/>\nmaturity  of any of the  Notes has been  accelerated  as a result of an Event of<br \/>\nDefault; provided further, however, that immediately after giving effect to each<br \/>\nsuch Advance,  the aggregate  principal amount of Revolving Credit  Outstandings<br \/>\nplus Letter of Credit Outstandings plus outstanding  Competitive Bid Loans shall<br \/>\nnot exceed the Total  Revolving  Credit  Commitment.  Within  such  limits,  the<br \/>\nBorrower may borrow, repay and reborrow under the Revolving Credit Facility on a<br \/>\nBusiness  Day  from  the  Closing  Date  until,   but  (as  to  borrowings   and<br \/>\nreborrowings) not including,  the Revolving Credit  Termination Date;  provided,<br \/>\nhowever, that (y) no Revolving Loan that is a Eurodollar Rate Loan shall be made<br \/>\nwhich  has  an  Interest  Period  that  extends  beyond  the  Revolving   Credit<br \/>\nTermination Date and (z) each Revolving Loan that is a Eurodollar Rate Loan may,<br \/>\nsubject to the  provisions of Section 2.4, be repaid only on the last day of the<br \/>\nInterest  Period with respect  thereto unless such payment is accompanied by the<br \/>\nadditional payment, if any, required by Section 4.2.<\/p>\n<p>                    (b)       Line of Credit Facility.  Subject to the terms and<br \/>\nconditions of this Agreement,  each Lender  severally agrees to make Advances to<br \/>\nthe  Borrower  under  the Line of  Credit  Facility  from  time to time from the<br \/>\nClosing Date until the Line of Credit Termination Date on a pro rata basis as to<br \/>\nthe total  borrowing  requested  by the Borrower on any day  determined  by such<br \/>\nLender&#8217;s  Applicable  Commitment  Percentage up to but not exceeding the Line of<br \/>\nCredit Commitment of such Lender,  provided,  however, that the Lenders will not<br \/>\nbe required and shall have no obligation to make any such Advance (i) so long as<br \/>\na Default or an Event of Default has occurred and is  continuing  or (ii) if the<br \/>\nmaturity  of any of the  Notes has been  accelerated  as a result of an Event of<br \/>\nDefault; provided further, however, that immediately after giving effect to each<br \/>\nsuch Advance,  the  principal  amount of Line of Credit  Outstandings  shall not<br \/>\nexceed the Total Line of Credit Commitment. Within such limits, the Borrower may<br \/>\nborrow,  repay and reborrow under the Line of Credit  Facility on a Business Day<br \/>\nfrom the Closing Date until, but (as to borrowings and reborrowings) not<\/p>\n<p>                                       32<\/p>\n<p>including,  the Line of Credit Termination Date; provided,  however, that (y) no<br \/>\nLine of Credit  Loan that is a  Eurodollar  Rate Loan shall be made which has an<br \/>\nInterest Period that extends beyond the Line of Credit  Termination Date and (z)<br \/>\neach Line of Credit  Loan that is a  Eurodollar  Rate Loan may,  subject  to the<br \/>\nprovisions of Section 2.4, be repaid only on the last day of the Interest Period<br \/>\nwith  respect  thereto  unless such  payment is  accompanied  by the  additional<br \/>\npayment, if any, required by Section 4.2.<\/p>\n<p>                    (c)       Amounts.  The aggregate unpaid principal amount of<br \/>\nthe  Revolving  Credit  Outstandings  plus  Letter of Credit  Outstandings  plus<br \/>\noutstanding  Competitive  Bid  Loans  shall  not  exceed  at any time the  Total<br \/>\nRevolving  Credit  Commitment,  and the aggregate unpaid principal amount of the<br \/>\nLine of Credit Outstandings shall not exceed the Total Line of Credit Commitment<br \/>\nand, in the event there shall be outstanding any such excess, the Borrower shall<br \/>\nimmediately  make such payments and  prepayments as shall be necessary to comply<br \/>\nwith this  restriction.  Each Syndicated  Loan  hereunder,  other than Base Rate<br \/>\nRefunding Loans, and each conversion under Section 2.9, shall be in an amount of<br \/>\nat least  $5,000,000,  and, if greater than $5,000,000,  an integral multiple of<br \/>\n$1,000,000.<\/p>\n<p>                    (d)      Advances.   An Authorized Representative shall give<br \/>\nthe Agent (1) at least three (3) Business  Days&#8217;  irrevocable  written notice by<br \/>\ntelefacsimile  transmission  of a Borrowing  Notice or Interest  Rate  Selection<br \/>\nNotice (as applicable) with appropriate  insertions,  effective upon receipt, of<br \/>\neach  Syndicated  Loan that is a Eurodollar  Rate Loan (whether  representing an<br \/>\nadditional  borrowing  hereunder or the conversion of a borrowing hereunder from<br \/>\nBase  Rate  Loans  to  Eurodollar  Rate  Loans)  prior  to  10:30  A.M.  and (2)<br \/>\nirrevocable  written notice by telefacsimile  transmission of a Borrowing Notice<br \/>\nor Interest Rate Selection Notice (as applicable)  with appropriate  insertions,<br \/>\neffective upon receipt,  of each Syndicated Loan (other than Base Rate Refunding<br \/>\nLoans to the extent the same are  effected  without  notice  pursuant to Section<br \/>\n2.1(d)(iv))  that  is a Base  Rate  Loan  (whether  representing  an  additional<br \/>\nborrowing  hereunder or the conversion of borrowing  hereunder  from  Eurodollar<br \/>\nRate Loans to Base Rate Loans)  prior to 10:30 A.M. on the day of such  proposed<br \/>\nSyndicated  Loan.  Each such notice shall  specify the amount of the  borrowing,<br \/>\nwhether the Loan is a Revolving Loan or Line of Credit Loan, the Type of Loan<\/p>\n<p>(Base Rate or Eurodollar  Rate), the date of borrowing and, if a Eurodollar Rate<br \/>\nLoan, the Interest Period to be used in the  computation of interest.  Notice of<br \/>\nreceipt of such Borrowing Notice or Interest Rate Selection  Notice, as the case<br \/>\nmay be,  together  with  the  amount  of each  Lender&#8217;s  portion  of an  Advance<br \/>\nrequested  thereunder,  shall  be  provided  by the  Agent  to  each  Lender  by<br \/>\ntelefacsimile  transmission with reasonable promptness,  but (provided the Agent<br \/>\nshall have  received  such notice by 10:30 A.M.) not later than 1:00 P.M. on the<br \/>\nsame day as the Agent&#8217;s receipt of such notice.<\/p>\n<p>                                       33<\/p>\n<p>         (ii)     Not  later  than  2:00  P.M.  on the date  specified  for each<br \/>\nborrowing  under this Section 2.1, each Lender shall,  pursuant to the terms and<br \/>\nsubject  to the  conditions  of this  Agreement,  make the amount of the Loan or<br \/>\nLoans to be made by it on such day  available  by wire  transfer to the Agent in<br \/>\nthe  amount  of its pro  rata  share,  determined  according  to  such  Lender&#8217;s<br \/>\nApplicable  Commitment  Percentage of the Syndicated Loan or Syndicated Loans to<br \/>\nbe made on such day.  Such wire  transfer  shall be directed to the Agent at the<br \/>\nPrincipal  Office and shall be in the form of Dollars  constituting  immediately<br \/>\navailable funds. The amount so received by the Agent shall, subject to the terms<br \/>\nand conditions of this Agreement,  be made available to the Borrower by delivery<br \/>\nof the proceeds thereof as shall be directed in the applicable  Borrowing Notice<br \/>\nby the Authorized Representative and reasonably acceptable to the Agent.<\/p>\n<p>         (iii)   The Borrower shall have the option to elect the duration of the<br \/>\ninitial and any subsequent  Interest Periods and to convert the Syndicated Loans<br \/>\nin accordance with Section 2.9. Eurodollar Rate Loans and Base Rate Loans may be<br \/>\noutstanding at the same time, provided,  however, there shall not be outstanding<br \/>\nat any one time Loans (whether Syndicated Loans or Competitive Bid Loans) having<br \/>\nmore than eight (8) different Interest Periods.  If the Agent does not receive a<br \/>\nBorrowing  Notice or an Interest Rate Selection Notice giving notice of election<br \/>\nof the  duration  of an  Interest  Period  or of  conversion  of any  Loan to or<br \/>\ncontinuation  of a Loan as a  Eurodollar  Rate  Loan by the time  prescribed  by<br \/>\nSection  2.1(d) or 2.9, the Borrower  shall be deemed to have elected to convert<br \/>\nsuch  Segment  to (or  continue  such  Segment  as) a Base Rate  Loan  until the<br \/>\nBorrower notifies the Agent in accordance with Section 2.9.<\/p>\n<p>         (iv)  Notwithstanding  the  foregoing,  if a drawing  is made under any<br \/>\nLetter of Credit,  such  drawing is  honored  by the  Issuing  Bank prior to the<br \/>\nRevolving Credit  Termination Date, and the Borrower shall not immediately fully<br \/>\nreimburse  the Issuing Bank in respect of such  drawing,  (A) provided  that the<br \/>\nconditions  to  making  a  Revolving  Loan  as  herein  provided  shall  then be<br \/>\nsatisfied,  the Reimbursement Obligation arising from such drawing shall be paid<br \/>\nto the Issuing Bank by the Agent  without the  requirement  of notice to or from<br \/>\nthe Borrower from immediately  available funds which shall be advanced as a Base<br \/>\nRate  Refunding  Loan by each Lender under the Revolving  Credit  Facility in an<br \/>\namount  equal  to  such  Lender&#8217;s  Applicable   Commitment  Percentage  of  such<br \/>\nReimbursement  Obligation,  and (B) if the conditions to making a Revolving Loan<br \/>\nas herein  provided shall not then be satisfied,  each of the Lenders shall fund<br \/>\nby payment to the Agent (for the  benefit of the  Issuing  Bank) in  immediately<br \/>\navailable  funds  the  purchase  from  the  Issuing  Bank  of  their  respective<br \/>\nParticipations in the related Reimbursement Obligation based on their respective<br \/>\nApplicable Commitment Percentages. If a drawing is presented under any Letter of<br \/>\nCredit  in  accordance  with  the  terms  thereof  and the  Borrower  shall  not<br \/>\nimmediately  reimburse the Issuing Bank in respect thereof,  then notice of such<br \/>\ndrawing or payment shall be provided promptly by the<\/p>\n<p>                                       34<\/p>\n<p>Issuing Bank to the Agent and the Agent shall  provide  notice to each Lender by<br \/>\ntelephone or telefacsimile  transmission.  If notice to the Lenders of a drawing<br \/>\nunder any Letter of Credit is given by the Agent at or before  12:00 noon on any<br \/>\nBusiness Day, each Lender shall,  pursuant to the  conditions  specified in this<br \/>\nSection 2.1(d)(iv),  either make a Base Rate Refunding Loan or fund the purchase<br \/>\nof its  Participation  in the  amount  of such  Lender&#8217;s  Applicable  Commitment<br \/>\nPercentage of such drawing or payment and shall pay such amount to the Agent for<br \/>\nthe  account of the  Issuing  Bank at the  Principal  Office in  Dollars  and in<br \/>\nimmediately available funds before 2:30 P.M. on the same Business Day. If notice<br \/>\nto the Lenders of a drawing under a Letter of Credit is given by the Agent after<br \/>\n12:00 noon on any Business Day, each Lender  shall,  pursuant to the  conditions<br \/>\nspecified in this Section 2.1(d)(iv),  either make a Base Rate Refunding Loan or<br \/>\nfund the purchase of its Participation in the amount of such Lender&#8217;s Applicable<br \/>\nCommitment  Percentage  of such  drawing or payment and shall pay such amount to<br \/>\nthe Agent for the account of the Issuing Bank at the Principal Office in Dollars<br \/>\nand in  immediately  available  funds  before  12:00 noon on the next  following<br \/>\nBusiness Day. Any such Base Rate  Refunding Loan shall be advanced as, and shall<br \/>\ncontinue as, a Base Rate Loan unless and until the Borrower  converts  such Base<br \/>\nRate Loan in accordance with the terms of Section 2.9.<\/p>\n<p>         2.2.     Competitive Bid Loans.<br \/>\n                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                  (a) In addition to borrowings of Syndicated Loans, at any time<br \/>\nprior to the Revolving Credit Termination Date the Borrower may, as set forth in<br \/>\nthis Section  2.2,  request the Lenders to make offers to make  Competitive  Bid<br \/>\nLoans to the Borrower in Dollars.  The Lenders may, but shall have no obligation<br \/>\nto, make such offers and the  Borrower  may,  but shall have no  obligation  to,<br \/>\naccept any such offers in the manner set forth in this Section 2.2.  Competitive<br \/>\nBid Loans may be  Eurodollar  Market Loans or Absolute Rate Loans (each a &#8220;Type&#8221;<br \/>\nof Competitive Bid Loan), provided that:<\/p>\n<p>                      (i) the aggregate  amount of outstanding  Competitive  Bid<br \/>\n                  Loans shall not exceed the Total Revolving  Credit  Commitment<br \/>\n                  less  the sum of the  principal  amount  of  Revolving  Credit<br \/>\n                  Outstandings and Letter of Credit Outstandings;<\/p>\n<p>                      (ii)  there  may  be no  more  than  eight  (8)  different<br \/>\n                  Interest Periods for both Syndicated Loans and Competitive Bid<br \/>\n                  Loans outstanding at the same time (for which purpose Interest<br \/>\n                  Periods  described  in  different   lettered  clauses  of  the<br \/>\n                  definition of the term &#8220;Interest Period&#8221; shall be deemed to be<br \/>\n                  different Interest Periods even if they are coterminous);<\/p>\n<p>                     (iii) the aggregate  amount of outstanding  Competitive Bid<br \/>\n                  Loans of a Lender shall not exceed at any time an<\/p>\n<p>                                       35<\/p>\n<p>                  amount equal to such Lender&#8217;s Revolving Credit Commitment;<\/p>\n<p>                      (iv) the aggregate principal amount of all Competitive Bid<br \/>\n                  Loans,  together with the sum of (i) the  aggregate  principal<br \/>\n                  amount of all outstanding  Revolving Loans and (ii) the Letter<br \/>\n                  of Credit  Outstandings  shall not exceed the Total  Revolving<br \/>\n                  Credit Commitment at such time; and<\/p>\n<p>                      (v)   no  Competitive  Bid Loan shall have a maturity date<br \/>\n                  subsequent to the Revolving Credit Termination Date.<\/p>\n<p>                  (b)  When  the  Borrower  wishes  to  request  offers  to make<br \/>\nCompetitive  Bid Loans, it shall give the Agent (which shall promptly notify the<br \/>\nLenders) notice (a &#8220;Competitive Bid Quote Request&#8221;) to be received no later than<br \/>\n11:00  a.m.  on (x) the  fourth  Business  Day  prior to the  date of  borrowing<br \/>\nproposed  therein,  in the case of a Eurodollar  Auction or (y) the Business Day<br \/>\nnext  preceding  the  date of  borrowing  proposed  therein,  in the  case of an<br \/>\nAbsolute  Rate  Auction  (or, in any such case,  such other time and date as the<br \/>\nBorrower and the Agent,  with the consent of the Required  Lenders,  may agree).<br \/>\nThe Borrower may request  offers to make  Competitive  Bid Loans for up to three<br \/>\n(3) different  Interest  Periods in a single notice (for which purpose  Interest<br \/>\nPeriods in different  lettered  clauses of the  definition of the term &#8220;Interest<br \/>\nPeriod&#8221;  shall be  deemed  to be  different  Interest  Periods  even if they are<br \/>\ncoterminous);  provided that the request for each separate Interest Period shall<br \/>\nbe  deemed  to be a  separate  Competitive  Bid  Quote  Request  for a  separate<br \/>\nborrowing (a &#8220;Competitive  Bid Borrowing&#8221;) and there shall not be outstanding at<br \/>\nany  one  time  more  than  four  (4)  Competitive  Bid  Borrowings.  Each  such<br \/>\nCompetitive  Bid Quote Request shall be  substantially  in the form of Exhibit J<br \/>\nand shall specify as to each Competitive Bid Borrowing:<\/p>\n<p>                       (i)        the  proposed  date  of such  Competitive  Bid<br \/>\n                  Borrowing, which shall be a Business Day;<\/p>\n<p>                      (ii)  the  aggregate   amount  of  such   Competitive  Bid<br \/>\n                  Borrowing,  which shall be at least  $10,000,000  (or a larger<br \/>\n                  integral  multiple  of  $1,000,000)  but  shall  not cause the<br \/>\n                  limits specified in Section 2.2(a) to be violated;<\/p>\n<p>                     (iii)  the  duration  of  the  Interest  Period  applicable<br \/>\n                  thereto;<\/p>\n<p>                      (iv) whether the  Competitive  Bid Quotes  requested for a<br \/>\n                  particular  Interest  Period are seeking quotes for Eurodollar<br \/>\n                  Market Loans or Absolute Rate Loans; and<\/p>\n<p>                       (v)      if  the  Competitive  Bid  Quotes  requested are<br \/>\n                  seeking quotes for Absolute Rate Loans, the date on which<\/p>\n<p>                                       36<\/p>\n<p>                  the Competitive Bid Quotes are to be submitted if it is before<br \/>\n                  the  proposed  date  of  borrowing  (the  date on  which  such<br \/>\n                  Competitive  Bid  Quotes  are to be  submitted  is called  the<br \/>\n                  &#8220;Quotation Date&#8221;).<\/p>\n<p>Except as otherwise  provided in this Section  2.2(b),  no Competitive Bid Quote<br \/>\nRequest  shall be given within five (5)  Business  Days (or such other number of<br \/>\ndays as the  Borrower and the Agent,  with the consent of the Required  Lenders,<br \/>\nmay agree) of any other Competitive Bid Quote Request.<\/p>\n<p>                  (c) (i) Each  Lender may submit  one or more  Competitive  Bid<br \/>\nQuotes,  each  containing an offer to make a Competitive Bid Loan in response to<br \/>\nany  Competitive  Bid Quote Request;  provided  that, if the Borrower&#8217;s  request<br \/>\nunder Section 2.2(b)  specified more than one Interest  Period,  such Lender may<br \/>\nmake a single submission  containing one or more Competitive Bid Quotes for each<br \/>\nsuch Interest Period.  Each Competitive Bid Quote must be submitted to the Agent<br \/>\nnot later than (x) 2:00 p.m. on the fourth  Business  Day prior to the  proposed<br \/>\ndate of borrowing,  in the case of a Eurodollar Auction or (y) 10:00 a.m. on the<br \/>\nQuotation  Date,  in the case of an Absolute Rate Auction (or, in any such case,<br \/>\nsuch other time and date as the Borrower and the Agent,  with the consent of the<br \/>\nRequired  Lenders,  may agree);  provided that any  Competitive Bid Quote may be<br \/>\nsubmitted by NationsBank (or its Applicable  Lending Office) only if NationsBank<br \/>\n(or such Applicable  Lending  Office)  notifies the Borrower of the terms of the<br \/>\noffer contained  therein not later than (x) 1:00 p.m. on the fourth Business Day<br \/>\nprior to the proposed date of borrowing,  in the case of a Eurodollar Auction or<br \/>\n(y) 9:45 a.m. on the  Quotation  Date,  in the case of an Absolute Rate Auction.<br \/>\nSubject to Article IV, Article VI and Article IX, any  Competitive  Bid Quote so<br \/>\nmade shall be  irrevocable  except  with the  consent of the Agent  given on the<br \/>\ninstructions of the Borrower.<\/p>\n<p>                      (ii) Each  Competitive Bid Quote shall be substantially in<br \/>\nthe form of Exhibit K and shall specify:<\/p>\n<p>                                    (A)   the proposed date of borrowing and the<br \/>\n                           Interest Period therefor;<\/p>\n<p>                                    (B) the principal  amount of the Competitive<br \/>\n                           Bid Loan for which each such Competitive Bid Quote is<br \/>\n                           being made,  which principal amount shall be at least<br \/>\n                           $5,000,000   (or  a  larger   integral   multiple  of<br \/>\n                           $1,000,000);  provided that the  aggregate  principal<br \/>\n                           amount  of all  Competitive  Bid  Loans  for  which a<br \/>\n                           Lender  submits  Competitive  Bid  Quotes (x) may not<br \/>\n                           exceed the Revolving Credit Commitment of such Lender<br \/>\n                           and (y) may not  exceed the  principal  amount of the<br \/>\n                           Competitive  Bid Borrowing for a particular  Interest<br \/>\n                           Period for which offers were requested;<\/p>\n<p>                                       37<\/p>\n<p>                                    (C) in the case of a Eurodollar Auction, the<br \/>\n                           margin  above  or  below  the  applicable   Interbank<br \/>\n                           Offered  Rate  adjusted  for any  Eurodollar  Reserve<br \/>\n                           Percentage (the &#8220;Eurodollar Margin&#8221;) offered for each<br \/>\n                           such Competitive Bid Loan,  expressed as a percentage<br \/>\n                           (rounded  upwards,  if  necessary,   to  the  nearest<br \/>\n                           1\/10,000th of 1%) to be added to or  subtracted  from<br \/>\n                           the applicable Interbank Offered Rate as so adjusted;<\/p>\n<p>                                    (D) in the case of an Absolute Rate Auction,<br \/>\n                           the rate of interest per annum (rounded  upwards,  if<br \/>\n                           necessary,  to the nearest  1\/10,000th of 1%) offered<br \/>\n                           for each such  Competitive  Bid Loan  (the  &#8220;Absolute<br \/>\n                           Rate&#8221;); and<\/p>\n<p>                                    (E) the identity of the quoting Lender.<\/p>\n<p>Unless otherwise agreed by the Agent and the Borrower,  no Competitive Bid Quote<br \/>\nshall contain qualifying, conditional or similar language or propose terms other<br \/>\nthan or in addition to those set forth in the applicable  Competitive  Bid Quote<br \/>\nRequest and, in  particular,  no Competitive  Bid Quote may be conditioned  upon<br \/>\nacceptance by the Borrower of all (or some  specified  minimum) of the principal<br \/>\namount of the Competitive Bid Loan for which such Competitive Bid Quote is being<br \/>\nmade.<\/p>\n<p>                  (d) The Agent shall (x) in the case of a  Eurodollar  Auction,<br \/>\nby 4:00 p.m. on the day a Competitive  Bid Quote is submitted or (y) in the case<br \/>\nof an Absolute Rate Auction,  as promptly as practicable  after the  Competitive<br \/>\nBid  Quote is  submitted  (but in any event not later  than  10:30  a.m.  on the<br \/>\nQuotation  Date),  notify the Borrower of the terms (i) of any  Competitive  Bid<br \/>\nQuote  submitted by a Lender that is in accordance  with Section 2.2(c) and (ii)<br \/>\nof any Competitive Bid Quote that amends,  modifies or is otherwise inconsistent<br \/>\nwith a previous  Competitive  Bid Quote submitted by such Lender with respect to<br \/>\nthe same  Competitive  Bid Quote Request.  Any such  subsequent  Competitive Bid<br \/>\nQuote shall be disregarded by the Agent unless such  subsequent  Competitive Bid<br \/>\nQuote is submitted solely to correct a manifest error in such former Competitive<br \/>\nBid Quote.  The Agent&#8217;s  notice to the Borrower  shall specify (A) the aggregate<br \/>\nprincipal  amount of the  Competitive  Bid Borrowing for which  Competitive  Bid<br \/>\nQuotes  have  been  received  and  (B)  the  respective  principal  amounts  and<br \/>\nEurodollar  Margins or  Absolute  Rates,  as the case may be, so offered by each<br \/>\nLender (identifying the Lender that made each Competitive Bid Quote).<\/p>\n<p>                  (e) Not later than 11:00 a.m.  on (x) the third  Business  Day<br \/>\nprior to the proposed date of borrowing,  in the case of a Eurodollar Auction or<br \/>\n(y) the Quotation Date, in the case of an Absolute Rate Auction (or, in any such<br \/>\ncase,  such other time and date as the Borrower and the Agent,  with the consent<br \/>\nof the<\/p>\n<p>                                       38<\/p>\n<p>Required  Lenders,  may  agree),  the  Borrower  shall  notify  the Agent of its<br \/>\nacceptance or  nonacceptance of the offers so notified to it pursuant to Section<br \/>\n2.2(d) (and the  failure of the  Borrower to give such notice by such time shall<br \/>\nconstitute  nonacceptance)  and the Agent shall  promptly  notify each  affected<br \/>\nLender.  In the case of  acceptance,  such notice  shall  specify the  aggregate<br \/>\nprincipal  amount of offers for each  Interest  Period  that are  accepted.  The<br \/>\nBorrower may accept any Competitive Bid Quote in whole or in part (provided that<br \/>\nany  Competitive  Bid Quote  accepted in part shall be at least  $5,000,000 or a<br \/>\nlarger integral multiple of $1,000,000); provided that:<\/p>\n<p>                      (i) the aggregate principal amount of each Competitive Bid<br \/>\n                  Borrowing  may not exceed the  applicable  amount set forth in<br \/>\n                  the related Competitive Bid Quote Request;<\/p>\n<p>                      (ii) the aggregate  principal  amount of each  Competitive<br \/>\n                  Bid  Borrowing  shall  be at  least  $10,000,000  (or a larger<br \/>\n                  integral  multiple  of  $1,000,000)  but  shall  not cause the<br \/>\n                  limits specified in Section 2.2(a) to be violated;<\/p>\n<p>                     (iii)  acceptance  of offers may be made only in  ascending<br \/>\n                  order of Eurodollar Margins or Absolute Rates, as the case may<br \/>\n                  be, in each case  beginning  with the lowest  rate so offered;<br \/>\n                  provided,  however, that the Borrower, in its sole discretion,<br \/>\n                  may accept other than the lowest rate where  acceptance of the<br \/>\n                  lowest  rate will  result in (x) the  outstanding  Loans other<br \/>\n                  than Line of Credit Loans of a Lender or Lenders  offering the<br \/>\n                  lowest  rate   exceeding   such  Lender&#8217;s   Revolving   Credit<br \/>\n                  Commitment  and (y) an  increase  in the Unused Fee payable by<br \/>\n                  Borrower under Section 2.11(a); and<\/p>\n<p>                      (iv) the Borrower may not accept any offer where the Agent<br \/>\n                  has  correctly  advised the Borrower  that such offer fails to<br \/>\n                  comply with Section  2.2(c)(ii)  or otherwise  fails to comply<br \/>\n                  with the  requirements of this Agreement  (including,  without<br \/>\n                  limitation, Section 2.2(a)).<\/p>\n<p>If offers are made by two or more  Lenders with the same  Eurodollar  Margins or<br \/>\nAbsolute Rates,  as the case may be, for a greater  aggregate  principal  amount<br \/>\nthan the amount in respect of which offers are  permitted to be accepted for the<br \/>\nrelated Interest Period after the acceptance of all offers, if any, of all lower<br \/>\nEurodollar  Margins or Absolute Rates, as the case may be, offered by any Lender<br \/>\nfor such related Interest Period,  the principal amount of Competitive Bid Loans<br \/>\nin respect of which such offers are accepted  shall be allocated by the Borrower<br \/>\namong such Lenders as nearly as possible (in amounts of at least  $5,000,000  or<br \/>\nlarger  integral  multiples  of  $1,000,000)  in  proportion  to  the  aggregate<br \/>\nprincipal amount of such offers. Determinations by the Borrower of the<\/p>\n<p>                                       39<\/p>\n<p>amounts of Competitive Bid Loans and the lowest bid after adjustment as provided<br \/>\nin Section 2.2(e)(iii) shall be conclusive in the absence of manifest error.<\/p>\n<p>                  (f) Any Lender  whose offer to make any  Competitive  Bid Loan<br \/>\nhas been accepted shall,  not later than 1:00 p.m. on the date specified for the<br \/>\nmaking of such Loan,  make the amount of such Loan available to the Agent at the<br \/>\nPrincipal  Office in Dollars and in immediately  available funds, for account of<br \/>\nthe  Borrower.  The amount so received by the Agent shall,  subject to the terms<br \/>\nand conditions of this Agreement, be made available to the Borrower on such date<br \/>\nby depositing the same, in Dollars and in  immediately  available  funds,  in an<br \/>\naccount of the Borrower maintained at the Principal Office.<\/p>\n<p>         2.3.     Payment of  Interest.  (a)  The Borrower shall pay interest to<br \/>\nthe Agent for the account of each Lender on the outstanding and unpaid principal<br \/>\namount of each Loan made by such Lender for the period commencing on the date of<br \/>\nsuch Loan until such Loan shall be due at the then applicable Base Rate for Base<br \/>\nRate Loans or applicable  Fixed Rate for Fixed Rate Loans,  as designated by the<br \/>\nAuthorized  Representative  pursuant  to Section 2.1 or Section  2.2;  provided,<br \/>\nhowever,  that if any amount payable under this Agreement shall not be paid when<br \/>\ndue (at maturity,  by  acceleration  or otherwise,  subject to the provisions of<br \/>\nSection  9.1(a)),   all  amounts  outstanding   hereunder  shall  bear  interest<br \/>\nthereafter at the Default Rate.<\/p>\n<p>                  (b)  Interest on  each Loan shall be computed on an Actual\/360<br \/>\nBasis.  Interest on each Loan shall be paid (i) quarterly in arrears on the last<br \/>\nBusiness Day of each March,  June,  September and December,  commencing June 30,<br \/>\n1996, for each Base Rate Loan,  (ii) on the last day of the applicable  Interest<br \/>\nPeriod for each Fixed Rate Loan and, if such  Interest  Period  extends for more<br \/>\nthan three (3) months,  at  intervals of three (3) months after the first day of<br \/>\nsuch  Interest  Period,  and (iii) upon the Line of Credit  Termination  Date or<br \/>\nRevolving Credit  Termination  Date, as the case may be. Interest payable at the<br \/>\nDefault Rate shall be payable on demand.<\/p>\n<p>         2.4.     Payment of Principal.  The principal  amount of each Revolving<br \/>\nLoan  shall be due and  payable to the Agent for the  benefit of each  Lender in<br \/>\nfull on the  Revolving  Credit  Termination  Date,  or earlier  as  specifically<br \/>\nprovided  herein.  The principal amount of each Line of Credit Loan shall be due<br \/>\nand  payable to the Agent for the  benefit of each  Lender in full on the Stated<br \/>\nTermination  Date, or earlier as  specifically  provided  herein.  The principal<br \/>\namount of each  Competitive  Bid Loan shall be due and  payable to the Agent for<br \/>\nthe  benefit of the  applicable  Lender in full on the last day of the  Interest<br \/>\nPeriod  applicable  thereto,  or earlier as specifically  provided  herein.  The<br \/>\nprincipal amount of any Base Rate Loan may be prepaid in whole or in part at any<br \/>\ntime. The principal amount of any Fixed Rate Loan may be prepaid only at<\/p>\n<p>                                       40<\/p>\n<p>the end of the applicable  Interest  Period unless the Borrower shall pay to the<br \/>\nAgent for the account of the Lenders the  additional  amount,  if any,  required<br \/>\nunder  Section 4.2. All  prepayments  of  Syndicated  Loans made by the Borrower<br \/>\nshall be in the amount of $5,000,000 or such greater amount which is an integral<br \/>\nmultiple of $1,000,000, or the amount equal to all Revolving Credit Outstandings<br \/>\nor Line of  Credit  Outstandings,  as the case may be, or such  other  amount as<br \/>\nnecessary to comply with Section 2.1(c) or Section 2.9.<\/p>\n<p>         2.5. Non-Conforming  Payments. (a) Each payment of principal (including<br \/>\nany  prepayment) and payment of interest and fees, and any other amount required<br \/>\nto be paid to the Lenders with respect to the Loans,  shall be made to the Agent<br \/>\nat the  Principal  Office,  for the  account of each  Lender,  in Dollars and in<br \/>\nimmediately  available  funds before 10:00 A.M. on the date such payment is due.<br \/>\nThe Agent  may,  but shall not be  obligated  to,  debit the  amount of any such<br \/>\npayment which is not made by such time to any ordinary deposit account,  if any,<br \/>\nof the Borrower with the Agent.  The Agent shall promptly notify the Borrower of<br \/>\nany such  debit;  however,  failure  to give such  notice  shall not  affect the<br \/>\nvalidity of such debit.<\/p>\n<p>              (b) The Agent shall deem any  payment  made by or on behalf of the<br \/>\nBorrower hereunder that is not made both in Dollars and in immediately available<br \/>\nfunds and prior to 10:00 A.M. to be a non-conforming  payment.  Any such payment<br \/>\nshall not be deemed to be  received by the Agent until the later of (i) the time<br \/>\nsuch  funds  become  available  funds  and  (ii)  the  next  Business  Day.  Any<br \/>\nnon-conforming  payment may  constitute or become a Default or Event of Default.<br \/>\nInterest shall continue to accrue on any principal as to which a  non-conforming<br \/>\npayment  is made  until the later of (x) the date such  funds  become  available<br \/>\nfunds or (y) the next Business Day at the Default Rate from the date such amount<br \/>\nwas due and payable.<\/p>\n<p>              (c) In the event  that any  payment  hereunder  or under the Notes<br \/>\nbecomes due and payable on a day other than a Business  Day,  then such due date<br \/>\nshall be extended to the next succeeding  Business Day unless provided otherwise<br \/>\nunder clause (ii) of the definition of &#8220;Interest Period&#8221;; provided that interest<br \/>\nshall  continue to accrue  during the period of any such  extension and provided<br \/>\nfurther,  that in no  event  shall  any such due  date be  extended  beyond  the<br \/>\nRevolving  Credit  Termination Date or Line of Credit  Termination  Date, as the<br \/>\ncase may be.<\/p>\n<p>         2.6.     Notes.  (a)  Revolving  Loans  made by each  Lender  shall  be<br \/>\nevidenced  by the  Revolving  Note  payable  to the order of such  Lender in the<br \/>\nrespective  amount of its  Applicable  Commitment  Percentage  of the  Revolving<br \/>\nCredit  Commitment,  which  Revolving  Note shall be dated the Closing Date or a<br \/>\nlater date pursuant to an Assignment and Acceptance and shall be duly completed,<br \/>\nexecuted and delivered by the Borrower.<\/p>\n<p>                                       41<\/p>\n<p>         (b) Line of Credit  Loans made by each Lender shall be evidenced by the<br \/>\nLine of Credit Note payable to the order of such Lender in the respective amount<br \/>\nof its Applicable Commitment Percentage of the Line of Credit Commitment,  which<br \/>\nLine of Credit Note shall be dated the Closing Date or a later date  pursuant to<br \/>\nan Assignment and Acceptance and shall be duly completed, executed and delivered<br \/>\nby the Borrower.<\/p>\n<p>         (c) Competitive Bid Loans made by each Lender shall be evidenced by the<br \/>\nCompetitive  Bid Note payable to the order of such Lender and  representing  the<br \/>\nobligation of the Borrower to pay the lesser of (a) the aggregate  amount of the<br \/>\nRevolving  Credit  Commitment of such Lender and (b) the unpaid principal amount<br \/>\nof all  Competitive  Bid Loans made by such Lender,  with interest on the unpaid<br \/>\nprincipal  amount from time to time  outstanding  of each  Competitive  Bid Loan<br \/>\nevidenced thereby as prescribed in Section 2.3. Each Lender is hereby authorized<br \/>\nto record the date and amount of each  Competitive Bid Loan made by such Lender,<br \/>\nthe  maturity  date  thereof,  the date and amount of each  payment of principal<br \/>\nthereof and the interest rate with respect  thereto on the schedule  attached to<br \/>\nand  constituting  part of its  Competitive  Bid Note, and any such  recordation<br \/>\nshall  constitute  prima facie  evidence of the accuracy of the  information  so<br \/>\nrecorded; provided, however, that the failure to make any such recordation shall<br \/>\nnot affect the  obligations of the Borrower  hereunder or under any  Competitive<br \/>\nBid Note.  Each  Competitive Bid Note shall be dated the Closing Date or a later<br \/>\ndate  pursuant to an  Assignment  and  Acceptance  and shall be duly  completed,<br \/>\nexecuted and delivered by the Borrower.<\/p>\n<p>         2.7.     Pro Rata Payments.  Except as otherwise  provided herein,  (a)<br \/>\neach payment on account of the principal of and interest on the Syndicated Loans<br \/>\nand the fees  described in Section 2.11 and the first sentence of Section 3.3(a)<br \/>\nshall be made to the Agent for the  account  of the  Lenders  pro rata  based on<br \/>\ntheir  Applicable  Commitment  Percentages,  (b) all  payments to be made by the<br \/>\nBorrower  for the  account  of each of the  Lenders  on  account  of  principal,<br \/>\ninterest  and fees,  shall be made without  diminution,  setoff,  recoupment  or<br \/>\ncounterclaim,  and (c) the Agent  will  promptly  distribute  to the  Lenders in<br \/>\nimmediately  available funds payments  received in fully collected,  immediately<br \/>\navailable funds from the Borrower.<\/p>\n<p>         2.8.     Reductions.  The Borrower shall, by irrevocable notice from an<br \/>\nAuthorized  Representative,  have  the  right  from  time to time  but not  more<br \/>\nfrequently than once each calendar month,  upon not less than three (3) Business<br \/>\nDays&#8217; written notice to the Agent, effective upon receipt, to permanently reduce<br \/>\nthe Total Revolving  Credit  Commitment or the Total Line of Credit  Commitment.<br \/>\nThe Agent shall give each Lender, within one (1) Business Day of receipt of such<br \/>\nnotice,  telefacsimile  notice, or telephonic notice (confirmed in writing),  of<br \/>\nsuch  reduction.  Each  such  reduction  shall  be in the  aggregate  amount  of<br \/>\n$10,000,000 or such greater amount which is<\/p>\n<p>                                       42<\/p>\n<p>in an integral  multiple of $1,000,000,  or the entire remaining Total Revolving<br \/>\nCredit Commitment or the Total Line of Credit Commitment,  and shall permanently<br \/>\nreduce  the  Total  Revolving  Credit  Commitment  or the  Total  Line of Credit<br \/>\nCommitment,  as the case may be. Each  reduction of the Total  Revolving  Credit<br \/>\nCommitment   shall  be  accompanied  by  payment  of  the  Revolving  Loans  and<br \/>\nCompetitive  Bid Loans to the  extent  that the  principal  amount of  Revolving<br \/>\nCredit   Outstandings  plus  Letter  of  Credit  Outstandings  plus  outstanding<br \/>\nCompetitive Bid Loans exceeds the Total Revolving Credit Commitment after giving<br \/>\neffect to such  reduction,  together  with  accrued  and unpaid  interest on the<br \/>\namounts prepaid.  Each reduction of the Total Line of Credit Commitment shall be<br \/>\naccompanied  by payment of Line of Credit Loans to the extent that the principal<br \/>\namount  of Line  of  Credit  Outstandings  exceeds  the  Total  Line  of  Credit<br \/>\nCommitment  after giving  effect to such  reduction,  together  with accrued and<br \/>\nunpaid  interest on the amounts  prepaid.  If any such reduction shall result in<br \/>\nthe  payment of any Fixed  Rate Loan other than on the last day of the  Interest<br \/>\nPeriod of such Fixed Rate Loan such  prepayment  shall be accompanied by amounts<br \/>\ndue, if any, under Section 4.2.<\/p>\n<p>         2.9.     Conversions  and  Elections of  Subsequent  Interest  Periods.<br \/>\nProvided  that no  Default  or Event  of  Default  shall  have  occurred  and be<br \/>\ncontinuing and subject to the limitations set forth below and in Article IV, the<br \/>\nBorrower may:<\/p>\n<p>                  (a)       upon delivery, effective upon receipt, of a properly<br \/>\ncompleted Interest Rate Selection Notice to the Agent on or before 10:30 A.M. on<br \/>\nany Business Day,  convert all or a part of  Eurodollar  Rate Loans under either<br \/>\nthe Revolving  Credit Facility or the Line of Credit Facility to Base Rate Loans<br \/>\non the last day of the Interest Period for such Eurodollar Rate Loans; and<\/p>\n<p>                  (b)       upon delivery, effective upon receipt, of a properly<br \/>\ncompleted  Interest Rate  Selection  Notice to the Agent on or before 10:30 A.M.<br \/>\nthree (3) Business Days prior to the date of such election or conversion:<\/p>\n<p>                            (i)     elect a subsequent  Interest  Period for all<br \/>\n                  or a  portion  of  Eurodollar  Rate  Loans  under  either  the<br \/>\n                  Revolving  Credit  Facility or the Line of Credit  Facility to<br \/>\n                  begin on the last day of the then current  Interest Period for<br \/>\n                  such Eurodollar Rate Loans; and<\/p>\n<p>                            (ii)    convert  Base Rate  Loans  under  either the<br \/>\n                  Revolving  Credit  Facility or the Line of Credit  Facility to<br \/>\n                  Eurodollar Rate Loans on any Business Day.<\/p>\n<p>         Each  election  and  conversion  pursuant to this  Section 2.9 shall be<br \/>\nsubject to the  limitations on Eurodollar Rate Loans set forth in the definition<br \/>\nof  &#8220;Interest  Period&#8221;  herein and in  Sections  2.1 and 2.4 and Article IV. The<br \/>\nAgent  shall give  written  notice to each  Lender of such notice of election or<br \/>\nconversion prior to 3:00<\/p>\n<p>                                       43<\/p>\n<p>P.M.  on the day such notice of election or  conversion  is  received.  All such<br \/>\ncontinuations  or  conversions  of Loans shall be effected pro rata based on the<br \/>\nApplicable Commitment Percentages of the Lenders.<\/p>\n<p>         2.10.    Increase  and  Decrease  in  Amounts.  The amount of the Total<br \/>\nRevolving Credit Commitment which shall be available to the Borrower as Advances<br \/>\nshall be reduced by the aggregate amount of Letter of Credit Outstandings.<\/p>\n<p>         2.11.   Unused Fees.<\/p>\n<p>         (a) Revolving Credit Facility.  For the period beginning on the Closing<br \/>\nDate and ending on the Revolving Credit Termination Date, the Borrower agrees to<br \/>\npay to the Agent,  for the  benefit of each  Lender,  an unused fee equal to the<br \/>\nApplicable  Unused Fee  multiplied  by the average  daily Unused  Amount of such<br \/>\nLender.  Such fees  shall be due in  arrears  on the last  Business  Day of each<br \/>\nMarch,  June,  September  and  December  commencing  June 30, 1996 to and on the<br \/>\nRevolving Credit Termination Date.<\/p>\n<p>         (b) Line of Credit  Facility.  For the period  beginning on the Closing<br \/>\nDate and ending on the Line of Credit  Termination  Date, the Borrower agrees to<br \/>\npay to the  Agent,  for the pro  rata  benefit  of the  Lenders  based  on their<br \/>\nApplicable Commitment Percentages,  an unused fee equal to the Applicable Unused<br \/>\nFee  multiplied  by the average  daily  amount by which the Total Line of Credit<br \/>\nCommitment   exceeds  the   aggregate   principal   amount  of  Line  of  Credit<br \/>\nOutstandings. Such fees shall be due in arrears on the last Business Day of each<br \/>\nMarch, June,  September and December commencing June 30, 1996 to and on the Line<br \/>\nof Credit Termination Date.<\/p>\n<p>         (c) Notwithstanding the foregoing,  so long as any Lender fails to make<br \/>\navailable  any  portion of its  Revolving  Credit  Commitment  or Line of Credit<br \/>\nCommitment when requested,  such Lender shall not be entitled to receive payment<br \/>\nof its pro rata share of such fees until such Lender shall make  available  such<br \/>\nportion.  All fees payable  pursuant to this Section 2.11 shall be calculated on<br \/>\nan Actual\/360 Basis.<\/p>\n<p>         2.12.     Deficiency  Advances.  No Lender shall be responsible for any<br \/>\ndefault of any other Lender in respect of such other Lender&#8217;s obligation to make<br \/>\nany Loan or fund its  purchase  of any  Participation  hereunder  nor  shall the<br \/>\nRevolving Credit Commitment or Line of Credit Commitment of any Lender hereunder<br \/>\nbe increased as a result of such default of any other Lender.  Without  limiting<br \/>\nthe generality of the  foregoing,  in the event any Lender shall fail to advance<br \/>\nfunds to the Borrower under the Revolving  Credit Facility or the Line of Credit<br \/>\nFacility as herein provided,  the Agent may in its discretion,  but shall not be<br \/>\nobligated to,  advance  under the Revolving  Note or Line of Credit Note, as the<br \/>\ncase may be,  in its  favor as a Lender  all or any  portion  of such  amount or<br \/>\namounts (each, a &#8220;deficiency advance&#8221;) and shall thereafter be<\/p>\n<p>                                       44<\/p>\n<p>entitled to payments of principal of and interest on such deficiency  advance in<br \/>\nthe same  manner  and at the same  interest  rate or rates to which  such  other<br \/>\nLender would have been  entitled had it made such  advance  under its  Revolving<br \/>\nNote or Line of Credit Note, as the case may be;  provided that, upon payment to<br \/>\nthe Agent from such other Lender of the entire  outstanding  amount of each such<br \/>\ndeficiency advance,  together with accrued and unpaid interest thereon, from the<br \/>\nmost recent date or dates interest was paid to the Agent by the Borrower on each<br \/>\nLoan  comprising  such  deficiency  advance at the  interest  rate per annum for<br \/>\novernight  borrowing  by the Agent from the Federal  Reserve  Bank of  Richmond,<br \/>\nVirginia, then such payment shall be credited against the applicable Note of the<br \/>\nAgent in full  payment of such  deficiency  advance  and the  Borrower  shall be<br \/>\ndeemed to have  borrowed the amount of such  deficiency  advance from such other<br \/>\nLender as of the most recent  date or dates,  as the case may be, upon which any<br \/>\npayments of interest were made by the Borrower thereon.<\/p>\n<p>         2.13.  Use of  Proceeds.  The  proceeds  of the Loans made  pursuant to<br \/>\nthis  Agreement  shall  be used  by the  Borrower  to  provide  funding  for the<br \/>\nacquisition and development of Facilities and to provide for the working capital<br \/>\nneeds  and  other  corporate  purposes  of the  Borrower  and  its  Consolidated<br \/>\nEntities.<\/p>\n<p>         2.14. (a)  Extension  of Stated  Termination  Date.  At the  request of<br \/>\nthe  Borrower  the Lenders  may, in their sole  discretion,  elect to extend the<br \/>\nStated  Termination Date then in effect for additional periods of up to 364 days<br \/>\neach; provided, however, that at no time shall the committed term of the Line of<br \/>\nCredit  Facility  exceed 364 days.  The Borrower shall notify the Lenders of its<br \/>\nrequest for such an extension by delivering to the Agent and the Lenders  notice<br \/>\nof such request signed by an Authorized Representative not more than ninety (90)<br \/>\ndays nor less than sixty (60) days prior to the Stated  Termination Date then in<br \/>\neffect.  If the  Lenders  shall elect to so extend,  the Agent shall  notify the<br \/>\nBorrower in writing  within  sixty (60) days of its receipt of such  request for<br \/>\nextension  of the  decision  of the  Lenders  as to whether to extend the Stated<br \/>\nTermination Date. Failure by any Lender to respond to a request for an extension<br \/>\nshall constitute a refusal of such Lender to give its consent to such extension.<br \/>\nFailure by the Agent to give such notice shall constitute refusal by the Lenders<br \/>\nto extend the Stated  Termination  Date.  The Borrower,  with the consent of the<br \/>\nAgent,  shall be entitled to replace any Lender who is  unwilling  to consent to<br \/>\nthe  extension of the Stated  Termination  Date.  Any Lender which elects not to<br \/>\nconsent to an  extension  shall  cooperate  with the  Borrower  and the Agent in<br \/>\nassigning  its interest as provided in Section  11.1 to a new lender;  provided,<br \/>\nall  obligations to such  assigning  Lender shall be paid in full, no assignment<br \/>\nfee shall be payable by such assigning  Lender but shall be paid by Borrower and<br \/>\nsuch  assigning  Lender shall be entitled to the benefits of this  Agreement set<br \/>\nforth in Sections 3.2(g),  11.6, and 11.12 and Article IV. In no event shall the<br \/>\nStated Termination Date extend beyond the Revolving Credit Termination Date.<\/p>\n<p>                                       45<\/p>\n<p>         (b)      Amortization  of  Line  of  Credit  Loans  Outstanding  at the<br \/>\nMaturity Date.<\/p>\n<p>                  (i) Election to Amortize.  The Borrower  shall have the option<br \/>\n         to pay all of the outstanding  principal  balance of the Line of Credit<br \/>\n         Loans outstanding as of the Line of Credit  Termination Date,  provided<br \/>\n         the Line of  Credit  Termination  Date  occurs on or prior to March 31,<br \/>\n         1999, in eight (8) equal consecutive quarterly installments on the last<br \/>\n         day of each March,  June,  September and December  commencing  with the<br \/>\n         first of such dates to occur after the Line of Credit  Termination Date<br \/>\n         (each such date referred to herein as a &#8220;Term Loan  Amortization  Date&#8221;<br \/>\n         and the last such date referred to herein as the &#8220;Term Loan Termination<br \/>\n         Date&#8221;).  The Borrower may exercise such option by giving written notice<br \/>\n         to the Agent at least  fifteen  (15)  days  prior to the Line of Credit<br \/>\n         Termination  Date.  In the event the Line of  Credit  Termination  Date<br \/>\n         shall occur  subsequent  to March 31, 1999 the Borrower  shall have the<br \/>\n         option upon the giving of fifteen (15) days&#8217; notice prior to the end of<br \/>\n         a calendar  quarter to pay the then outstanding Line of Credit Loans in<br \/>\n         quarterly  installments,  which  installments shall be in approximately<br \/>\n         equal  amounts  determined  by  dividing  the  number of full  calendar<br \/>\n         quarters  remaining  from the date of  exercise of such option to March<br \/>\n         31, 2001 by such  outstanding  Line of Credit Loans.  If the Agent does<br \/>\n         not receive such  notification  within the time period specified in the<br \/>\n         preceding  two  sentences  (and unless such Line of Credit  Termination<br \/>\n         Date has been extended in accordance  with the terms of subsection  (a)<br \/>\n         above),  the principal  amount of all Line of Credit Loans shall be due<br \/>\n         and  payable  on the Line of Credit  Termination  Date.  Line of Credit<br \/>\n         Loans remaining  outstanding after the Line of Credit  Termination Date<br \/>\n         at the  election of the Borrower in  accordance  with the terms of this<br \/>\n         subsection (b) shall be referred to  collectively  as the &#8220;Term Loans&#8221;.<br \/>\n         The Term Loans may be comprised of Base Rate Loans and Eurodollar  Rate<br \/>\n         Loans as the  Borrower  may  elect in  accordance  with the  provisions<br \/>\n         hereof.  Amounts  repaid  or  prepaid  on the  Term  Loans  may  not be<br \/>\n         reborrowed.  For  purposes  of this  Agreement,  in the event  that the<br \/>\n         Borrower  shall elect to amortize the Line of Credit Loans  outstanding<br \/>\n         as of the Line of Credit Termination Date in accordance herewith,  then<br \/>\n         on and after the Line of Credit  Termination Date (x) references herein<br \/>\n         to the  &#8220;Total  Line of Credit  Commitment&#8221;  shall  mean the  aggregate<br \/>\n         principal amount of the Term Loans as of the Line of Credit Termination<br \/>\n         Date less all payments  made or required to be made with respect to the<br \/>\n         Term Loans hereunder, whether scheduled amortization payment, voluntary<br \/>\n         or optional prepayment or otherwise,  (y) references herein to &#8220;Line of<br \/>\n         Credit  Commitment&#8221;  shall  mean,  with  respect  to each  Lender,  the<br \/>\n         obligation  of such  Lender to make Term  Loans in a  principal  amount<br \/>\n         equal  to  such  Lender&#8217;s  Applicable   Commitment  Percentage  of  the<br \/>\n         aggregate  Term  Loans  and (z)  references  herein  to &#8220;Line of Credit<br \/>\n         Termination Date&#8221;<\/p>\n<p>                                       46<\/p>\n<p>         shall mean the Term Loan Termination  Date. Any prepayments of the Term<br \/>\n         Loan shall be applied to installments of principal in the inverse order<br \/>\n         of maturities.<\/p>\n<p>                  (ii)  Interest  on Term  Loans.  The  Term  Loans  shall  bear<br \/>\n         interest  on the same terms as apply to Line of Credit  Loans  prior to<br \/>\n         the Line of Credit Termination Date.<\/p>\n<p>                                       47<\/p>\n<p>                                   ARTICLE III<\/p>\n<p>         3.1. Letters of Credit.  The Issuing Bank agrees,  subject to the terms<br \/>\nand  conditions  of this  Agreement,  upon request of the Borrower to issue from<br \/>\ntime to time for the account of the Borrower  Letters of Credit upon delivery to<br \/>\nthe Issuing Bank of an Application  and Agreement for Letter of Credit  relating<br \/>\nthereto in form and content acceptable to the Issuing Bank;  provided,  that (i)<br \/>\nthe Letter of Credit  Outstandings  shall not exceed the Total  Letter of Credit<br \/>\nCommitment,  (ii) no Letter of Credit shall be issued so long as a Default or an<br \/>\nEvent of Default has occurred or is continuing or if the  applicable  conditions<br \/>\nset forth in  Article V shall  not have  been  satisfied  and (iii) no Letter of<br \/>\nCredit  shall be  issued  if,  after  giving  effect  thereto,  Letter of Credit<br \/>\nOutstandings   plus  the  aggregate   principal   amount  of  Revolving   Credit<br \/>\nOutstandings  and  outstanding  Competitive  Bid Loans  shall  exceed  the Total<br \/>\nRevolving  Credit  Commitment.  No Letter of Credit  shall  have an expiry  date<br \/>\n(including all rights of the Borrower or any beneficiary named in such Letter of<br \/>\nCredit to  require  renewal)  or  payment  date  occurring  later than the fifth<br \/>\nBusiness Day prior to the Revolving Credit Termination Date.<\/p>\n<p>         3.2. Reimbursement.<\/p>\n<p>              (a)  The  Borrower  hereby  unconditionally  agrees  to pay to the<br \/>\nIssuing Bank  immediately on demand at the Principal Office all amounts required<br \/>\nto pay all drafts  drawn or  purporting  to be drawn under the Letters of Credit<br \/>\nand all reasonable  expenses incurred by the Issuing Bank in connection with the<br \/>\nLetters of Credit, and in any event and without demand to place in possession of<br \/>\nthe Issuing  Bank (which  shall  include  Advances  under the  Revolving  Credit<br \/>\nFacility if permitted by Section 2.1(d))  sufficient  funds to pay all debts and<br \/>\nliabilities  arising in respect of any Letter of Credit. The Issuing Bank agrees<br \/>\nto give the Borrower  prompt  notice of any request for a draw under a Letter of<br \/>\nCredit.  The Issuing  Bank may charge any account the  Borrower may have with it<br \/>\nfor any and all  amounts the  Issuing  Bank pays under a Letter of Credit,  plus<br \/>\ncharges  and  reasonable  expenses as from time to time agreed to by the Issuing<br \/>\nBank  and  the  Borrower;  provided  that to the  extent  permitted  by  Section<br \/>\n2.1(d)(iv),  amounts  shall be paid  pursuant  to Advances  under the  Revolving<br \/>\nCredit  Facility.  The Borrower  agrees to pay the Issuing Bank  interest on any<br \/>\nReimbursement  Obligations not paid when due hereunder at the Base Rate plus two<br \/>\npercent (2.0%),  or the maximum rate permitted by applicable law, if lower, such<br \/>\nrate to be calculated on an Actual\/360 Basis.<\/p>\n<p>              (b) In  accordance  with the  provisions  of Section  2.1(d),  the<br \/>\nIssuing  Bank shall  notify the Agent of any drawing  under any Letter of Credit<br \/>\npromptly following the receipt by the Issuing Bank of such drawing.<\/p>\n<p>                                       48<\/p>\n<p>              (c) Each Lender (other than the Issuing Bank) shall  automatically<br \/>\nacquire on the date of issuance  thereof a Participation in the liability of the<br \/>\nIssuing  Bank in  respect  of each  Letter of Credit in an amount  equal to such<br \/>\nLender&#8217;s Applicable Commitment  Percentage of such liability,  and to the extent<br \/>\nthat the Borrower is obligated  to pay the Issuing  Bank under  Section  3.2(a),<br \/>\neach  Lender  (other  than  the  Issuing   Bank)   thereby   shall   absolutely,<br \/>\nunconditionally and irrevocably  assume, and shall be unconditionally  obligated<br \/>\nto pay to the Issuing Bank as hereinafter  described,  its Applicable Commitment<br \/>\nPercentage of the liability of the Issuing Bank under such Letter of Credit.<\/p>\n<p>                  (i) Each Lender (including the Issuing Bank in its capacity as<br \/>\n         a Lender) shall, subject to the terms and conditions of Article II, pay<br \/>\n         to the Agent  for the  account  of the  Issuing  Bank at the  Principal<br \/>\n         Office in Dollars and in immediately  available  funds, an amount equal<br \/>\n         to its Applicable  Commitment  Percentage of any drawing under a Letter<br \/>\n         of Credit, such funds to be provided in the manner described in Section<br \/>\n         2.1(d)(iv).<\/p>\n<p>                  (ii)  Simultaneously  with the  making  of each  payment  by a<br \/>\n         Lender to the  Issuing  Bank  pursuant to Section  2.1(d)(iv)(B),  such<br \/>\n         Lender shall,  automatically and without any further action on the part<br \/>\n         of the  Issuing  Bank or such  Lender,  acquire a  Participation  in an<br \/>\n         amount  equal  to  such   payment   (excluding   the  portion   thereof<br \/>\n         constituting  interest  accrued  prior to the date such Lender made its<br \/>\n         payment) in the related Reimbursement  Obligation of the Borrower.  The<br \/>\n         Reimbursement  Obligations of the Borrower shall be immediately due and<br \/>\n         payable whether by Advances made in accordance with Section  2.1(d)(iv)<br \/>\n         or otherwise.<\/p>\n<p>                  (iii) Each  Lender&#8217;s  obligation  to make payment to the Agent<br \/>\n         for the account of the Issuing Bank pursuant to Section  2.1(d)(iv) and<br \/>\n         this Section  3.2(c),  and the right of the Issuing Bank to receive the<br \/>\n         same, shall be absolute and unconditional, shall not be affected by any<br \/>\n         circumstance   whatsoever   and  shall  be  made  without  any  offset,<br \/>\n         abatement,  withholding  or  reduction  whatsoever.  If any  Lender  is<br \/>\n         obligated  to pay but does not pay amounts to the Agent for the account<br \/>\n         of the  Issuing  Bank in full upon such  request as required by Section<br \/>\n         2.1(d)(iv) or this Section 3.2(c), such Lender shall, on demand, pay to<br \/>\n         the Agent for the  account of the Issuing  Bank  interest on the unpaid<br \/>\n         amount for each day during the period  commencing on the date of notice<br \/>\n         given to such Lender  pursuant to Section 2.1(d) until such Lender pays<br \/>\n         such amount to the Agent for the account of the Issuing Bank in full at<br \/>\n         the interest rate per annum for  overnight  borrowing by the Agent from<br \/>\n         the Federal Reserve Bank of Richmond, Virginia.<\/p>\n<p>                                       49<\/p>\n<p>                  (iv) In the event the Lenders have purchased Participations in<br \/>\n         any Reimbursement Obligation as set forth in clause (ii) above, then at<br \/>\n         any time payment (in fully collected,  immediately  available funds) of<br \/>\n         such  Reimbursement  Obligation,  in whole or in part,  is  received by<br \/>\n         Issuing Bank from the Borrower,  the Issuing Bank shall promptly pay to<br \/>\n         each Lender an amount equal to its Applicable  Commitment Percentage of<br \/>\n         such payment from the Borrower.<\/p>\n<p>              (d)  Promptly  following  the end of each  calendar  quarter,  the<br \/>\nIssuing  Bank  shall  deliver to the Agent and the Agent  shall  deliver to each<br \/>\nLender a notice describing the aggregate undrawn amount of all Letters of Credit<br \/>\nat the end of such quarter.  The Agent shall promptly  notify each Lender of the<br \/>\nissuance of a Letter of Credit.<\/p>\n<p>              (e) The  issuance  by the  Issuing  Bank of each  Letter of Credit<br \/>\nshall,  in  addition  to the  conditions  precedent  set forth in  Article V, be<br \/>\nsubject to the conditions that such Letter of Credit be in such form and contain<br \/>\nsuch terms as shall be reasonably  satisfactory  to the Issuing Bank  consistent<br \/>\nwith the then current  practices and procedures of the Issuing Bank with respect<br \/>\nto similar letters of credit, and the Borrower shall have executed and delivered<br \/>\nsuch other instruments and agreements  relating to such Letters of Credit as the<br \/>\nIssuing Bank shall have reasonably  requested consistent with such practices and<br \/>\nprocedures  and shall not be in conflict  with any of the express  terms  herein<br \/>\ncontained.  All Letters of Credit shall be issued pursuant to and subject to the<br \/>\nUniform   Customs  and  Practice  for   Documentary   Credits,   1993  revision,<br \/>\nInternational  Chamber  of  Commerce  Publication  No.  500 and  all  subsequent<br \/>\namendments and revisions thereto.<\/p>\n<p>              (f) The  Borrower  agrees  that  Issuing  Bank  may,  in its  sole<br \/>\ndiscretion,  accept or pay, as complying with the terms of any Letter of Credit,<br \/>\nany drafts or other  documents  otherwise in order which may be signed or issued<br \/>\nby an  administrator,  executor,  trustee in  bankruptcy,  debtor in possession,<br \/>\nassignee for the benefit of creditors, liquidator, receiver, attorney in fact or<br \/>\nother legal  representative  of a party who is  authorized  under such Letter of<br \/>\nCredit to draw or issue any drafts or other documents.<\/p>\n<p>              (g) Without  limiting the  generality of the provisions of Section<br \/>\n11.12,  the Borrower  hereby  agrees to indemnify  and hold harmless the Issuing<br \/>\nBank,  each other  Lender and the Agent from and  against any and all claims and<br \/>\ndamages,  losses,  liabilities,  reasonable costs and expenses which the Issuing<br \/>\nBank,  such other Lender or the Agent may incur (or which may be claimed against<br \/>\nthe Issuing Bank,  such other Lender or the Agent) by any Person by reason of or<br \/>\nin  connection  with the  issuance  or  transfer of or payment or failure to pay<br \/>\nunder any Letter of Credit;  provided that the Borrower shall not be required to<br \/>\nindemnify  the  Issuing  Bank,  any other  Lender  or the Agent for any  claims,<br \/>\ndamages, losses, liabilities, costs or expenses to the extent, but only to the<\/p>\n<p>                                       50<\/p>\n<p>extent,  (i) caused by the willful  misconduct  or negligence of the party to be<br \/>\nindemnified  or (ii) in the case of the Issuing  Bank,  caused by the failure of<br \/>\nthe Issuing Bank to pay under any Letter of Credit after the  presentation to it<br \/>\nof a request for payment  strictly  complying  with the terms and  conditions of<br \/>\nsuch Letter of Credit, unless such payment is prohibited by any law, regulation,<br \/>\ncourt order or decree. The  indemnification and hold harmless provisions of this<br \/>\nSection  3.2(g) shall survive  repayment of the  Obligations,  occurrence of the<br \/>\nRevolving  Credit  Termination  Date  and  expiration  or  termination  of  this<br \/>\nAgreement.<\/p>\n<p>              (h) Without limiting the Borrower&#8217;s rights as set forth in Section<br \/>\n3.2(g), the obligation of the Borrower to immediately reimburse the Issuing Bank<br \/>\nfor drawings  made under Letters of Credit and to repay Loans made under Section<br \/>\n2.1(d) and the Issuing  Bank&#8217;s and each  Lender&#8217;s  right to receive such payment<br \/>\nshall be absolute,  unconditional  and irrevocable,  and such obligations of the<br \/>\nBorrower  shall be  performed  strictly  in  accordance  with the  terms of this<br \/>\nAgreement and such Letters of Credit and the related  Applications and Agreement<br \/>\nfor any Letter of Credit,  under all  circumstances  whatsoever,  including  the<br \/>\nfollowing circumstances:<\/p>\n<p>                  (i) any lack of  validity or  enforceability  of any Letter of<br \/>\n         Credit,  the obligation  supported by any Letter of Credit or any other<br \/>\n         agreement or instrument relating thereto (collectively, the &#8220;Related LC<br \/>\n         Documents&#8221;);<\/p>\n<p>                  (ii) any amendment or waiver of or any consent to or departure<br \/>\n         from all or any of the Related LC Documents;<\/p>\n<p>                  (iii) the existence of any claim, setoff,  defense (other than<br \/>\n         the defense of payment in accordance  with the terms of this Agreement)<br \/>\n         or other  rights  which the  Borrower  may have at any time against any<br \/>\n         beneficiary  or any transferee of a Letter of Credit (or any persons or<br \/>\n         entities for whom any such  beneficiary  or any such  transferee may be<br \/>\n         acting),  the  Agent,  the  Lenders  or any other  Person,  whether  in<br \/>\n         connection  with the Loan  Documents,  the Related LC  Documents or any<br \/>\n         unrelated transaction;<\/p>\n<p>                  (iv) any  breach of  contract  or other  dispute  between  the<br \/>\n         Borrower and any  beneficiary  or any  transferee of a Letter of Credit<br \/>\n         (or any  persons  or  entities  for whom such  beneficiary  or any such<br \/>\n         transferee may be acting), the Agent, the Lenders or any other Person;<\/p>\n<p>                  (v) any draft, statement or any other document presented under<br \/>\n         any  Letter of Credit  proving  to be  forged,  fraudulent,  invalid or<br \/>\n         insufficient  in any respect or any  statement  therein being untrue or<br \/>\n         inaccurate in any respect whatsoever;<\/p>\n<p>                  (vi) any delay,  extension  of time,  renewal,  compromise  or<br \/>\n         other  indulgence or modification  granted or agreed to by the Agent or<br \/>\n         the requisite number of Lenders,<\/p>\n<p>                                       51<\/p>\n<p>         with or without notice to or approval by the Borrower in respect of any<br \/>\n         of Borrower&#8217;s Obligations under this Agreement; or<\/p>\n<p>                  (vii) any other circumstance or happening whatsoever,  whether<br \/>\n         or not similar to any of the foregoing;<\/p>\n<p>provided,  however,  that nothing in this Section  3.2(h) shall give the Issuing<br \/>\nBank any  right to  reimbursement  for  drawings  made  under a Letter of Credit<br \/>\notherwise  than pursuant to a request for payment  strictly  complying  with the<br \/>\nterms  and  conditions  of  such  Letter  of  Credit  unless  the  Borrower  has<br \/>\nspecifically waived such strict compliance in writing.<\/p>\n<p>         3.3.  Letter of Credit Facility Fees. (a) The Borrower shall pay to the<br \/>\nAgent,  for the pro rata  benefit  of the  Lenders  based  on  their  Applicable<br \/>\nCommitment  Percentages,  a fee on the aggregate amount available to be drawn on<br \/>\neach outstanding  Letter of Credit at a rate equal to the Applicable  Margin. In<br \/>\naddition, the Borrower agrees to pay to the Agent for the benefit of the Issuing<br \/>\nBank an issuance fee equal to one-eighth  of one percent  (1\/8%) per annum times<br \/>\nthe amount of outstanding Letters of Credit. Such fees shall be due with respect<br \/>\nto each Letter of Credit  quarterly in arrears on the last  Business Day of each<br \/>\nMarch,  June,  September and December,  the first such payment to be made on the<br \/>\nfirst such date occurring after the date of issuance of a Letter of Credit.  The<br \/>\nfees described in this Section 3.3 shall be calculated on the basis of a year of<br \/>\n360 days for the actual number of days elapsed.<\/p>\n<p>         (b) The Borrower  acknowledges  that the Issuing Bank as issuer of each<br \/>\nLetter of Credit will be required by  applicable  rules and  regulations  of the<br \/>\nBoard to maintain  reserves for its  liability to honor draws made pursuant to a<br \/>\nLetter  of  Credit   notwithstanding   the  obligation  of  the  Lenders  for  a<br \/>\nParticipation in such liability.  The Borrower agrees to promptly  reimburse the<br \/>\nIssuing Bank for all  additional  costs which it may  hereafter  incur solely by<br \/>\nreason of its acting as issuer of the  Letters of Credit and its being  required<br \/>\nto reserve for such  liability,  it being  understood by the Borrower that other<br \/>\ninterest and fees payable under this  Agreement do not include  compensation  of<br \/>\nthe  Issuing  Bank for such  reserves.  The  Issuing  Bank shall  furnish to the<br \/>\nBorrower at the time of its demand for  payment of such  additional  costs,  the<br \/>\ncomputation of such  additional  cost which shall be conclusive  absent manifest<br \/>\nerror, provided that such computations are made on a reasonable basis.<\/p>\n<p>         3.4.  Administrative  Fees.  The Borrower shall pay to the Issuing Bank<br \/>\nsuch  administrative  fee and other fees, if any, in connection with the Letters<br \/>\nof Credit in such amounts and at such times as the Issuing Bank and the Borrower<br \/>\nshall agree from time to time.<\/p>\n<p>                                       52<\/p>\n<p>                                   ARTICLE IV<\/p>\n<p>              Termination of Eurodollar Rate and Yield Protection<\/p>\n<p>         4.1. Suspension of Loans.<\/p>\n<p>              (a) If at any time the Agent  shall  reasonably  determine  (which<br \/>\ndetermination,  if reasonable,  shall be final,  conclusive and binding upon all<br \/>\nparties) that:<\/p>\n<p>                  (i) by reason of any changes  arising  after the Closing  Date<br \/>\n         affecting the applicable  interbank market or affecting the position of<br \/>\n         any Lender or the Agent in such market,  adequate and fair means do not<br \/>\n         exist for  ascertaining  the  Interbank  Offered Rate with respect to a<br \/>\n         Eurodollar Loan or Eurodollar Market Loan; or<\/p>\n<p>                  (ii) the continuation by any Lender of any Eurodollar Loans or<br \/>\n         Eurodollar  Market  Loans  or the  funding  thereof  in the  applicable<br \/>\n         interbank  market would be unlawful by reason of any law,  governmental<br \/>\n         rule, regulation, guidelines or order; or<\/p>\n<p>                  (iii) the  continuation by any Lender of any Eurodollar  Loans<br \/>\n         or  Eurodollar  Market Loans or the funding  thereof in the  applicable<br \/>\n         interbank  market would be  impracticable  as a result of a contingency<br \/>\n         occurring  after  the  date  of  this  Agreement  that  materially  and<br \/>\n         adversely affects the applicable interbank market;<\/p>\n<p>then,  and in any such  event,  the Agent  shall on such date  give  notice  (by<br \/>\ntelephone and confirmed in writing) to the Borrower of such  determination.  The<br \/>\nobligation of any Lender to make or maintain  Fixed Rate Segments so affected or<br \/>\nto permit interest to be computed thereon based upon the Interbank  Offered Rate<br \/>\nshall be terminated,  and interest shall  thereafter be computed on the affected<br \/>\nSegment or Segments at the then applicable Base Rate.<\/p>\n<p>                  (b) It is the  intention  of the parties  that the Fixed Rates<br \/>\nshall  accurately  reflect the cost to each Lender of maintaining any Fixed Rate<br \/>\nSegment during any period in which interest accrues thereon at a Fixed Rate.<br \/>\nAccordingly:<\/p>\n<p>                  (i) if by reason of any  change  after the date  hereof in any<br \/>\n         applicable  law or  governmental  rule,  regulation  or  order  (or any<br \/>\n         interpretation thereof and including the introduction of any new law or<br \/>\n         governmental  rule,  regulation or order),  including any change in the<br \/>\n         Eurodollar  Reserve  Percentage,  the cost to any Lender of maintaining<br \/>\n         any Fixed Rate  Segment or  funding  the same by means of an  interbank<br \/>\n         market time deposit in the relevant  interbank  market shall  increase,<br \/>\n         the Fixed Rate  applicable to such Fixed Rate Segment shall be adjusted<\/p>\n<p>                                       53<\/p>\n<p>         as necessary  to reflect such change in cost to such Lender,  effective<br \/>\n         as of the date on which such change in any applicable law, governmental<br \/>\n         rule, regulation or order becomes effective; and<\/p>\n<p>                  (ii) If any Lender  shall have  determined  that the  adoption<br \/>\n         after  the date of this  Agreement  of any  law,  rule,  regulation  or<br \/>\n         guideline  regarding  capital  adequacy,  or any  change  in any of the<br \/>\n         foregoing  or in the  interpretation  or  administration  of any of the<br \/>\n         foregoing by any  Governmental  Authority,  central bank or  comparable<br \/>\n         agency charged with the  interpretation or administration  thereof,  or<br \/>\n         compliance by any Lender (or any lending  office of any Lender) or such<br \/>\n         Lender&#8217;s  holding  company  with any  request  or  directive  regarding<br \/>\n         capital  adequacy  (whether or not having the force of law) of any such<br \/>\n         authority,  central bank or  comparable  agency,  has or would have the<br \/>\n         effect of reducing  the rate of return on such  Lender&#8217;s  capital or on<br \/>\n         the capital of such Lender&#8217;s holding company,  as a consequence of such<br \/>\n         Lender&#8217;s  obligations under this Agreement or the Advances made by such<br \/>\n         Lender pursuant hereto, to a level below that which such Lender or such<br \/>\n         Lender&#8217;s  holding  company could have  achieved but for such  adoption,<br \/>\n         change  or  compliance   (taking  into   consideration   such  Lender&#8217;s<br \/>\n         guidelines  with respect to capital  adequacy) by an amount  reasonably<br \/>\n         deemed  by such  Lender  to be  material,  then  from  time to time the<br \/>\n         Borrower shall pay to such Lender such additional  amount or amounts as<br \/>\n         will  compensate  such Lender or such Lender&#8217;s  holding company for any<br \/>\n         such reduction suffered.<\/p>\n<p>         4.2.  Compensation.  The Borrower  shall  compensate any Lender for all<br \/>\nreasonable losses, expenses and liabilities (including any interest owed by such<br \/>\nLender to lenders on funds  borrowed  by such  Lender to make or carry any Fixed<br \/>\nRate  Segment  and any loss  sustained  by such  Lender in  connection  with the<br \/>\nre-employment  of such  funds),  that such  Lender may  sustain:  (a) if for any<br \/>\nreason  (other than a default by such Lender)  following  agreement  between the<br \/>\nBorrower and the Agent or the  Borrower and such Lender,  as the case may be, as<br \/>\nto the Fixed Rate  applicable  to a Fixed Rate  Segment  the  Borrower  fails to<br \/>\naccept such Fixed Rate Segment,  (b) as a consequence of any unauthorized action<br \/>\ntaken or default by the Borrower in the repayment of any Fixed Rate Segment when<br \/>\nrequired  by the  terms of this  Agreement  or (c) with  respect  to any loss of<br \/>\nincome  incurred  by a Lender  (as  determined  in a  reasonable  manner by such<br \/>\nLender)  associated  with the payment of principal other than the last day of an<br \/>\nInterest  Period with  respect to any Fixed Rate Loan. A  certificate  as to the<br \/>\namount of any additional  amounts payable  pursuant to this Section 4.2 (setting<br \/>\nforth in reasonable  detail the basis for requesting such amounts)  submitted by<br \/>\nsuch  Lender to the  Borrower  shall be  conclusive,  in the absence of manifest<br \/>\nerror. The Borrower shall pay to such Lender the <\/p>\n<p>                                       54<\/p>\n<p>amount shown as due on any such  certificate  delivered by such Lender within 30<br \/>\ndays after the Borrower&#8217;s receipt of the same.<\/p>\n<p>         4.3. All payments by the Borrower of principal of, and interest on, the<br \/>\nLoans and all other amounts  payable  hereunder  shall be made free and clear of<br \/>\nand without deduction for any present or future excise, stamp or franchise taxes<br \/>\nor other  taxes,  whatsoever  imposed by any  taxing  authority,  but  excluding<br \/>\nfranchise  taxes and taxes  imposed on or measured by any Lender&#8217;s net income or<br \/>\nreceipts (such non-excluded  items being called &#8220;Taxes&#8221;).  In the event that any<br \/>\nwithholding or deduction  from any payment to be made by the Borrower  hereunder<br \/>\nis required  in respect of any Taxes  pursuant to any  applicable  law,  rule or<br \/>\nregulation, then the Borrower will<\/p>\n<p>              (a)  pay  directly  to the  relevant  authority  the  full  amount<br \/>\n         required to be so withheld or deducted;<\/p>\n<p>              (b)  promptly  forward to the Agent an  official  receipt or other<br \/>\n         documentation satisfactory to the Agent evidencing such payment to such<br \/>\n         authority; and<\/p>\n<p>              (c) pay to the Agent for the account of each affected  Lender such<br \/>\n         additional  amount or amounts as is  necessary  to ensure  that the net<br \/>\n         amount actually received by each Lender will equal the full amount such<br \/>\n         Lender would have received had no such  withholding  or deduction  been<br \/>\n         required.<\/p>\n<p>Moreover,  if any Taxes are  directly  asserted  against the Agent or any Lender<br \/>\nwith respect to any payment received by the Agent or such Lender hereunder,  the<br \/>\nAgent or such Lender may pay such Taxes and the Borrower  will promptly pay such<br \/>\nadditional  amounts  (including  any  penalties,  interest  or  expenses)  as is<br \/>\nnecessary  in order that the net  amount  received  by the Agent or such  Lender<br \/>\nafter the payment of such Taxes (including any Taxes on such additional  amount)<br \/>\nshall equal the amount the Agent or such Lender would have  received had no such<br \/>\nTaxes been asserted.  Upon the request of the Borrower or the Agent, each Lender<br \/>\nand each  participant  that is organized under the laws of a jurisdiction  other<br \/>\nthan the United States shall, prior to the due date of any payments hereunder or<br \/>\nunder the Notes,  execute and deliver to the  Borrower and the Agent one or more<br \/>\n(as the Borrower or the Agent may  reasonably  request)  United States  Internal<br \/>\nRevenue  Service  Forms 4224 or Forms 1001 or such other forms or documents  (or<br \/>\nsuccessor forms or documents), appropriately completed, as may be applicable (if<br \/>\nany are) to establish  the extent,  if any, to which a payment to such Lender or<br \/>\nparticipant is exempt from withholding or deduction of Taxes.<\/p>\n<p>         If the  Borrower  fails to pay any  Taxes  when due to the  appropriate<br \/>\ntaxing  authority  or  fails  to  remit to the  Agent,  for the  account  of the<br \/>\nrespective Lender, the required amounts,  receipts or other required documentary<br \/>\nevidence,  the Borrower shall <\/p>\n<p>                                       55<\/p>\n<p>indemnify the Lenders for any incremental Taxes,  interest or penalties that may<br \/>\nbecome  payable by any Lender as a result of any such  failure.  For purposes of<br \/>\nthis Section 4.3, a distribution  hereunder by the Agent or any Lender to or for<br \/>\nthe account of any Lenders shall be deemed a payment by the Borrower.<\/p>\n<p>         If Taxes are  incorrectly  or illegally  paid or  assessed,  and if any<br \/>\nLender or the Agent  contests the  assessment of such Taxes,  such Lender or the<br \/>\nAgent  shall  refund,  to the  extent of any refund  made to such  Lender or the<br \/>\nAgent,  any amounts paid by the  Borrower  under this Section in respect of such<br \/>\nTaxes (less the costs and expenses  incurred by such Lender in  connection  with<br \/>\nsuch contest, including legal fees).<\/p>\n<p>         Without  prejudice  to the  survival  of any  other  agreements  of the<br \/>\nBorrower  hereunder  or under any other Loan  Document,  the  agreements  of the<br \/>\nBorrower  contained in this Section shall survive the payment in full of all its<br \/>\nObligations and the termination of all Commitments.<\/p>\n<p>         To the extent any Lender  shall  become  liable for the  payment of any<br \/>\nTaxes hereunder and shall seek  reimbursement  therefor pursuant to this Section<br \/>\n4.3, the  Borrower  shall be entitled,  upon the giving of five  Business  Days&#8217;<br \/>\nnotice  to the  Agent  and  such  Lender,  (i) to  replace  such  Lender  with a<br \/>\nsubstitute  lender,  and (ii) in connection  with such  substitution,  cause the<br \/>\npayment  in full of the  outstanding  Obligation  due to the  Lender  requesting<br \/>\nreimbursement without penalty or payment other than under Section 4.2; provided,<br \/>\nall  obligations to such  assigning  Lender shall be paid in full, no assignment<br \/>\nfee shall be payable by such assigning  Lender but shall be paid by Borrower and<br \/>\nsuch  assigning  Lender shall be entitled to the benefits of this  Agreement set<br \/>\nforth in Sections 3.2(g), 11.6 and 11.12 and Article IV.<\/p>\n<p>                                       56<\/p>\n<p>                                    ARTICLE V<\/p>\n<p>         5.1.  Conditions of Initial  Advance.  The obligation of the Lenders to<br \/>\nmake the initial Advance under the Revolving Credit Facility, the Line of Credit<br \/>\nFacility or the Competitive  Bid Facility,  and of the Issuing Bank to issue the<br \/>\ninitial Letter of Credit, is subject to the conditions precedent that:<\/p>\n<p>               (a) the Agent shall have  received on the Closing  Date,  in form<br \/>\n         and substance satisfactory to the Agent and Lenders, the following:<\/p>\n<p>                  (i) executed  originals of each of this Agreement,  the Notes,<br \/>\n              the LC Account  Agreement and the other Loan  Documents,  together<br \/>\n              with all schedules and exhibits thereto;<\/p>\n<p>                  (ii) the favorable written opinion or opinions with respect to<br \/>\n              the Loan Documents and the  transactions  contemplated  thereby of<br \/>\n              counsel to the Borrower  dated the Closing Date,  addressed to the<br \/>\n              Agent and the Lenders and  satisfactory  to Smith Helms  Mulliss &amp; Moore, L.L.P., special counsel to the Agent,  substantially in the<br \/>\n              form of Exhibit L;<\/p>\n<p>                  (iii)  resolutions  of the board of  directors of the Borrower<br \/>\n              certified  by  its  secretary  or  assistant  secretary  as of the<br \/>\n              Closing  Date,  approving  and adopting  the Loan  Documents to be<br \/>\n              executed  by the  Borrower,  and  authorizing  the  execution  and<br \/>\n              delivery and performance thereof;<\/p>\n<p>                  (iv) specimen signatures of officers of the Borrower executing<br \/>\n              the Loan  Documents  on behalf of the  Borrower,  certified by the<br \/>\n              secretary or assistant secretary of the Borrower;<\/p>\n<p>                  (v) the charter  documents of the  Borrower  certified as of a<br \/>\n              recent   date  by  the   Secretary   of  State  of  its  state  of<br \/>\n              organization;<\/p>\n<p>                  (vi) the bylaws of the  Borrower  certified  as of the Closing<br \/>\n              Date as true and correct by its secretary or assistant secretary;<\/p>\n<p>                  (vii) certificates issued as of a recent date by the Secretary<br \/>\n              of State of the  jurisdiction  of  formation of the Borrower as to<br \/>\n              the valid existence and good standing of the Borrower;<\/p>\n<p>                                       57<\/p>\n<p>                  (viii)   appropriate   certificates  of  qualification  to  do<br \/>\n              business,  good  standing  and,  where  appropriate,  authority to<br \/>\n              conduct  business  under  assumed  name,  issued in respect of the<br \/>\n              Borrower  as of a  recent  date  by  the  Secretary  of  State  or<br \/>\n              comparable  official of each  jurisdiction in which the failure to<br \/>\n              be qualified to do business or authorized  so to conduct  business<br \/>\n              could have a Material Adverse Effect;<\/p>\n<p>                  (ix)  notice  of   appointment   of  the  initial   Authorized<br \/>\n              Representative(s);<\/p>\n<p>                  (x) evidence of all insurance required by the Loan Documents;<\/p>\n<p>                  (xi) a  certificate  in the form of Exhibit M completed  as of<br \/>\n              December 31, 1995;<\/p>\n<p>                  (xii) an initial  Borrowing Notice, if any, and, if elected by<br \/>\n              the Borrower, Interest Rate Selection Notice;<\/p>\n<p>                  (xiii)  evidence  that all fees payable by the Borrower on the<br \/>\n              Closing  Date to the Agent and the Lenders have been paid in full;<br \/>\n              and<\/p>\n<p>                  (xiv)  such other  documents,  instruments,  certificates  and<br \/>\n              opinions as the Agent or any Lender may  reasonably  request on or<br \/>\n              prior to the Closing Date in connection  with the  consummation of<br \/>\n              the transactions contemplated hereby; and<\/p>\n<p>              (b) In the good faith judgment of the Agent and the Lenders:<\/p>\n<p>                  (i) there shall not have occurred or become known to the Agent<br \/>\n              or the Lenders any event, condition, situation or status since the<br \/>\n              date of the  information  contained in the  financial and business<br \/>\n              projections,  budgets, pro forma data and forecasts concerning the<br \/>\n              Borrower  and its  Consolidated  Entities  delivered  to the Agent<br \/>\n              prior to the  Closing  Date  that has had or could  reasonably  be<br \/>\n              expected to result in a Material Adverse Effect;<\/p>\n<p>                  (ii) no  litigation,  action,  suit,  investigation  or  other<br \/>\n              arbitral,  administrative or judicial  proceeding shall be pending<br \/>\n              or  threatened  which  could  reasonably  be likely to result in a<br \/>\n              Material Adverse Effect; and<\/p>\n<p>                  (iii) the Borrower and its  Consolidated  Entities  shall have<br \/>\n              received all approvals,  consents and waivers, and shall have made<br \/>\n              or given all necessary  filings and notices,  as shall be required<br \/>\n              to consummate  the  <\/p>\n<p>                                       58<\/p>\n<p>              transactions  contemplated  hereby  without the  occurrence of any<br \/>\n              default  under,  conflict with or violation of (A) any  applicable<br \/>\n              law,  rule,  regulation,  order  or  decree  of  any  Governmental<br \/>\n              Authority or arbitral authority or (B) any agreement,  document or<br \/>\n              instrument to which any of the Borrower or any Consolidated Entity<br \/>\n              is a party or by which any of them or their  properties  is bound,<br \/>\n              except for such approvals,  consents, waivers, filings and notices<br \/>\n              the  receipt,  making or giving of which  will not have a Material<br \/>\n              Adverse Effect.<\/p>\n<p>         5.2.  Conditions of Loans and Letters of Credit. The obligations of the<br \/>\nLenders  to make any Loans,  and the  Issuing  Bank to issue  Letters of Credit,<br \/>\nhereunder on or subsequent to the Closing Date, are subject to the  satisfaction<br \/>\nof the following conditions:<\/p>\n<p>               (a) the Agent shall have received a Borrowing  Notice if required<br \/>\n         by Article II;<\/p>\n<p>               (b) the  representations  and  warranties of the Borrower and the<br \/>\n         Subsidiaries  set forth in  Article  VI and in each of the  other  Loan<br \/>\n         Documents shall be true and correct in all material  respects on and as<br \/>\n         of the date of such  Advance or Letter of Credit  issuance  or renewal,<br \/>\n         with the same effect as though such  representations and warranties had<br \/>\n         been  made on and as of such  date,  except  to the  extent  that  such<br \/>\n         representations and warranties  expressly relate to an earlier date and<br \/>\n         except that the  financial  statements  referred  to in Section  6.6(a)<br \/>\n         shall  be  deemed  to  be  those  financial  statements  most  recently<br \/>\n         delivered to the Agent and the Lenders pursuant to Section 7.1 from the<br \/>\n         date financial statements are delivered to the Agent and the Lenders in<br \/>\n         accordance with such Section;<\/p>\n<p>               (c) in the  case of the  issuance  of a  Letter  of  Credit,  the<br \/>\n         Borrower  shall have  executed  and  delivered  to the Issuing  Bank an<br \/>\n         Application  and  Agreement  for  Letter of Credit in form and  content<br \/>\n         acceptable to the Issuing Bank together with such other instruments and<br \/>\n         documents as it shall request;<\/p>\n<p>               (d) at the time of (and after  giving  effect to) each Advance or<br \/>\n         the  issuance  of a Letter of  Credit,  no  Default or Event of Default<br \/>\n         shall have occurred and be continuing; and<\/p>\n<p>               (e) immediately after giving effect to:<\/p>\n<p>                   (i) a Revolving Loan, the aggregate  principal balance of all<br \/>\n                   outstanding  Revolving  Loans of a Lender plus such  Lender&#8217;s<br \/>\n                   Applicable  Commitment  Percentage of the aggregate amount of<br \/>\n                   Letter of Credit  Outstandings shall not exceed such Lender&#8217;s<br \/>\n                   Revolving Credit Commitment;<\/p>\n<p>                                       59<\/p>\n<p>                   (ii) a Line of Credit Loan, the aggregate  principal  balance<br \/>\n                   of all outstanding Line of Credit Loans for each Lender shall<br \/>\n                   not exceed such Lender&#8217;s Line of Credit Commitment;<\/p>\n<p>                   (iii) a Letter of Credit or renewal  thereof,  the  aggregate<br \/>\n                   principal  balance  of  all  outstanding   Participations  in<br \/>\n                   Letters of Credit and  Reimbursement  Obligations  (or in the<br \/>\n                   case  of the  Issuing  Bank,  its  remaining  interest  after<br \/>\n                   deduction  of all  Participations  in  Letters  of Credit and<br \/>\n                   Reimbursement  Obligations  of other Lenders) for each Lender<br \/>\n                   and in the aggregate shall not exceed, respectively, (X) such<br \/>\n                   Lender&#8217;s Letter of Credit  Commitment or (Y) the Total Letter<br \/>\n                   of Credit Commitment; and<\/p>\n<p>                   (iv) a  Revolving  Loan or a  Letter  of  Credit  or  renewal<br \/>\n                   thereof,  the sum of Letter of Credit  Outstandings  plus the<br \/>\n                   aggregate  principal amount of Revolving Credit  Outstandings<br \/>\n                   plus  outstanding  Competitive Bid Loans shall not exceed the<br \/>\n                   Total Revolving Credit Commitment.<\/p>\n<p>         Each  borrowing  hereunder  and each  issuance  of a Letter  of  Credit<br \/>\n         hereunder  shall  constitute  a  representation  and  warranty  by  the<br \/>\n         Borrower to the effect that the  conditions  set forth in clauses  (b),<br \/>\n         (d) and (e) have been satisfied as of the date thereof.<\/p>\n<p>                                       60<\/p>\n<p>                                   ARTICLE VI<\/p>\n<p>                         Representations and Warranties<\/p>\n<p>         The Borrower represents and warrants with respect to itself and (to the<br \/>\nextent   expressly   set  forth   below)  its   Consolidated   Entities   (which<br \/>\nrepresentations  and  warranties  shall  survive the  delivery of the  documents<br \/>\nmentioned  herein  and the  making  of Loans  and the  issuance  of a Letter  of<br \/>\nCredit), that:<\/p>\n<p>        6.1. Organization and Authority.<\/p>\n<p>              (a) The Borrower and each  Consolidated  Entity is a  corporation,<br \/>\n        partnership  or limited  liability  company duly  organized  and validly<br \/>\n        existing under the laws of the jurisdiction of its formation;<\/p>\n<p>              (b)  The  Borrower  and  each  Consolidated  Entity  (x)  has  the<br \/>\n        requisite  power and authority to own its  properties  and assets and to<br \/>\n        carry on its business as now being  conducted and as contemplated in the<br \/>\n        Loan   Documents,   and  (y)  is  qualified  to  do  business  in  every<br \/>\n        jurisdiction  in which  failure  so to  qualify  would  have a  Material<br \/>\n        Adverse Effect;<\/p>\n<p>              (c) The Borrower has the power and  authority to execute,  deliver<br \/>\n        and perform this Agreement and the Notes, and to borrow and obtain other<br \/>\n        extensions of credit hereunder, and to execute, deliver and perform each<br \/>\n        of the other Loan Documents to which it is a party; and<\/p>\n<p>              (d) When  executed and  delivered,  each of the Loan  Documents to<br \/>\n        which the  Borrower  is a party  will be the  legal,  valid and  binding<br \/>\n        obligation  or  agreement,   as  the  case  may  be,  of  the  Borrower,<br \/>\n        enforceable  against the Borrower in accordance with its terms,  subject<br \/>\n        to the  effect of any  applicable  bankruptcy,  moratorium,  insolvency,<br \/>\n        reorganization  or other  similar law affecting  the  enforceability  of<br \/>\n        creditors&#8217;  rights generally and to the effect of general  principles of<br \/>\n        equity (whether considered in a proceeding at law or in equity).<\/p>\n<p>         6.2. Loan  Documents.  The execution,  delivery and  performance by the<br \/>\nBorrower of each of the Loan Documents and the credit extensions hereunder:<\/p>\n<p>              (a) have been duly authorized by all requisite  corporate  actions<br \/>\n         (including any required shareholder  approval) of the Borrower required<br \/>\n         for the lawful execution, delivery and performance thereof;<\/p>\n<p>              (b) do not violate any provisions of (i)  applicable  law, rule or<br \/>\n         regulation,  (ii) any judgment, writ, order,  determination,  decree or<br \/>\n         arbitral  award of any  Governmental  <\/p>\n<p>                                       61<\/p>\n<p>         Authority  or  arbitral  authority  binding  on  the  Borrower  or  any<br \/>\n         Subsidiary or its or any Subsidiary&#8217;s properties,  or (iii) the charter<br \/>\n         documents or bylaws of the Borrower;<\/p>\n<p>              (c) do not and will not be in conflict with, result in a breach of<br \/>\n         or  constitute an event of default,  or an event which,  with notice or<br \/>\n         lapse of time or both, would constitute an event of default,  under any<br \/>\n         contract, indenture, agreement or other instrument or document to which<br \/>\n         Borrower  or any  Consolidated  Entity  is a  party,  or by  which  the<br \/>\n         properties  or assets of the  Borrower or any  Consolidated  Entity are<br \/>\n         bound; and<\/p>\n<p>              (d) do not and will not result in the  creation or  imposition  of<br \/>\n         any Lien  upon any of the  properties  or  assets  of  Borrower  or any<br \/>\n         Subsidiary.<\/p>\n<p>         6.3.  Solvency.  The  Borrower  is  Solvent  and the  Borrower  and its<br \/>\nConsolidated  Entities  taken as a whole are Solvent,  in each case after giving<br \/>\neffect to the transactions contemplated by the Loan Documents.<\/p>\n<p>         6.4.  Subsidiaries.  The Borrower has no Subsidiaries  other than those<br \/>\nPersons  listed as  Subsidiaries  in Schedule  6.4 and  additional  Subsidiaries<br \/>\ncreated or acquired after the Closing Date.<\/p>\n<p>         6.5. Ownership Interest.  Borrower owns no interest in any Person other<br \/>\nthan the  Persons  listed in Schedule  6.4,  equity  investments  in Persons not<br \/>\nconstituting   Subsidiaries   permitted   under   Section  8.2  and   additional<br \/>\nSubsidiaries created or acquired after the Closing Date.<\/p>\n<p>         6.6. Financial Condition.<\/p>\n<p>              (a) The  Borrower  has  heretofore  furnished  to each  Lender  an<br \/>\n         audited consolidated balance sheet of the Borrower and its Consolidated<br \/>\n         Entities as at December 31, 1995 and the notes  thereto and the related<br \/>\n         consolidated statements of income,  stockholders&#8217; equity and cash flows<br \/>\n         for the Fiscal Year then ended as  examined  and  certified  by Ernst &amp; Young  LLP.  Except as set forth  therein,  such  financial  statements<br \/>\n         (including the notes thereto) present fairly the financial condition of<br \/>\n         the Borrower and its Consolidated Entities as of the end of such Fiscal<br \/>\n         Year and results of their  operations and the changes in  stockholders&#8217;<br \/>\n         equity for the Fiscal  Year then  ended,  all in  conformity  with GAAP<br \/>\n         applied on a Consistent Basis;<\/p>\n<p>              (b) since  December  31, 1995 there has been no  material  adverse<br \/>\n         change in the  condition,  financial or otherwise,  of the Borrower and<br \/>\n         its  Consolidated  Entities  taken  as a  whole  or in the  businesses,<br \/>\n         properties,  performance,  prospects or  operations of the Borrower and<br \/>\n         Consolidated  Entities  taken as a whole,  nor have such  businesses or<br \/>\n         properties been <\/p>\n<p>                                       62<\/p>\n<p>         materially  adversely  affected  as a result  of any  fire,  explosion,<br \/>\n         earthquake,  accident, strike, lockout,  combination of workers, flood,<br \/>\n         embargo or act of God;  provided that one-time  expenses  recognized in<br \/>\n         the first quarter of 1996 with respect to the  Acquisitions of Surgical<br \/>\n         Care  Affiliates,  Inc. and Advantage Health  Corporation  shall not be<br \/>\n         deemed to constitute material adverse changes; and<\/p>\n<p>              (c)  neither  the  Borrower  nor any  Consolidated  Entity has any<br \/>\n         material  Indebtedness,  Guaranteed Obligations or other obligations or<br \/>\n         liabilities,  direct or contingent, in an aggregate amount in excess of<br \/>\n         $300,000 other than (a) the liabilities reflected in such balance sheet<br \/>\n         and the notes  thereto  or (b)  liabilities  incurred  in the  ordinary<br \/>\n         course of business.<\/p>\n<p>         6.7. Title to Properties. The Borrower and each Consolidated Entity has<br \/>\ngood and marketable title to all its real and personal properties, subject to no<br \/>\ntransfer restrictions or Liens of any kind, except for the transfer restrictions<br \/>\nand Liens permitted by this Agreement.<\/p>\n<p>         6.8.  Taxes.  The Borrower and each  Consolidated  Entity have filed or<br \/>\ncaused to be filed all federal,  state and local tax returns  which are required<br \/>\nto be filed by it and, except for taxes and assessments  being contested in good<br \/>\nfaith by appropriate proceedings diligently conducted and against which reserves<br \/>\nreflected  in  the  financial   statements   described  in  Section  6.6(a)  and<br \/>\nsatisfactory to the Borrower&#8217;s  independent  certified  public  accountants have<br \/>\nbeen  established,  have  paid or  caused  to be paid all taxes as shown on said<br \/>\nreturns or on any assessment  received by it, to the extent that such taxes have<br \/>\nbecome due.<\/p>\n<p>         6.9.  Other Agreements.<\/p>\n<p>              (a) Neither the Borrower nor any Consolidated Entity is a party to<br \/>\n         or  subject  to  any  judgment,  order,  decree,  agreement,  lease  or<br \/>\n         instrument, or subject to other restrictions, compliance with the terms<br \/>\n         of which  individually or in the aggregate could reasonably be expected<br \/>\n         to have a Material Adverse Effect;<\/p>\n<p>               (b)  neither  the  Borrower  nor any  Consolidated  Entity  is in<br \/>\n         default in the  performance,  observance or  fulfillment  of any of the<br \/>\n         obligations,  covenants  or  conditions  contained  in (i) any Medicaid<br \/>\n         Provider  Agreement,  Medicare Provider Agreement or other agreement or<br \/>\n         instrument to which the Borrower or any Consolidated Entity is a party,<br \/>\n         which default has resulted in, or if not remedied within any applicable<br \/>\n         grace period could result in, the revocation, termination, cancellation<br \/>\n         or suspension of Medicaid  Certification  or Medicare  Certification of<br \/>\n         Borrower or any Consolidated Entity which could have a Material Adverse<br \/>\n         Effect or (ii) any other  <\/p>\n<p>                                       63<\/p>\n<p>         agreement  or  instrument  to which the  Borrower  or any  Consolidated<br \/>\n         Entity is a party,  which  default has, or if not  remedied  within any<br \/>\n         applicable  grace period could reasonably be likely to have, a Material<br \/>\n         Adverse Effect;<\/p>\n<p>               (c)  to  the  knowledge  of  Borrower&#8217;s  Executive  Officers,  no<br \/>\n         Contract Provider is a party to any judgment,  order, decree, agreement<br \/>\n         or instrument, or subject to restrictions, compliance with the terms of<br \/>\n         which could individually or in the aggregate  reasonably be expected to<br \/>\n         have a Material Adverse Effect; and<\/p>\n<p>               (d)  to  the  knowledge  of  Borrower&#8217;s  Executive  Officers,  no<br \/>\n         Contract  Provider  is in default  in the  performance,  observance  or<br \/>\n         fulfillment  of  any  of  the  obligations,   covenants  or  conditions<br \/>\n         contained  in  any  Medicaid  Provider  Agreement,   Medicare  Provider<br \/>\n         Agreement or other  agreement or  instrument  to which such Person is a<br \/>\n         party,  which  default has resulted  in, or if not remedied  within any<br \/>\n         applicable  grace period could result in, the revocation,  termination,<br \/>\n         cancellation  or  suspension  of  Medicaid  Certification  or  Medicare<br \/>\n         Certification   of  such   Person,   which   revocation,   termination,<br \/>\n         cancellation  or  suspension  could  reasonably  be  likely  to  have a<br \/>\n         Material Adverse Effect.<\/p>\n<p>         6.10. Litigation. There is no action, suit, investigation or proceeding<br \/>\nat law or in equity or by or before any governmental  instrumentality  or agency<br \/>\nor arbitral body pending or, to the knowledge of the Borrower,  threatened by or<br \/>\nagainst the  Borrower or any  Consolidated  Entity or, to the  knowledge  of the<br \/>\nBorrower,  pending  or  threatened  by or  against  any  Contract  Provider,  or<br \/>\naffecting  the Borrower or any  Consolidated  Entity or, to the knowledge of the<br \/>\nBorrower,  any Contract  Provider or any properties or rights of the Borrower or<br \/>\nany  Consolidated  Entity or, to the  knowledge  of the  Borrower,  any Contract<br \/>\nProvider,  which could  reasonably be expected (i) to result in the  revocation,<br \/>\ntermination,  cancellation or suspension of Medicaid  Certification  or Medicare<br \/>\nCertification of such Person,  which  revocation,  termination,  cancellation or<br \/>\nsuspension could reasonably be likely to have a Material Adverse Effect, or (ii)<br \/>\nto have a Material Adverse Effect.<\/p>\n<p>         6.11.  The proceeds of the  borrowings  and other  extensions of credit<br \/>\nmade  hereunder  will be used by the Borrower  only for the  purposes  expressly<br \/>\nauthorized herein.  None of such proceeds will be used,  directly or indirectly,<br \/>\nfor the purpose of purchasing or carrying any margin stock or for the purpose of<br \/>\nreducing or retiring any Indebtedness which was originally  incurred to purchase<br \/>\nor carry margin stock or for any other purpose which might constitute any of the<br \/>\nLoans or Letters of Credit under this  Agreement a &#8220;purpose  credit&#8221;  within the<br \/>\nmeaning of Regulation U or  Regulation X of the Board.  Neither the Borrower nor<br \/>\nany agent  acting in its behalf has taken or will take any  action  which  might<\/p>\n<p>                                       64<\/p>\n<p>cause this Agreement or any of the documents or instruments  delivered  pursuant<br \/>\nhereto to violate any  regulation of the Board or to violate the Exchange Act or<br \/>\nthe Securities Act of 1933, as amended,  or any state  securities  laws, in each<br \/>\ncase as in effect on the date hereof.<\/p>\n<p>         6.12.  Investment  Company.  Neither the Borrower nor any  Consolidated<br \/>\nEntity is an &#8220;investment  company,&#8221; or an &#8220;affiliated  person&#8221; of, or &#8220;promoter&#8221;<br \/>\nor  &#8220;principal  underwriter&#8221;  for, an  &#8220;investment  company&#8221;,  as such terms are<br \/>\ndefined in the Investment  Company Act of 1940, as amended (15 U.S.C. ss. 80a-1,<br \/>\net seq.). The application of the proceeds of the Loans and repayment  thereof by<br \/>\nthe Borrower and the  issuance of Letters of Credit and the  performance  by the<br \/>\nBorrower and any  Consolidated  Entity of the  transactions  contemplated by the<br \/>\nLoan  Documents  will not  violate  any  provision  of said  Act,  or any  rule,<br \/>\nregulation or order issued by the Securities and Exchange Commission thereunder,<br \/>\nin each case as in effect on the date hereof.<\/p>\n<p>         6.13. The Borrower and each  Consolidated  Entity owns or has the right<br \/>\nto use,  under valid  license  agreements or  otherwise,  all material  patents,<br \/>\nlicenses,  franchises,  trademarks,  trademark rights,  trade names,  trade name<br \/>\nrights,  trade  secrets,  service  marks,  service  mark  rights and  copyrights<br \/>\nnecessary to or used in the conduct of its  businesses  as now  conducted and as<br \/>\ncontemplated  by the Loan  Documents,  without known  conflict by, or with,  any<br \/>\npatent, license,  franchise,  trademark, trade secret, trade name, service mark,<br \/>\ncopyright or other proprietary right of, any other Person.<\/p>\n<p>         6.14.  Neither  (a) this  Agreement  nor any  other  Loan  Document  or<br \/>\ncertificate  or document  executed and delivered by or on behalf of the Borrower<br \/>\nor any  Consolidated  Entity in accordance with or pursuant to any Loan Document<br \/>\nnor (b) any statement,  representation, or warranty provided to the Agent or any<br \/>\nLender in connection  with the  negotiation or preparation of the Loan Documents<br \/>\ncontains any  misrepresentation or untrue statement of material fact or omits to<br \/>\nstate a material fact necessary, in light of the circumstance under which it was<br \/>\nmade, in order to make any such warranty,  representation or statement contained<br \/>\ntherein not misleading.<\/p>\n<p>         6.15.  Neither the respective  businesses or properties of the Borrower<br \/>\nor any Consolidated  Entity,  nor any  relationship  between the Borrower or any<br \/>\nConsolidated  Entity and any other Person,  nor any  circumstance  in connection<br \/>\nwith the  execution,  delivery and  performance  of the Loan  Documents  and the<br \/>\ntransactions  contemplated thereby, is such as to require a consent, approval or<br \/>\nauthorization   of,  or  filing,   registration  or   qualification   with,  any<br \/>\nGovernmental  Authority  or any other  Person on the part of the Borrower or any<br \/>\nConsolidated  Entity as a condition to the execution,  delivery and  performance<br \/>\nof, or  consummation  of the  transactions  contemplated  by, or the validity<\/p>\n<p>                                       65<\/p>\n<p>or  enforceability  of, the Loan Documents,  which, if not obtained or effected,<br \/>\nwould be reasonably  likely to have a Material  Adverse  Effect,  or if so, such<br \/>\nconsent, approval, authorization, filing, registration or qualification has been<br \/>\nduly obtained or effected, as the case may be;<\/p>\n<p>         6.16.  ERISA  Requirement.  (i) The  execution and delivery of the Loan<br \/>\nDocuments  will not involve  any  prohibited  transaction  within the meaning of<br \/>\nERISA,  (ii) the Borrower and each ERISA Affiliate has fulfilled its obligations<br \/>\nunder the minimum funding  standards  imposed by ERISA and each is in compliance<br \/>\nin all material  respects with the applicable  provisions of ERISA, and (iii) no<br \/>\n&#8220;Reportable  Event,&#8221; as defined  in  Section  4043(b) of Title IV of ERISA,  has<br \/>\noccurred with respect to any plan maintained by the Borrower or any of its ERISA<br \/>\nAffiliate.<\/p>\n<p>         6.17.  No  Default.  As of the date  hereof,  there  does not exist any<br \/>\nDefault or Event of Default.<\/p>\n<p>         6.18. Hazardous Materials. The Borrower and each Consolidated Entity is<br \/>\nin compliance with all applicable  Environmental  Laws in all material respects.<br \/>\nNeither  the  Borrower  nor any  Consolidated  Entity has been  notified  of any<br \/>\naction,  suit,  proceeding or investigation  which, and neither the Borrower nor<br \/>\nany Consolidated Entity is aware of any facts which, (i) calls into question, or<br \/>\ncould  reasonably be expected to call into question,  compliance in all material<br \/>\nrespects by the Borrower or any Consolidated Entity with any Environmental Laws,<br \/>\n(ii)  which  seeks,  or could  reasonably  be  expected  to form the  basis of a<br \/>\nmeritorious  proceeding,  to suspend,  revoke or terminate any material license,<br \/>\npermit or approval necessary for the generation, handling, storage, treatment or<br \/>\ndisposal of any Hazardous Material, or (iii) seeks to cause, or could reasonably<br \/>\nbe expected to form the basis of a meritorious proceeding to cause, any property<br \/>\nof the  Borrower  or any  Consolidated  Entity  to be  subject  to any  material<br \/>\nrestrictions  on  ownership,   use,  occupancy  or  transferability   under  any<br \/>\nEnvironmental Law.<\/p>\n<p>         6.19.  Employment  Matters.  (a) Except as set forth on Schedule  6.19,<br \/>\nnone of the employees of the Borrower or any  Consolidated  Entity is subject to<br \/>\nany collective  bargaining  agreement and there are no strikes,  work stoppages,<br \/>\nelection or  decertification  petitions or  proceedings,  unfair labor  charges,<br \/>\nequal  opportunity   proceedings,   or  other  material  labor\/employee  related<br \/>\ncontroversies or proceedings  pending or, to the best knowledge of the Borrower,<br \/>\nthreatened  against  the  Borrower  or any  Consolidated  Entity or between  the<br \/>\nBorrower  or any  Consolidated  Entity  and  any of its  employees,  other  than<br \/>\nemployee grievances, controversies or proceedings arising in the ordinary course<br \/>\nof business  which could not  reasonably  be  expected,  individually  or in the<br \/>\naggregate, to have a Material Adverse Effect; and<\/p>\n<p>                                       66<\/p>\n<p>         (b)  Except to the extent a failure to  maintain  compliance  would not<br \/>\nhave a Material Adverse Effect, the Borrower and each Consolidated  Entity is in<br \/>\ncompliance  in all respects  with all  applicable  laws,  rules and  regulations<br \/>\npertaining to labor or employment  matters,  including without  limitation those<br \/>\npertaining  to wages,  hours,  occupational  safety  and  taxation  and there is<br \/>\nneither pending nor threatened any litigation,  administrative proceeding or, to<br \/>\nthe knowledge of the  Borrower,  any  investigation,  in respect of such matters<br \/>\nwhich, if decided adversely, could reasonably be likely,  individually or in the<br \/>\naggregate, to have a Material Adverse Effect.<\/p>\n<p>         6.20. RICO. Neither the Borrower nor any Consolidated Entity is engaged<br \/>\nin or has  engaged  in any course of conduct  that  could  subject  any of their<br \/>\nrespective  properties  to any  Lien,  seizure  or other  forfeiture  under  any<br \/>\ncriminal law,  racketeer  influenced  and corrupt  organizations  law,  civil or<br \/>\ncriminal, or other similar laws.<\/p>\n<p>         6.21. Reimbursement from Third Party Payors. The accounts receivable of<br \/>\nthe Borrower and each  Consolidated  Entity and each Contract Provider have been<br \/>\nand will  continue  to be adjusted  to reflect  reimbursement  policies of third<br \/>\nparty  payors  such as  Medicare,  Medicaid,  Blue  Cross\/Blue  Shield,  private<br \/>\ninsurance  companies,  health  maintenance  organizations,   preferred  provider<br \/>\norganizations,  alternative delivery systems,  managed care systems,  government<br \/>\ncontracting  agencies  and other third party  payors.  In  particular,  accounts<br \/>\nreceivable  relating  to such  third  party  payors do not and shall not  exceed<br \/>\namounts any obligee is entitled to receive under any capitation arrangement, fee<br \/>\nschedule,  discount  formula,  cost-based  reimbursement  or other adjustment or<br \/>\nlimitation to its usual charges.<\/p>\n<p>                                       67<\/p>\n<p>                                   ARTICLE VII<\/p>\n<p>                             Affirmative Covenants<\/p>\n<p>         Until the Facility  Termination  Date and termination of this Agreement<br \/>\nin accordance with the terms hereof, unless the Required Lenders shall otherwise<br \/>\nconsent in writing,  the Borrower  will,  and where  applicable  will cause each<br \/>\nConsolidated Entity to:<\/p>\n<p>         7.1. Financial Statements,  Reports, Etc. The Borrower shall deliver or<br \/>\ncause to be delivered to the Agent and each Lender:<\/p>\n<p>              (a) Not  later  than 50 days  after  the end of each of the  first<br \/>\n         three  quarters of each Fiscal Year, a balance sheet and a statement of<br \/>\n         revenues and expenses of the Borrower and its Consolidated  Entities on<br \/>\n         a  consolidated  basis and a statement of cash flow of the Borrower and<br \/>\n         its  Consolidated  Entities on a  consolidated  basis for such calendar<br \/>\n         quarter  and for the period  beginning  on the first day of such Fiscal<br \/>\n         Year and ending on the last day of such quarter (in  sufficient  detail<br \/>\n         to indicate the Borrower&#8217;s and each  Consolidated  Entity&#8217;s  compliance<br \/>\n         with the financial  covenants set forth in Section 8.1),  together with<br \/>\n         statements in comparative form for the corresponding  date or period in<br \/>\n         the preceding Fiscal Year as summarized in the Borrower&#8217;s Form 10-Q for<br \/>\n         the corresponding  period,  and certified as to fairness,  accuracy and<br \/>\n         completeness by the chief executive officer, chief financial officer or<br \/>\n         Treasurer of the Borrower.<\/p>\n<p>              (b) Not later  than 100 days  after the end of each  Fiscal  Year,<br \/>\n         financial  statements  (including  a  balance  sheet,  a  statement  of<br \/>\n         revenues and expenses,  a statement of changes in shareholders&#8217;  equity<br \/>\n         and a  statement  of cash flow) of the  Borrower  and its  Consolidated<br \/>\n         Entities on a  consolidated  basis for such Fiscal Year (in  sufficient<br \/>\n         detail  to  indicate  the  Borrower&#8217;s  and each  Consolidated  Entity&#8217;s<br \/>\n         compliance  with the  financial  covenants  set forth in Section  8.1),<br \/>\n         together with  statements in comparative  form as of the end of and for<br \/>\n         the preceding Fiscal Year as summarized in the Borrower&#8217;s Form 10-K for<br \/>\n         the  corresponding  period,  and accompanied by an opinion of certified<br \/>\n         public  accountants  acceptable to the Agent, which opinion shall state<br \/>\n         in  effect  that  such  financial  statements  (A) were  audited  using<br \/>\n         generally accepted auditing standards,  (B) were prepared in accordance<br \/>\n         with generally accepted  accounting  principles applied on a Consistent<br \/>\n         Basis,  and (C) present  fairly the financial  condition and results of<br \/>\n         operations  of the  Borrower  and  its  Consolidated  Entities  for the<br \/>\n         periods covered.<\/p>\n<p>              (c) Together with the financial  statements required by paragraphs<br \/>\n         (1) and (2) above a compliance  certificate  duly executed by the chief<br \/>\n         executive  officer  or chief  financial  <\/p>\n<p>                                       68<\/p>\n<p>         officer  or  Treasurer  of  the  Borrower  in the  form  of  Exhibit  M<br \/>\n         (&#8220;Compliance Certificate&#8221;).<\/p>\n<p>              (d)  Contemporaneously   with  the  distribution  thereof  to  the<br \/>\n         Borrower&#8217;s or any Consolidated Entity&#8217;s stockholders or partners or the<br \/>\n         filing thereof with the Securities and Exchange Commission, as the case<br \/>\n         may  be,  copies  of  all  statements,  reports,  notices  and  filings<br \/>\n         distributed  by  the  Borrower  or  any  Consolidated   Entity  to  its<br \/>\n         stockholders  or partners  or filed with the  Securities  and  Exchange<br \/>\n         Commission (including reports on SEC Forms 10-K, 10-Q and 8-K).<\/p>\n<p>              (e) Promptly after the Borrower knows or has reason to know of the<br \/>\n         occurrence  of any  &#8220;reportable  event&#8221;  under  Section  4043 of  ERISA<br \/>\n         applicable to the Borrower or any ERISA Affiliate, a certificate of the<br \/>\n         president or chief financial  officer of the Borrower setting forth the<br \/>\n         details as to such &#8220;reportable  event&#8221; and the action that the Borrower<br \/>\n         or the ERISA Affiliate has taken or will take with respect thereto, and<br \/>\n         promptly after the filing or receiving  thereof,  copies of all reports<br \/>\n         and notices that the Borrower and each Consolidated  Entity files under<br \/>\n         ERISA  with the  Internal  Revenue  Service  or the PBGC or the  United<br \/>\n         States Department of Labor.<\/p>\n<p>              (f)  Promptly  after  the  Borrower  or any  of  its  Consolidated<br \/>\n         Entities  becomes  aware of the  commencement  thereof,  notice  of any<br \/>\n         investigation,  action,  suit or  proceeding  before  any  Governmental<br \/>\n         Authority  involving  the  condemnation  or  taking  under the power of<br \/>\n         eminent  domain of any of its property or the  revocation or suspension<br \/>\n         of any  permit,  license,  certificate  of need or  other  governmental<br \/>\n         requirement applicable to any Facility.<\/p>\n<p>              (g) Within 10 days of the  receipt by the  Borrower  or any of its<br \/>\n         Consolidated  Entities,  copies  of all  material  deficiency  notices,<br \/>\n         compliance  orders  or  adverse  reports  issued  by  any  Governmental<br \/>\n         Authority  or  accreditation   commission   having   jurisdiction  over<br \/>\n         licensing,   accreditation  or  operation  of  a  Facility  or  by  any<br \/>\n         Governmental  Authority  or private  insurance  company  pursuant  to a<br \/>\n         provider  agreement,  which,  if not promptly  complied  with or cured,<br \/>\n         could  result  in  the   suspension   or  forfeiture  of  any  license,<br \/>\n         certification or accreditation  necessary in order for such Facility to<br \/>\n         carry on its  business  as then  conducted  or the  termination  of any<br \/>\n         material insurance or reimbursement program available to such Facility.<\/p>\n<p>              (h) Such other information regarding any Facility or the financial<br \/>\n         condition or operations of the Borrower or its Consolidated Entities as<br \/>\n         the Agent shall reasonably request from time to time or at any time.<\/p>\n<p>                                       69<\/p>\n<p>         7.2.  Maintain  Properties.  Maintain all  properties  necessary to its<br \/>\noperations  in good  working  order  and  condition,  make all  needed  repairs,<br \/>\nreplacements and renewals to such  properties,  and maintain free from Liens all<br \/>\ntrademarks,  trade names,  service marks,  patents,  copyrights,  trade secrets,<br \/>\nknow-how,  and other  intellectual  property  and  proprietary  information  (or<br \/>\nadequate licenses thereto),  in each case as are reasonably necessary to conduct<br \/>\nits business as currently conducted or as contemplated hereby, all in accordance<br \/>\nwith customary and prudent business practices.<\/p>\n<p>         7.3.  Existence,  Qualification,  Etc.  Except as  otherwise  expressly<br \/>\npermitted  under  Section  8.4, do or cause to be done all things  necessary  to<br \/>\npreserve and keep in full force and effect its existence and all material rights<br \/>\nand franchises,  and maintain its license or  qualification  to do business as a<br \/>\nforeign  corporation  and  good  standing  in each  jurisdiction  in  which  its<br \/>\nownership or lease of property or the nature of its business  makes such license<br \/>\nor qualification necessary.<\/p>\n<p>         7.4.  Regulations  and Taxes.  Comply in all material  respects with or<br \/>\ncontest in good faith all  statutes  and  governmental  regulations  and pay all<br \/>\ntaxes,  assessments,  governmental charges, claims for labor, supplies, rent and<br \/>\nany other  obligation  which, if unpaid,  would become a Lien against any of its<br \/>\nproperties  except  liabilities  being  contested  in good faith by  appropriate<br \/>\nproceedings  diligently conducted and against which adequate reserves acceptable<br \/>\nto the Borrower&#8217;s independent certified public accountants have been established<br \/>\nunless and until any Lien  resulting  therefrom  attaches to any of its property<br \/>\nand becomes enforceable by its creditors.<\/p>\n<p>         7.5.  Insurance.  At all times maintain in force,  and pay all premiums<br \/>\nand costs related to, insurance coverages in amounts deemed by the management of<br \/>\nthe Borrower to be sufficient in  accordance  with usual and customary  business<br \/>\npractices  and  any  other  coverages  required  under  applicable  governmental<br \/>\nrequirements. The Borrower shall deliver to the Agent annually on or before each<br \/>\nanniversary date of this Agreement, and at such other time or times as the Agent<br \/>\nmay request (but not more often than monthly), a certificate of the president or<br \/>\nchief financial  officer of the Borrower setting out in such detail as the Agent<br \/>\nmay reasonably  require a description of all insurance  coverages  maintained by<br \/>\nthe Borrower and each Consolidated Entity. The Agent shall have no obligation to<br \/>\ngive the Borrower or any Consolidated Entity notice of any notification received<br \/>\nby the Agent with respect to any insurance policies or take any steps to protect<br \/>\nthe Borrower&#8217;s or any Consolidated Entity&#8217;s interests under such policies.<\/p>\n<p>         7.6.  True Books.  Keep true books of record and account in which full,<br \/>\ntrue and correct  entries will be made of all of its dealings and  transactions,<br \/>\nand set up on its books such reserves as <\/p>\n<p>                                       70<\/p>\n<p>may be  required  by GAAP with  respect  to  doubtful  accounts  and all  taxes,<br \/>\nassessments,  charges,  levies and claims and with  respect to its  business  in<br \/>\ngeneral,  and include  such  reserves  in interim as well as year-end  financial<br \/>\nstatements.<\/p>\n<p>         7.7. Right of Inspection.  Permit any Person designated by the Agent to<br \/>\nvisit and inspect any of the properties,  corporate books and financial  reports<br \/>\nof the  Borrower or any  Subsidiary  and to discuss its  affairs,  finances  and<br \/>\naccounts  with  its  principal   officers  and  independent   certified   public<br \/>\naccountants,   all  at  reasonable  times,  at  reasonable  intervals  and  with<br \/>\nreasonable prior notice.<\/p>\n<p>         7.8.  Observe  all Laws.  Conform  to and duly  observe,  and cause all<br \/>\nContract Providers to conform to and duly observe,  in all material respects all<br \/>\nlaws,  rules and regulations and all other valid  requirements of any regulatory<br \/>\nauthority  with  respect  to the  conduct  of its  business,  including  without<br \/>\nlimitation   Titles  XVIII  and  XIX  of  the  Social  Security  Act,   Medicare<br \/>\nRegulations,  Medicaid  Regulations,  and all  laws,  rules and  regulations  of<br \/>\nGovernmental  Authorities  pertaining to the licensing of professional and other<br \/>\nhealth care providers, except where the failure to do so could not reasonably be<br \/>\nexpected to have a Material Adverse Effect.<\/p>\n<p>         7.9.  Governmental  Licenses.  Obtain and maintain,  and use reasonable<br \/>\neffort to cause all Contract  Providers to obtain and  maintain,  all  licenses,<br \/>\npermits, certifications and approvals of all applicable Governmental Authorities<br \/>\nas are  required  for the conduct of its  business as  currently  conducted  and<br \/>\nherein  contemplated,   including  without  limitation   professional  licenses,<br \/>\nMedicaid Certifications and Medicare Certifications, except where the failure to<br \/>\ndo so could not reasonably be expected to have a Material Adverse Effect.<\/p>\n<p>         7.10.  Covenants  Extending  to  Other  Persons.   Cause  each  of  its<br \/>\nConsolidated Entities to do with respect to itself, its business and its assets,<br \/>\neach of the things  required of the Borrower in Sections  7.2 through 7.9,  7.15<br \/>\nand 7.16 inclusive.<\/p>\n<p>         7.11. Officer&#8217;s Knowledge of Default. Upon any Executive Officer of the<br \/>\nBorrower  obtaining  knowledge of any Default or Event of Default or any default<br \/>\nor  event  of  default  under  any  other  obligation  of  the  Borrower  or any<br \/>\nConsolidated Entity to any Lender, or any event, development or occurrence which<br \/>\ncould  reasonably  be expected  to have a Material  Adverse  Effect,  cause such<br \/>\nExecutive  Officer or an Authorized  Representative to promptly notify the Agent<br \/>\nof the nature  thereof,  the period of  existence  thereof,  and what action the<br \/>\nBorrower or such Consolidated Entity proposes to take with respect thereto.  The<br \/>\nAgent shall notify the Lenders of receipt of such notice.<\/p>\n<p>         7.12.  Suits or Other  Proceedings.  Upon any Executive  Officer of the<br \/>\nBorrower  obtaining  knowledge  of any  litigation  or<\/p>\n<p>                                       71<\/p>\n<p>other  proceedings  being instituted (i) against the Borrower or any Subsidiary,<br \/>\nor any attachment, levy, execution or other process being instituted against any<br \/>\nassets of the Borrower or any  Subsidiary  or Controlled  Partnership,  which if<br \/>\nadversely  determined  could  reasonably  be likely to have a  Material  Adverse<br \/>\nEffect or (ii) against the Borrower,  any  Subsidiary  or any Contract  Provider<br \/>\n(but only with respect to services  provided to the Borrower or any Consolidated<br \/>\nEntity)  to  suspend,  revoke or  terminate  any  Medicaid  Provider  Agreement,<br \/>\nMedicaid  Certification,  Medicare Provider Agreement or Medicare Certification,<br \/>\nwhich suspension, revocation or termination could reasonably be likely to have a<br \/>\nMaterial  Adverse  Effect,   cause  such  Executive  Officer  or  an  Authorized<br \/>\nRepresentative  to promptly  deliver to the Agent written notice thereof stating<br \/>\nthe nature and status of such litigation,  dispute,  proceeding, levy, execution<br \/>\nor other process.<\/p>\n<p>         7.13.  Notice of  Discharge  of  Hazardous  Material  or  Environmental<br \/>\nComplaint.  Promptly provide to the Agent true,  accurate and complete copies of<br \/>\nany and all  notices,  complaints,  orders,  directives,  claims,  or  citations<br \/>\nreceived  by the  Borrower  or any  Consolidated  Entity  relating to any of the<br \/>\nfollowing which is likely to have a Material  Adverse  Effect:  (a) violation or<br \/>\nalleged  violation by the Borrower or any Consolidated  Entity of any applicable<br \/>\nEnvironmental  Law;  (b) release or  threatened  release by the  Borrower or any<br \/>\nConsolidated  Entity, or at any Facility or property owned or leased or operated<br \/>\nby the Borrower or any Consolidated  Entity, of any Hazardous  Material,  except<br \/>\nwhere occurring  legally;  or (c) liability or alleged liability of the Borrower<br \/>\nor any Consolidated  Entity for the costs of cleaning up, removing,  remediating<br \/>\nor responding to a release of Hazardous Materials.<\/p>\n<p>         7.14.  Environmental  Compliance.  If the Borrower or any  Consolidated<br \/>\nEntity shall receive any letter, notice, complaint,  order, directive,  claim or<br \/>\ncitation  from any  Governmental  Authority  alleging  that the  Borrower or any<br \/>\nConsolidated  Entity has  violated  any  Environmental  Law or is liable for the<br \/>\ncosts of  cleaning  up,  removing,  remediating  or  responding  to a release of<br \/>\nHazardous   Materials  within  the  time  period  permitted  by  the  applicable<br \/>\nEnvironmental Law or the Governmental  Authority  responsible for enforcing such<br \/>\nEnvironmental Law, remove or remedy, or cause the applicable Consolidated Entity<br \/>\nto remove or remedy,  such violation or release or satisfy such liability unless<br \/>\nand only during the period that the applicability of such Environmental Law, the<br \/>\nfact of such violation or liability or what is required to remove or remedy such<br \/>\nviolation  is being  contested by the  Borrower or the  applicable  Consolidated<br \/>\nEntity by  appropriate  proceedings  diligently  conducted and all reserves with<br \/>\nrespect  thereto as may be required  under GAAP, if any, have been made,  and no<br \/>\nLien in connection therewith shall have attached to any property of the Borrower<br \/>\nor the  applicable  Consolidated  Entity  which  shall have  become  enforceable<br \/>\nagainst creditors of such Person.<\/p>\n<p>                                       72<\/p>\n<p>         7.15.  Continuation  of Current  Business.  Not engage in any  business<br \/>\nother than the business now being conducted by the Borrower and other businesses<br \/>\ndirectly related to such services.<\/p>\n<p>         7.16.  Management  Contracts.  Not enter into any agreement whereby the<br \/>\nmanagement,  supervision  or control of its  business or any  Facility  shall be<br \/>\ndelegated  to or  placed  in any  persons  other  than  its  governing  body and<br \/>\nofficers,  the Borrower or a Consolidated Entity,  except that (i) management of<br \/>\nthe Facility owned by Vanderbilt  Stallworth  Rehabilitation  Hospital,  L.P. is<br \/>\nvested in part in a  Governance  Committee  and in part in a  Subsidiary  of the<br \/>\nBorrower  pursuant  to  the  applicable  limited  partnership  agreement  and  a<br \/>\nmanagement  agreement  and (ii) the Facility  known as Nashville  Rehabilitation<br \/>\nHospital  located in Nashville,  Tennessee may be managed by an independent body<br \/>\nuntil such time as such Facility is sold.<\/p>\n<p>                                       73<\/p>\n<p>                                  ARTICLE VIII<\/p>\n<p>                               Negative Covenants<\/p>\n<p>         Until the Facility  Termination  Date and termination of this Agreement<br \/>\nin accordance with the terms hereof, unless the Required Lenders shall otherwise<br \/>\nconsent in writing,  the  Borrower  will not, nor (to the extent  expressly  set<br \/>\nforth below) will it permit any Consolidated Entity to:<\/p>\n<p>         8.1. Financial Convenants.<\/p>\n<p>              (a) Minimum Net Worth.  Permit  Consolidated  Net Worth to be less<br \/>\n         than  $917,711,000 plus (A) 50% of Consolidated Net Income (if positive<br \/>\n         and   including   for  purposes  of  this   Section   8.1(a)  only  any<br \/>\n         extraordinary  gain),  on an  ongoing  basis  for each  fiscal  quarter<br \/>\n         beginning  with the fiscal  quarter ended March 31, 1996,  plus (B) the<br \/>\n         aggregate  amount of all  increases,  if any, in its  capital  accounts<br \/>\n         resulting from the issuance of Capital Stock or conversion of debt into<br \/>\n         Capital  Stock or other  securities  properly  classified  as equity in<br \/>\n         accordance with generally accepted accounting  principles,  or from the<br \/>\n         sale or other  disposition  of treasury  shares,  from the date of this<br \/>\n         Agreement   through  the  date  of   determination   plus  (c)  without<br \/>\n         duplication,   any  addition  to  Consolidated   Stockholders&#8217;   Equity<br \/>\n         resulting  from an  Acquisition  after the Closing  Date which shall be<br \/>\n         accounted for on a pooling-of-interests basis.<\/p>\n<p>              (b)  Consolidated  EBITDA to Consolidated  Interest Expense Ratio.<br \/>\n         Permit  the  ratio of  Consolidated  EBITDA  to  Consolidated  Interest<br \/>\n         Expense at any time to be less than or equal to 2.50 to 1.00.<\/p>\n<p>              (c)  Consolidated  Indebtedness  to  Consolidated  Total  Capital.<br \/>\n         Permit the ratio of Consolidated  Indebtedness  to  Consolidated  Total<br \/>\n         Capital at any time to equal or exceed .65 to 1.00.<\/p>\n<p>         8.2.  Investments and Loans.  Purchase or otherwise  acquire any stock,<br \/>\nsecurity,   obligation  or  evidence  of  indebtedness   of,  make  any  capital<br \/>\ncontribution to, own any equity interest in, or make any loan or advance to, any<br \/>\nother Person; provided, however, that the Borrower and its Consolidated Entities<br \/>\nmay (A)  continue  to hold all  stock of and own  partnership  interests  in the<br \/>\nPersons that  constitute  Consolidated  Entities on the Closing Date and Persons<br \/>\nthat  thereafter  become  Consolidated  Entities  as a  result  of  Acquisitions<br \/>\npermitted  under  Section  8.8;  (B) make  Permitted  Investments;  and (C) make<br \/>\ninvestments in an amount not exceeding 15% of Consolidated Total Assets.<\/p>\n<p>         8.3. Indebtedness.  Permit to exist Indebtedness,  howsoever evidenced,<br \/>\nof Subsidiaries  and Controlled  Partnerships  (exclusive <\/p>\n<p>                                       74<\/p>\n<p>of  Indebtedness  to the Borrower) in an aggregate  amount at any time exceeding<br \/>\nthe greater of $70,000,000 or 15% of Consolidated Tangible Net Worth, excluding,<br \/>\nhowever, Indebtedness of Subsidiaries and Controlled Partnerships existing as of<br \/>\nthe date hereof and described on Schedule 8.3.<\/p>\n<p>         8.4. Disposition of Assets. Sell, lease,  transfer or otherwise dispose<br \/>\nof assets in excess of 15% of  Consolidated  Total Assets as at the Closing Date<br \/>\nplus an amount equal to 15% of assets acquired following the Closing Date.<\/p>\n<p>         8.5.  Consolidation or Merger. Merge or consolidate with another Person<br \/>\nunless  (i) in the  case of a  merger  or  consolidation  of the  Borrower,  the<br \/>\nBorrower is the continuing or surviving entity,  (ii) in the case of a merger or<br \/>\nconsolidation  involving a  Consolidated  Entity,  the  continuing  or surviving<br \/>\nentity  is  majority-owned  by  the  Borrower  (with  such  majority   ownership<br \/>\nconstituting a controlling  interest),  and (iii) before and after giving effect<br \/>\nto the proposed  merger or  consolidation,  no Default or Event of Default shall<br \/>\nexist.<\/p>\n<p>         8.6. Liens. Incur, create,  assume or permit to exist any Lien upon any<br \/>\nof  its  accounts  receivable,   contract  rights,  chattel  paper,   inventory,<br \/>\nequipment,  instruments,  general intangibles or other personal or real property<br \/>\nof any character,  whether now owned or hereafter acquired, other than (i) Liens<br \/>\nthat  constitute  Permitted  Encumbrances,  and (ii) Liens on assets which at no<br \/>\ntime have a book value of greater than 5% of Consolidated Total Assets.<\/p>\n<p>         8.7. Dividends and Distributions.  Permit any Consolidated Entity to be<br \/>\nor become subject to any restrictions on the ability of such Consolidated Entity<br \/>\nto pay dividends or to make partnership  distributions other than as required by<br \/>\nthis Agreement or restrictions imposed by applicable law.<\/p>\n<p>         8.8.  Acquisitions.  Enter into any  agreement to acquire any Person or<br \/>\nFacility  unless (i) the Person or Facility  to be acquired is in  substantially<br \/>\nthe  same  line  of  business  presently  engaged  in by  the  Borrower  or  its<br \/>\nConsolidated  Entities, and (ii) if the Cost of Acquisition exceeds $150,000,000<br \/>\nthe  Borrower  shall  have  furnished  to the  Agent  (A) pro  forma  historical<br \/>\nfinancial statements as of the end of the most recently completed Fiscal Year of<br \/>\nthe Borrower and most recent  interim  fiscal  quarter,  if  applicable,  giving<br \/>\neffect to such  Acquisition  and (B) a  Compliance  Certificate  prepared  on an<br \/>\nhistorical pro forma basis giving effect to such Acquisition,  which certificate<br \/>\nshall  demonstrate  that no Default or Event of Default would exist  immediately<br \/>\nafter giving effect thereto.<\/p>\n<p>         8.9. Restricted  Payments.  Make any Restricted Payment or apply or set<br \/>\napart  any of  their  assets  therefor  or  agree  to do  any of the  foregoing;<br \/>\nprovided,  however,  the Borrower may make the Restricted Payments in any Fiscal<br \/>\nYear (on a  non-cumulative  basis,<\/p>\n<p>                                       75<\/p>\n<p>with the effect that amounts not paid in any Fiscal Year may not be carried over<br \/>\nfor payment in a subsequent  period) if immediately  prior and immediately after<br \/>\ngiving effect thereto no Default or Event of Default shall exist or occur and be<br \/>\ncontinuing.<\/p>\n<p>         8.10. Compliance with ERISA. With respect to any Pension Plan, Employee<br \/>\nBenefit Plan or Multiemployer Plan:<\/p>\n<p>                (a) permit the occurrence of any  Termination  Event which would<br \/>\n         result  in a  liability  on the  part  of  the  Borrower  or any  ERISA<br \/>\n         Affiliate  to the PBGC which  liability  would have a Material  Adverse<br \/>\n         Effect; or<\/p>\n<p>                (b) permit the present  value of all benefit  liabilities  under<br \/>\n         all  Pension  Plans to exceed the  current  value of the assets of such<br \/>\n         Pension Plans allocable to such benefit liabilities; or<\/p>\n<p>                (c) permit any  accumulated  funding  deficiency  (as defined in<br \/>\n         Section 302 of ERISA and  Section 412 of the Code) with  respect to any<br \/>\n         Pension Plan, whether or not waived; or<\/p>\n<p>                (d)  fail  to  make  any   contribution   or   payment   to  any<br \/>\n         Multiemployer  Plan which the  Borrower or any ERISA  Affiliate  may be<br \/>\n         required to make under any  agreement  relating  to such  Multiemployer<br \/>\n         Plan, or any law pertaining thereto; or<\/p>\n<p>                (e) engage,  or permit any Subsidiary or any ERISA  Affiliate to<br \/>\n         engage,  in any  prohibited  transaction  under Section 406 of ERISA or<br \/>\n         Section 4975 of the Code for which a civil penalty  pursuant to Section<br \/>\n         502(I) of ERISA or a tax  pursuant  to Section  4975 of the Code may be<br \/>\n         imposed; or<\/p>\n<p>                (f)  permit  the  establishment  of any  Employee  Benefit  Plan<br \/>\n         providing  post-retirement  welfare  benefits or establish or amend any<br \/>\n         Employee Benefit Plan which  establishment or amendment could result in<br \/>\n         liability  to the  Borrower  or any ERISA  Affiliate  or  increase  the<br \/>\n         obligation  of the Borrower or any ERISA  Affiliate to a  Multiemployer<br \/>\n         Plan which  liability or increase,  individually  or together  with all<br \/>\n         similar liabilities and increases, is in excess of $5,000,000; or<\/p>\n<p>                (g) fail,  or permit any  Subsidiary  or any ERISA  Affiliate to<br \/>\n         fail, to establish,  maintain and operate each Employee Benefit Plan in<br \/>\n         compliance in all material  respects with the provisions of ERISA,  the<br \/>\n         Code, all applicable Foreign Benefit Laws and all other applicable laws<br \/>\n         and the regulations and interpretations thereof.<\/p>\n<p>         8.11.  Fiscal Year.  Change its Fiscal Year.<\/p>\n<p>         8.12. Dissolution,  etc. Wind up, liquidate or dissolve (voluntarily or<br \/>\ninvoluntarily)  or commence or suffer any <\/p>\n<p>                                       76<\/p>\n<p>proceedings  seeking any such winding up, liquidation or dissolution,  except in<br \/>\nconnection with a merger or consolidation permitted pursuant to Section 8.5.<\/p>\n<p>                                       77<\/p>\n<p>                                   ARTICLE IX<\/p>\n<p>                         Events of Default Acceleration<\/p>\n<p>         9.1  Events  of  Default.  If any one or more of the  following  events<br \/>\n(herein called &#8220;Events of Default&#8221;)  shall occur for any reason  whatsoever (and<br \/>\nwhether such  occurrence  shall be voluntary or  involuntary or come about or be<br \/>\neffected by operation of law or pursuant to or in compliance  with any judgment,<br \/>\ndecree  or  order  of  any  court  or  any  order,  rule  or  regulation  of any<br \/>\nGovernmental Authority), that is to say:<\/p>\n<p>                  (a) the Borrower  shall fail to pay (i) when due any principal<br \/>\n         payable under the terms of any Note or any Reimbursement  Obligation or<br \/>\n         (ii)  not  later  than  five  Business  Days of the  date  when due any<br \/>\n         interest  or fees  payable  under  the  terms of any Note or any  other<br \/>\n         amount  payable  under  this  Agreement  or  any  other  of  the  other<br \/>\n         Obligations or any other amount owed to the Agent or any of the Lenders<br \/>\n         under or in connection with the Loan Documents; or<\/p>\n<p>                  (b) The  Borrower or any Material  Group shall  default in the<br \/>\n         performance  or  observance  of any other  provision of this  Agreement<br \/>\n         (other than the provisions of Article VII and Article VIII),  except as<br \/>\n         covered  by clause (a) above,  and shall not cure such  default  within<br \/>\n         thirty  days  after the first to occur of (i) the date the Agent or any<br \/>\n         Lender  gives  written  or  telephonic  notice of such  default  to the<br \/>\n         Borrower or (ii) the date the Borrower otherwise has notice thereof; or<\/p>\n<p>                  (c) the  Borrower or any Material  Group shall  default in the<br \/>\n         observance  or  performance  of any provision in Article VII or Article<br \/>\n         VIII; or<\/p>\n<p>                  (d) the Agent shall  reasonably  determine that any statement,<br \/>\n         certification,  representation or warranty  contained herein, or in any<br \/>\n         of the other Loan  Documents  or in any  report,  financial  statement,<br \/>\n         certificate or other instrument delivered to the Agent or any Lender by<br \/>\n         or on behalf of the Borrower or any Consolidated Entity, was misleading<br \/>\n         or untrue  in any  material  respect  at the time it was made or deemed<br \/>\n         made; or<\/p>\n<p>                  (e)  default   shall  be  made  (i)  in  the  payment  of  any<br \/>\n         Indebtedness  exceeding  $5,000,000 (other than the Obligations) of the<br \/>\n         Borrower  or  any   Consolidated   Entity  when  due  or  (ii)  in  the<br \/>\n         performance,   observance  or  fulfillment  of  any  term  or  covenant<br \/>\n         contained in any agreement or instrument under or pursuant to which any<br \/>\n         such Indebtedness may have been issued, created, assumed, guaranteed or<br \/>\n         secured by Borrower or any Consolidated  Entity,  if the effect of such<br \/>\n         default in the performance,  observance or fulfillment is to accelerate<br \/>\n         the maturity of such  Indebtedness  or to permit the holder  thereof <\/p>\n<p>                                       78<\/p>\n<p>         to cause such  Indebtedness to become due prior to its stated maturity,<br \/>\n         and such default shall not be cured within 10 days after the occurrence<br \/>\n         of such default,  and the amount of the  Indebtedness  involved exceeds<br \/>\n         $5,000,000; or<\/p>\n<p>                  (f) the  Borrower or any  Material  Group shall fail to pay or<br \/>\n         admit in writing its  inability to pay its or their debts  generally as<br \/>\n         they come due, or a receiver,  trustee,  liquidator or other  custodian<br \/>\n         shall be appointed for the Borrower or any Material Group or for any of<br \/>\n         the  property of the  Borrower or any  Material  Group or a petition in<br \/>\n         bankruptcy,  or under any insolvency  law, shall be filed by or against<br \/>\n         the  Borrower or any  Material  Group or the  Borrower or any  Material<br \/>\n         Group shall apply for the benefit of, or take advantage of, any law for<br \/>\n         relief of debtors, or enter into an arrangement or composition with, or<br \/>\n         make an assignment for the benefit of, creditors; or<\/p>\n<p>                  (g) final  judgment  for the payment of money in excess of any<br \/>\n         aggregate  of $500,000  shall be rendered  against the  Borrower or any<br \/>\n         Material Group, and the same shall remain  undischarged for a period of<br \/>\n         30 days during which execution shall not be effectively stayed; or<\/p>\n<p>                  (h) an event of default, as therein defined, shall occur under<br \/>\n         any other Loan Document; or<\/p>\n<p>                  (i) any of the Notes or LC Account  Agreement  shall be deemed<br \/>\n         unenforceable  by a court of competent  jurisdiction or shall no longer<br \/>\n         be effective; or<\/p>\n<p>                  (j) the Borrower or any Consolidated  Entity shall, other than<br \/>\n         in the ordinary  course of business (as determined by past  practices),<br \/>\n         suspend  all or any part of its  operations  material to the conduct of<br \/>\n         the business of the Borrower and its Consolidated Entities,  taken as a<br \/>\n         whole, for a period of more than 60 days;<\/p>\n<p>                  (k) the Borrower or any  Consolidated  Entity shall breach any<br \/>\n         of the material  terms or conditions  of any agreement  under which any<br \/>\n         Rate Hedging  Obligations  are created and such breach  shall  continue<br \/>\n         beyond any grace period, if any, relating thereto pursuant to the terms<br \/>\n         of such  agreement,  or the Borrower or any  Consolidated  Entity shall<br \/>\n         disaffirm  or  seek  to  disaffirm  any  such  agreement  or any of its<br \/>\n         obligations thereunder;<\/p>\n<p>                  (l)  there  shall  occur  (i)  any  cancellation,  revocation,<br \/>\n         suspension  or  termination  of any  Medicare  Certification,  Medicare<br \/>\n         Provider  Agreement,   Medicaid   Certification  or  Medicaid  Provider<br \/>\n         Agreement  affecting  the  Borrower,  any  Subsidiary  or any  Contract<br \/>\n         Provider,   or  (ii)  the  loss  of  any   other   permits,   licenses,<br \/>\n         authorizations,  certifications or approvals from any federal, state or<br \/>\n         local  Governmental  <\/p>\n<p>                                       79<\/p>\n<p>         Authority or  termination of any contract with any such  authority,  in<br \/>\n         either case which cancellation,  revocation, suspension, termination or<br \/>\n         loss  (X) in the  case  of  any  suspension  or  temporary  loss  only,<br \/>\n         continues  for a period  greater  than 60 days and (Y)  results  in the<br \/>\n         suspension  or  termination  of  operations  of  the  Borrower  or  any<br \/>\n         Subsidiary or in the failure of the Borrower or any Subsidiaries or any<br \/>\n         Contract Provider to be eligible to participate in Medicare or Medicaid<br \/>\n         programs  or to accept  assignments  of rights to  reimbursement  under<br \/>\n         Medicaid  Regulations  or  Medicare  Regulations,  if and  only if such<br \/>\n         Person,  in  the  ordinary  course  of  business,  participates  in the<br \/>\n         Medicare  or  Medicare  programs  or accepts  assignments  of rights to<br \/>\n         reimbursement  thereunder;  provided that any such events  described in<br \/>\n         this Section  9.1(l) shall  constitute an Event of Default only if such<br \/>\n         event  shall  result   either   singly  or  in  the  aggregate  in  the<br \/>\n         termination,   cancellation,   suspension  or  material  impairment  of<br \/>\n         operations or rights to  reimbursement  which produce 5% or more of the<br \/>\n         Borrower&#8217;s gross revenues (on an annualized basis); or<\/p>\n<p>                  (m)      there shall occur a Change of Control;<\/p>\n<p>then, and in any such event and at any time thereafter, if such Event of Default<br \/>\nor any other Event of Default shall then be  continuing  and shall have not been<br \/>\nwaived,<\/p>\n<p>                  (A) either or both of the following  actions may be taken: (i)<br \/>\n         the Agent,  with the consent of the Required  Lenders,  may, and at the<br \/>\n         direction of the Required Lenders shall,  declare any obligation of the<br \/>\n         Lenders  and the  Issuing  Bank  to  make  further  Loans  or to  issue<br \/>\n         additional  Letters of Credit  terminated,  whereupon the obligation of<br \/>\n         each  Lender to make  further  Loans and of the  Issuing  Bank to issue<br \/>\n         additional Letters of Credit hereunder shall terminate immediately, and<br \/>\n         (ii) the Agent shall at the direction of the Required Lenders, at their<br \/>\n         option, declare by notice to the Borrower any or all of the Obligations<br \/>\n         to be immediately due and payable, and the same, including all interest<br \/>\n         accrued thereon and all other  obligations of the Borrower to the Agent<br \/>\n         and the Lenders,  shall  forthwith  become  immediately due and payable<br \/>\n         without presentment,  demand, protest, notice or other formality of any<br \/>\n         kind,  all of which are hereby  expressly  waived,  anything  contained<br \/>\n         herein or in any instrument  evidencing the Obligations to the contrary<br \/>\n         notwithstanding;  provided, however, that notwithstanding the above, if<br \/>\n         there shall occur an Event of Default under clause (f) above,  then the<br \/>\n         obligation  of the  Lenders  to make Loans and of the  Issuing  Bank to<br \/>\n         issue Letters of Credit hereunder shall automatically terminate and any<br \/>\n         and all of the Obligations shall be immediately due and payable without<br \/>\n         the  necessity  of any action by the Agent or the  Required  Lenders or<br \/>\n         notice to the Agent or the Lenders;<\/p>\n<p>                                       80<\/p>\n<p>                  (B) the  Borrower  shall,  upon  demand  of the  Agent  or the<br \/>\n         Required Lenders, deposit cash with the Agent in an amount equal to the<br \/>\n         aggregate  amount  remaining  undrawn under all outstanding  Letters of<br \/>\n         Credit, as collateral security for the repayment of any future drawings<br \/>\n         or payments  under such Letters of Credit,  and such  amounts  shall be<br \/>\n         held by the Agent  pursuant  to the terms of the LC Account  Agreement;<br \/>\n         and<\/p>\n<p>                  (C) the Agent and each of the  Lenders  shall  have all of the<br \/>\n         rights and  remedies  available  under the Loan  Documents or under any<br \/>\n         applicable law.<\/p>\n<p>         9.2.  Agent to Act.  In case any one or more  Events of  Default  shall<br \/>\noccur and be  continuing  and not have been  waived,  the Agent may,  and at the<br \/>\ndirection of the Required  Lenders  shall,  proceed to protect and enforce their<br \/>\nrights or  remedies  either  by suit in  equity  or by  action at law,  or both,<br \/>\nwhether  for the  specific  performance  of any  covenant,  agreement  or  other<br \/>\nprovision  contained  herein or in any other Loan  Document,  or to enforce  the<br \/>\npayment of the Obligations or any other legal or equitable right or remedy.<\/p>\n<p>         9.3.  Cumulative  Rights.  No right or remedy herein conferred upon the<br \/>\nLenders or the Agent is intended to be exclusive of any other rights or remedies<br \/>\ncontained  herein or in any other Loan Document,  and every such right or remedy<br \/>\nshall be cumulative and shall be in addition to every other such right or remedy<br \/>\ncontained herein and therein or now or hereafter existing at law or in equity or<br \/>\nby statute, or otherwise.<\/p>\n<p>         9.4.  No Waiver.  No course of dealing  between  the  Borrower  and any<br \/>\nLender or the  Agent or any  failure  or delay on the part of any  Lender or the<br \/>\nAgent in exercising  any rights or remedies under any Loan Document or otherwise<br \/>\navailable  to it shall  operate  as a waiver of any  rights or  remedies  and no<br \/>\nsingle or partial  exercise of any rights or remedies  shall operate as a waiver<br \/>\nor preclude  the  exercise of any other  rights or remedies  hereunder or of the<br \/>\nsame right or remedy on a future occasion.<\/p>\n<p>         9.5.  Allocation  of Proceeds.  If an Event of Default has occurred and<br \/>\nnot been waived, and the maturity of the Notes has been accelerated  pursuant to<br \/>\nthis Article IX, all payments received by the Agent hereunder, in respect of any<br \/>\nprincipal of or interest on the  Obligations or any other amounts payable by the<br \/>\nBorrower hereunder, shall be applied by the Agent in the following order:<\/p>\n<p>               (i)  amounts  due to the  Lenders  pursuant  to  Section  2.11 or<br \/>\n         Section 11.6;<\/p>\n<p>               (ii)  amounts due to the Agent and the Issuing  Bank  pursuant to<br \/>\n         Section 10.11, Section 3.3 and Section 3.4;<\/p>\n<p>               (iii)  payments of interest,  to be applied pro rata based on the<br \/>\n         proportion  which  the  principal  amount  of  outstanding  <\/p>\n<p>                                       81<\/p>\n<p>         Loans and  Reimbursement  Obligations of each Lender bears to the total<br \/>\n         of all outstanding Loans and Reimbursement Obligations;<\/p>\n<p>               (iv) payments of  principal,  to be applied pro rata based on the<br \/>\n         proportion  which  the  principal  amount  of  outstanding   Loans  and<br \/>\n         Reimbursement  Obligations  of each  Lender  bears to the  total of all<br \/>\n         outstanding Loans and Reimbursement Obligations;<\/p>\n<p>               (v) payment of cash amounts to the Agent pursuant to Section 9.1;<\/p>\n<p>               (vi) payments of all other amounts due under this  Agreement,  if<br \/>\n         any, to be applied in  accordance  with each Lender&#8217;s pro rata share of<br \/>\n         all such other amounts due to the Lenders; and<\/p>\n<p>               (vii) any surplus  remaining  after  application  as provided for<br \/>\n         herein,  to the Borrower or otherwise as may be required by  applicable<br \/>\n         law.<\/p>\n<p>                                       82<\/p>\n<p>                                    ARTICLE X<\/p>\n<p>                                   The Agent<\/p>\n<p>         10.1.  Appointment.  Each  Lender  hereby  irrevocably  designates  and<br \/>\nappoints NationsBank as the Agent for the Lenders under this Agreement, and each<br \/>\nof the Lenders hereby irrevocably  authorizes  NationsBank as the Agent for such<br \/>\nLender, to take such action on its behalf under the provisions of this Agreement<br \/>\nand the other  Loan  Documents  and to  exercise  such  powers as are  expressly<br \/>\ndelegated  to the  Agent by the  terms of this  Agreement  and such  other  Loan<br \/>\nDocuments, together with such other powers as are reasonably incidental thereto.<br \/>\nThe Agent shall not have any duties or responsibilities,  except those expressly<br \/>\nset forth herein, or any fiduciary  relationship with any of the Lenders, and no<br \/>\nimplied  covenants,   functions,   responsibilities,   duties,   obligations  or<br \/>\nliabilities  shall be read into this  Agreement  or any other Loan  Document  or<br \/>\notherwise exist against the Agent.<\/p>\n<p>         10.2. Attorneys-in-fact.  The Agent may execute any of its duties under<br \/>\nthe Loan  Documents  by or  through  agents  or  attorneys-in-fact  and shall be<br \/>\nentitled to advice of counsel  concerning all matters pertaining to such duties.<br \/>\nThe Agent shall not be  responsible  for the  negligence,  gross  negligence  or<br \/>\nwillful  misconduct  of any  agents  or  attorneys-in-fact  selected  by it with<br \/>\nreasonable care.<\/p>\n<p>         10.3.  Limitation  on  Liability.  A  Neither  the Agent nor any of its<br \/>\nofficers,  directors,  employees, agents or attorneys-in-fact shall be liable to<br \/>\nthe Lenders for any action  lawfully  taken or omitted to be taken by it or them<br \/>\nunder or in connection with the Loan Documents except for its or their own gross<br \/>\nnegligence or willful  misconduct.  Neither the Agent nor any of its  Affiliates<br \/>\nshall be  responsible  in any  manner to any of the  Lenders  for any  recitals,<br \/>\nstatements, representations or warranties made by the Borrower or any officer or<br \/>\nrepresentative  thereof  contained in any Loan Document,  or in any certificate,<br \/>\nreport,  statement or other document  referred to or provided for in or received<br \/>\nby the Agent under or in connection  with any Loan  Document,  or for the value,<br \/>\nvalidity, effectiveness,  genuineness, enforceability or sufficiency of any Loan<br \/>\nDocument,  or for any failure of the Borrower to perform its  obligations  under<br \/>\nany  Loan  Document,  or  for  any  recitals,  statements,   representations  or<br \/>\nwarranties  made,  or  for  the  value,  validity,  effectiveness,  genuineness,<br \/>\nenforceability  or sufficiency of any  collateral.  The Agent shall not be under<br \/>\nany  obligation  to any of the  Lenders  to  ascertain  or to  inquire as to the<br \/>\nobservance or  performance  of any of the terms,  covenants or conditions of any<br \/>\nLoan Document on the part of the Borrower or to inspect the properties, books or<br \/>\nrecords of the Borrower or its Subsidiaries.<\/p>\n<p>         10.4. Reliance. The Agent shall be entitled to rely, and shall be fully<br \/>\nprotected  in  relying,  upon any Note,  writing,  resolution,  notice,  consent<br \/>\ncertificate,  affidavit,  letter, <\/p>\n<p>                                       83<\/p>\n<p>cablegram,  telegram,  telefacsimile or telex message, statement, order or other<br \/>\ndocument  or  conversation  believed by it to be genuine and correct and to have<br \/>\nbeen  signed,  sent or made by the proper  Person or Persons and upon advice and<br \/>\nstatements  of legal  counsel  (including,  without  limitation,  counsel to the<br \/>\nBorrower),  independent accountants and other experts selected by the Agent. The<br \/>\nAgent may deem and treat  the  payee of any Note as the  owner  thereof  for all<br \/>\npurposes  unless an  Assignment  and  Acceptance  shall have been filed with and<br \/>\naccepted by the Agent. The Agent shall be fully justified in failing or refusing<br \/>\nto take any action under the Loan Documents unless it shall first receive advice<br \/>\nor  concurrence  of the  Lenders or the  Required  Lenders as  provided  in this<br \/>\nAgreement or it shall first be  indemnified to its  satisfaction  by the Lenders<br \/>\nagainst any and all  liability and expense which may be incurred by it by reason<br \/>\nof taking or continuing to take any such action. The Agent shall in all cases be<br \/>\nfully  protected  in  acting,  or in  refraining  from  acting,  under  the Loan<br \/>\nDocuments in accordance with a request of the Required Lenders or all Lenders as<br \/>\nrequired in this Agreement,  and such request and any action taken or failure to<br \/>\nact pursuant  thereto  shall be binding upon all the Lenders and all present and<br \/>\nfuture holders of the Notes.<\/p>\n<p>         10.5.  Notice  of  Default.  The  Agent  shall  not be  deemed  to have<br \/>\nknowledge or notice of the  occurrence of any Default or Event of Default unless<br \/>\nthe Agent has received notice from a Lender, an Authorized Representative or the<br \/>\nBorrower  referring  to this  Agreement,  describing  such  Default  or Event of<br \/>\nDefault and stating that such notice is a &#8220;notice of default&#8221;. In the event that<br \/>\nthe Agent  receives such a notice,  the Agent shall promptly give notice thereof<br \/>\nto the Lenders. The Agent shall take such action with respect to such Default or<br \/>\nEvent of Default as shall be reasonably  directed by the Required Lenders or all<br \/>\nLenders as required in this Agreement; provided that, unless and until the Agent<br \/>\nshall have received such  directions,  the Agent may (but shall not be obligated<br \/>\nto) take such action,  or refrain from taking such action,  with respect to such<br \/>\nEvent of  Default  as it shall  deem  advisable  in the  best  interests  of the<br \/>\nLenders.<\/p>\n<p>         10.6.  No  Representation.  Each  Lender  expressly  acknowledges  that<br \/>\nneither  the Agent nor any of its  affiliates  has made any  representations  or<br \/>\nwarranties  to it and that no act by the Agent  hereafter  taken,  including any<br \/>\nreview of the affairs of the  Borrower or its  Consolidated  Entities,  shall be<br \/>\ndeemed to constitute any  representation or warranty by the Agent to any Lender.<br \/>\nEach  Lender  represents  to the Agent that it has,  independently  and  without<br \/>\nreliance  upon the Agent or any other  Lender,  and based on such  documents and<br \/>\ninformation  as it  has  deemed  appropriate,  made  its  own  appraisal  of and<br \/>\ninvestigation into the financial condition,  creditworthiness,  affairs,  status<br \/>\nand  nature  of the  Borrower  and  each  Consolidated  Entity  and made its own<br \/>\ndecision to enter into this Agreement. Each Lender also represents that it will,<br \/>\nindependently and without reliance upon the Agent or any other Lender, and based<br \/>\non such  documents and<\/p>\n<p>                                       84<\/p>\n<p>information as it shall deem  appropriate at the time,  continue to make its own<br \/>\ncredit  analysis,  appraisals and decisions in taking or not taking action under<br \/>\nthe Loan  Documents  and to make such  investigation  as it deems  necessary  to<br \/>\ninform  itself as to the status and  affairs,  financial  or  otherwise,  of the<br \/>\nBorrower and its Subsidiaries.  Except for notices,  reports and other documents<br \/>\nexpressly  required to be furnished to the Lenders by the Agent  hereunder,  the<br \/>\nAgent shall not have any duty or  responsibility  to provide any Lender with any<br \/>\ncredit or other  information  concerning  the  affairs,  financial  condition or<br \/>\nbusiness of the Borrower and its Subsidiaries which may come into the possession<br \/>\nof the Agent or any of its affiliates.<\/p>\n<p>         10.7 Indemnification. Each of the Lenders agrees to indemnify the Agent<br \/>\nin its capacity as such (to the extent not  reimbursed by the Borrower or any of<br \/>\nits  Consolidated  Entities and without limiting any obligations of the Borrower<br \/>\nor any  of  its  Consolidated  Entities  to do  so),  ratably  according  to the<br \/>\nrespective  principal  amount  of the Notes  held by them  (or,  if no Notes are<br \/>\noutstanding,  ratably in accordance with their respective  Applicable Commitment<br \/>\nPercentages  as  then in  effect)  from  and  against  any and all  liabilities,<br \/>\nobligations,  losses  (excluding any losses suffered by the Agent as a result of<br \/>\nthe Borrower&#8217;s failure to pay any fee owing to the Agent),  damages,  penalties,<br \/>\nactions,  judgments,  suits,  costs,  expenses or  disbursements  of any kind or<br \/>\nnature  whatsoever  which may at any time (including  without  limitation at any<br \/>\ntime following the payment of the Notes) be imposed on,  incurred by or asserted<br \/>\nagainst the Agent in any way relating to or arising out of any Loan  Document or<br \/>\nany other document  contemplated  by or referred to therein or the  transactions<br \/>\ncontemplated  thereby  or any action  taken or omitted by the Agent  under or in<br \/>\nconnection  with any of the  foregoing;  provided that no Lender shall be liable<br \/>\nfor the  payment  of any  portion  of  such  liabilities,  obligations,  losses,<br \/>\ndamages, penalties,  actions, judgments, suits, costs, expenses or disbursements<br \/>\nresulting  from  the  Agent&#8217;s  gross  negligence  or  willful  misconduct.   The<br \/>\nagreements  in this  Section  10.7 shall  survive  the  payment of the  Facility<br \/>\nTermination Date.<\/p>\n<p>         10.8.  Lender.  The Agent and its  Affiliates may make loans to, accept<br \/>\ndeposits from and generally engage in any kind of business with the Borrower and<br \/>\nits Subsidiaries as though it were not the Agent hereunder.  With respect to its<br \/>\nLoans made or renewed by it and any Note  issued to it, the Agent shall have the<br \/>\nsame rights and powers  under this  Agreement as any Lender and may exercise the<br \/>\nsame as  though it were not the  Agent,  and the terms  &#8220;Lender&#8221;  and  &#8220;Lenders&#8221;<br \/>\nshall,  unless  the  context  otherwise  indicates,  include  the  Agent  in its<br \/>\nindividual capacity.<\/p>\n<p>         10.9.  Resignation.  If the  Agent  shall  resign as Agent  under  this<br \/>\nAgreement,  then the Required Lenders may appoint,  with the consent, so long as<br \/>\nthere shall not have  occurred and be  continuing a Default or Event of Default,<br \/>\nof the Borrower,  which consent shall <\/p>\n<p>                                       85<\/p>\n<p>not be unreasonably withheld, a successor Agent for the Lenders, which successor<br \/>\nAgent shall be a commercial  bank organized  under the laws of the United States<br \/>\nor any state  thereof,  having a combined  surplus  and capital of not less than<br \/>\n$500,000,000, whereupon such successor Agent shall succeed to the rights, powers<br \/>\nand duties of the former Agent and the  obligations of the former Agent shall be<br \/>\nterminated and canceled, without any other or further act or deed on the part of<br \/>\nsuch former Agent or any of the parties to this  Agreement;  provided,  however,<br \/>\nthat the  former  Agent&#8217;s  resignation  shall not  become  effective  until such<br \/>\nsuccessor  Agent has been  appointed  and has  succeeded of record to all right,<br \/>\ntitle and interest in any collateral held by the Agent; provided,  further, that<br \/>\nif the Required  Lenders and, if applicable,  the Borrower  cannot agree as to a<br \/>\nsuccessor Agent within ninety (90) days after such resignation,  the Agent shall<br \/>\nappoint a successor  Agent which  satisfies the criteria set forth above in this<br \/>\nSection  10.9 for a  successor  Agent and the  parties  hereto  agree to execute<br \/>\nwhatever  documents are necessary to effect such action under this  Agreement or<br \/>\nany other document executed pursuant to this Agreement;  provided,  however that<br \/>\nin such event all provisions of the Loan  Documents,  shall remain in full force<br \/>\nand effect.  After any retiring  Agent&#8217;s  resignation  hereunder  as Agent,  the<br \/>\nprovisions  of this Article X shall inure to its benefit as to any actions taken<br \/>\nor omitted to be taken by it while it was Agent under this Agreement.<\/p>\n<p>         10.10.  Sharing of Payments,  etc. Each Lender agrees that if it shall,<br \/>\nthrough the  exercise  of a right of banker&#8217;s  lien,  set-off,  counterclaim  or<br \/>\notherwise,  obtain payment with respect to its Obligations  (other than pursuant<br \/>\nto Section 2.14 or Article IV) which results in its receiving  more than its pro<br \/>\nrata share of the  aggregate  payments  with  respect to all of the  Obligations<br \/>\n(other than any payment expressly  provided hereunder to be distributed on other<br \/>\nthan a pro rata basis and payments pursuant to Article IV), then (a) such Lender<br \/>\nshall be deemed to have simultaneously  purchased from the other Lenders a share<br \/>\nin their  Obligations so that the amount of the Obligations  held by each of the<br \/>\nLenders shall be pro rata and (b) such other adjustments shall be made from time<br \/>\nto time as shall be  equitable  to insure that the Lenders  share such  payments<br \/>\nratably;  provided,  however,  that for purposes of this Section  10.10 the term<br \/>\n&#8220;pro  rata&#8221;  shall be  determined  with  respect  to both the  Revolving  Credit<br \/>\nCommitment  and  Line of  Credit  Commitment  of each  Lender  and to the  Total<br \/>\nRevolving  Credit   Commitment  and  Total  Line  of  Credit   Commitment  after<br \/>\nsubtraction  in each case of  amounts,  if any, by which any such Lender has not<br \/>\nfunded its share of the outstanding Loans and Obligations. If all or any portion<br \/>\nof any such  excess  payment  is  thereafter  recovered  from the  Lender  which<br \/>\nreceived  the  same,  the  purchase  provided  in this  Section  10.10  shall be<br \/>\nrescinded  to the  extent  of such  recovery,  without  interest.  The  Borrower<br \/>\nexpressly consents to the foregoing  arrangements and agrees that each Lender so<br \/>\npurchasing a portion of the other Lenders&#8217;  Obligations  may exercise all rights<br \/>\nof payment (including,  without limitation, all rights of set-off, <\/p>\n<p>                                       86<\/p>\n<p>banker&#8217;s lien or counterclaim)  with respect to such portion as fully as if such<br \/>\nLender were the direct holder of such portion.<\/p>\n<p>         10.11.  Fees.  The  Borrower  agrees  to  pay  to the  Agent,  for  its<br \/>\nindividual  account,  in advance a quarterly  Agent&#8217;s fee in such amount as from<br \/>\ntime to time agreed to by the Borrower and Agent in writing.<\/p>\n<p>         10.12.  Independent  Agreements.  The provisions  contained in Sections<br \/>\n10.1 through 10.8 and 10.10 (other than the last  sentence  thereof)  constitute<br \/>\nindependent  obligations  and  agreements  of the Agent and the  Lenders and the<br \/>\nBorrower  shall not be deemed a party thereto nor bound  thereby.  Borrower does<br \/>\nacknowledge  the rights of Lenders and Agent under  Sections  10.9 and 10.11 and<br \/>\nthe last sentence of Section 10.10.<\/p>\n<p>                                       87<\/p>\n<p>                                   ARTICLE XI<\/p>\n<p>                                 Miscellaneous<\/p>\n<p>         11.1. Assignments and Participations. (a) At any time after the Closing<br \/>\nDate each  Lender  may,  with the prior  consent of the Agent and (so long as no<br \/>\nDefault or Event of Default shall have occurred and be continuing) the Borrower,<br \/>\nwhich consents shall not be unreasonably  withheld,  assign to one or more banks<br \/>\nor financial  institutions all or a portion of its rights and obligations  under<br \/>\nthe Loan Documents (including, without limitation, all or a portion of any Notes<br \/>\npayable to its order);  provided,  that (i) each such  assignment  shall be of a<br \/>\nconstant and not a varying  percentage of all of the assigning  Lender&#8217;s  rights<br \/>\nand obligations  under the Revolving Credit Facility,  Letter of Credit Facility<br \/>\nand the Line of Credit Facility, (ii) for each assignment involving the issuance<br \/>\nand transfer of Notes,  the assigning  Lender shall  execute an  Assignment  and<br \/>\nAcceptance and the Borrower hereby agrees to execute  replacement  Notes to give<br \/>\neffect to such assignment,  (iii) the minimum Commitment which shall be assigned<br \/>\nis (x)  $5,000,000,  in the case of an  assignment  by one  existing  Lender  to<br \/>\nanother  existing  Lender,  and  (y)  $10,000,000  in all  other  cases,  and in<br \/>\nmultiples of $1,000,000  in excess  thereof  (together  with which the assigning<br \/>\nLender&#8217;s   applicable  portion  of  Participations  and  the  Letter  of  Credit<br \/>\nCommitment  shall also be  assigned),  (iv) such  assignee  shall have an office<br \/>\nlocated in the United  States,  and (v) no consent of the  Borrower or the Agent<br \/>\nshall be required in connection  with any assignment by a Lender to an affiliate<br \/>\nof such Lender. Upon such execution, delivery, approval and acceptance, from and<br \/>\nafter the effective date specified in each  Assignment and  Acceptance,  (x) the<br \/>\nassignee  thereunder  shall be a party hereto and, to the extent that rights and<br \/>\nobligations  hereunder or under any such Notes have been  assigned or negotiated<br \/>\nto  it  pursuant  to  such  Assignment  and  Acceptance,  have  the  rights  and<br \/>\nobligations  of a  Lender  hereunder  and a  holder  of such  Notes  and (y) the<br \/>\nassignor  thereunder shall, to the extent that rights and obligations  hereunder<br \/>\nor under such Note have been  assigned  or  negotiated  by it  pursuant  to such<br \/>\nAssignment and Acceptance,  relinquish its rights, other than those set forth in<br \/>\nSection 3.2(g), Article IV, Section 11.6 and Section 11.12 of this Agreement and<br \/>\nbe released  from its  obligations  under this  Agreement.  Except as  otherwise<br \/>\nprovided  herein,  any Lender who makes an  assignment  shall pay to the Agent a<br \/>\none-time  administrative  fee of $3,000 which fee shall not be reimbursed by the<br \/>\nBorrower.<\/p>\n<p>         (b) By executing  and  delivering  an Assignment  and  Acceptance,  the<br \/>\nLender assignor thereunder and the assignee thereunder confirm to and agree with<br \/>\neach other and the other  parties  hereto as follows:  (i) the  assignment  made<br \/>\nunder  such  Assignment  and  Acceptance  is  made  under  such  Assignment  and<br \/>\nAcceptance  without recourse to such assignor;  (ii) such assigning Lender makes<br \/>\nno representation or warranty and assumes no responsibility  with respect to (x)<br \/>\nthe statements, warranties or representations made <\/p>\n<p>                                       88<\/p>\n<p>in or in connection  with this Agreement or any other Loan Document or any other<br \/>\ninstrument or document furnished  pursuant hereto, (y) the execution,  legality,<br \/>\nvalidity, enforceability, genuineness, sufficiency or value of this Agreement or<br \/>\nany of the other Loan  Documents or any other  document or instrument  furnished<br \/>\npursuant  hereto,  or  (z)  the  financial  condition  of  the  Borrower  or its<br \/>\nSubsidiaries  or the performance or observance by the Borrower or any Subsidiary<br \/>\nof any of its  obligations  under any Loan  Document or any other  instrument or<br \/>\ndocument  furnished  pursuant hereto;  (iii) such assignee  confirms that it has<br \/>\nreceived  a copy  of this  Agreement,  together  with  copies  of the  financial<br \/>\nstatements  delivered pursuant to Section 6.6(a) or Section 7.1, as the case may<br \/>\nbe, and such other Loan Documents and other  documents and information as it has<br \/>\ndeemed  appropriate  to make its own credit  analysis and decision to enter into<br \/>\nsuch  Assignment  and  Acceptance;  (iv) such assignee will,  independently  and<br \/>\nwithout  reliance upon the Agent,  such assigning Lender or any other Lender and<br \/>\nbased on such  documents and  information  as it shall deem  appropriate  at the<br \/>\ntime,  continue to make its own credit  decisions in taking or not taking action<br \/>\nunder any Loan Document;  (v) such assignee appoints and authorizes the Agent to<br \/>\ntake such  action as Agent on its behalf and to exercise  such powers  under the<br \/>\nLoan  Documents  as are  delegated to the Agent by the terms hereof and thereof,<br \/>\ntogether with such powers as are reasonably  incidental  thereto;  and (vi) such<br \/>\nassignee  agrees that it will perform in accordance  with their terms all of the<br \/>\nobligations  which  by the  terms  of the  Loan  Documents  are  required  to be<br \/>\nperformed by it as a Lender and a holder of such Notes.<\/p>\n<p>         (c) The Agent shall  maintain at its address  referred to herein a copy<br \/>\nof each Assignment and Acceptance delivered to and accepted by it.<\/p>\n<p>         (d) Upon its receipt of an  Assignment  and  Acceptance  executed by an<br \/>\nassigning Lender, the Agent shall give prompt notice thereof to Borrower.<\/p>\n<p>         (e)  Nothing   herein  shall  prohibit  any  Lender  from  pledging  or<br \/>\nassigning, without notice to or consent of the Borrower or the Agent and without<br \/>\nthe payment of the administrative  fee referred to in Section 13.1(a),  any Note<br \/>\nto any Federal Reserve Bank in accordance with applicable law.<\/p>\n<p>         (f) Each Lender may sell  participations  at its expense to one or more<br \/>\nbanks or other  entities  as to all or a portion of its  rights and  obligations<br \/>\nunder this Agreement;  provided,  that (i) such Lender&#8217;s  obligations under this<br \/>\nAgreement  shall  remain  unchanged,   (ii)  such  Lender  shall  remain  solely<br \/>\nresponsible to the other parties hereto for the performance of such obligations,<br \/>\n(iii) such  Lender  shall  remain  the  holder of any Note  issued to it for the<br \/>\npurpose of this Agreement, (iv) such participations shall be in a minimum amount<br \/>\nof  $5,000,000  and, if  greater,  an amount  which is an  integral  multiple of<br \/>\n$1,000,000   and  shall   include  an   allocable   <\/p>\n<p>                                       89<\/p>\n<p>portion of such Lender&#8217;s  Participations,  (v) the  Borrower,  the Agent and the<br \/>\nother  Lenders  shall  continue to deal solely and directly  with such Lender in<br \/>\nconnection with such Lender&#8217;s  rights and  obligations  under this Agreement and<br \/>\nwith regard to any and all payments to be made under this  Agreement;  provided,<br \/>\nthat the  participation  agreement  between a Lender  and its  participants  may<br \/>\nprovide that such Lender will obtain the approval of such  participant  prior to<br \/>\nsuch Lender&#8217;s  agreeing to any amendment or waiver of any provisions of any Loan<br \/>\nDocument which would (A) extend the maturity of any Note or scheduled payment of<br \/>\nany Obligations,  (B) reduce the interest rates, unused fees or letter of credit<br \/>\nfacility fees  hereunder or (C) increase or extend the  termination  date of the<br \/>\nRevolving  Credit  Commitment,  Line of  Credit  Commitment  or Letter of Credit<br \/>\nCommitment of the Lender  granting the  participation,  and (vi) the sale of any<br \/>\nsuch participations which require Borrower to file a registration statement with<br \/>\nthe United States  Securities  and Exchange  Commission or under the  securities<br \/>\nregulations or laws of any state shall not be permitted.<\/p>\n<p>         (g)  The  Borrower  may  not  assign  any  rights,  powers,  duties  or<br \/>\nobligations  under this Agreement or the other Loan Documents  without the prior<br \/>\nwritten consent of all the Lenders.<\/p>\n<p>         11.2.  Notices.  Any notice shall be  conclusively  deemed to have been<br \/>\nreceived by any party hereto and be effective (i) on the day on which  delivered<br \/>\n(including hand delivery by commercial  courier  service) to such party (against<br \/>\nreceipt  therefor),  (ii) on the date of receipt at such address,  telefacsimile<br \/>\nnumber or telex  number as may from time to time be  specified  by such party in<br \/>\nwritten notice to the other parties hereto or otherwise  received),  in the case<br \/>\nof notice by telegram,  telefacsimile or telex,  respectively (where the receipt<br \/>\nof such message is verified by return), or (iii) on the fifth Business Day after<br \/>\nthe day on which mailed, if sent prepaid by certified or registered mail, return<br \/>\nreceipt  requested,  in each case delivered,  transmitted or mailed, as the case<br \/>\nmay be, to the address,  telex number or telefacsimile  number,  as appropriate,<br \/>\nset forth below or such other  address or number as such party shall  specify by<br \/>\nnotice hereunder:<\/p>\n<p>                  (a)      if to the Borrower:<\/p>\n<p>                           Two Perimeter Park South<br \/>\n                           Suite 224W<br \/>\n                           Birmingham, Alabama  35243<br \/>\n                           Attention:  Richard M. Scrushy<\/p>\n<p>                           with a copy to:<\/p>\n<p>                           Chief Financial Officer<br \/>\n                           HEALTHSOUTH  Corporation<br \/>\n                           Two Perimeter Park South<br \/>\n                           Suite 224W<br \/>\n                           Birmingham,  Alabama   35243 <\/p>\n<p>                                       90<\/p>\n<p>                           with a copy to:<\/p>\n<p>                           Treasurer<br \/>\n                           HEALTHSOUTH Corporation<br \/>\n                           Two Perimeter Park South<br \/>\n                           Suite 224W<br \/>\n                           Birmingham, Alabama  35243<\/p>\n<p>                           with a copy to:<\/p>\n<p>                           William W. Horton<br \/>\n                           HEALTHSOUTH Corporation<br \/>\n                           Two Perimeter Park South<br \/>\n                           Birmingham, Alabama  35243<\/p>\n<p>                  (b)      if to the Agent at:<\/p>\n<p>                           One Independence Center<br \/>\n                           15th Floor<br \/>\n                           101 North Tryon Street<br \/>\n                           Charlotte, North Carolina  28255<br \/>\n                           Attention:  Agency Services<\/p>\n<p>                           with a copy to:<\/p>\n<p>                           600 Peachtree Street, N.E.<br \/>\n                           21st Floor<br \/>\n                           Atlanta, Georgia  30308-2213<br \/>\n                           Attention:  Corporate Banking<\/p>\n<p>                  (c)      if to  NationsBank  in its  capacity as issuer of the<br \/>\n                           Letters of Credit:<\/p>\n<p>                           NationsBank, N.A.<br \/>\n                           One Independence Center, 15th Floor<br \/>\n                           101 North Tryon Street<br \/>\n                           Charlotte, North Carolina  28255<br \/>\n                           Attention:  Letter of Credit Department<\/p>\n<p>                  (d)      if to the Lenders:<\/p>\n<p>                           At the  addresses  set forth on the  signature  pages<br \/>\n                           hereof and on the signature  page of each  Assignment<br \/>\n                           and Acceptance.<\/p>\n<p>         11.3.  No Waiver.  No  failure  or delay on the part of the Agent,  any<br \/>\nLender  or the  Borrower  in the  exercise  of any  right,  power  or  privilege<br \/>\nhereunder  shall  operate as a waiver of any such right,  power or privilege nor<br \/>\nshall any such failure or delay preclude any other or further exercise  thereof.<br \/>\nThe rights and remedies  herein provided are cumulative and not exclusive of any<br \/>\nrights or remedies provided by law.<\/p>\n<p>                                       91<\/p>\n<p>         11.4.  Setoff. The Borrower agrees that the Agent and each Lender shall<br \/>\nhave a lien for all the Obligations of the Borrower upon all deposits or deposit<br \/>\naccounts,  of any kind,  or any  interest in any  deposits  or deposit  accounts<br \/>\nthereof,  now or hereafter  pledged,  mortgaged,  transferred or assigned to the<br \/>\nAgent or such Lender or otherwise in the  possession  or control of the Agent or<br \/>\nsuch  Lender  (other  than for  safekeeping)  for any purpose for the account or<br \/>\nbenefit of the Borrower and including  any balance of any deposit  account or of<br \/>\nany credit of the Borrower  with the Agent or such Lender,  whether now existing<br \/>\nor hereafter  established,  hereby  authorizing the Agent and each Lender at any<br \/>\ntime or times from and after the  occurrence of a Default or an Event of Default<br \/>\nwith or without  prior notice to set off against and apply such  balances or any<br \/>\npart thereof to such of the Obligations of the Borrower to the Lenders then past<br \/>\ndue and in such amounts as they may elect,  and whether or not the collateral or<br \/>\nthe responsibility of other Persons  primarily,  secondarily or otherwise liable<br \/>\nmay be deemed adequate. For the purposes of this paragraph,  all remittances and<br \/>\nproperty  shall be deemed to be in the possession of the Agent or such Lender as<br \/>\nsoon as the  same may be put in  transit  to it by mail or  carrier  or by other<br \/>\nbailee.<\/p>\n<p>         11.5.  Survival.   All  covenants,   agreements,   representations  and<br \/>\nwarranties  made herein shall survive the making by the Lenders of the Loans and<br \/>\nthe  issuance of the  Letters of Credit and the  execution  and  delivery to the<br \/>\nLenders of this  Agreement  and the Notes and shall  continue  in full force and<br \/>\neffect so long as any of  Obligations  remain  outstanding or any Lender has any<br \/>\ncommitment hereunder or the Borrower has continuing obligations hereunder unless<br \/>\notherwise provided herein.  Whenever in this Agreement any of the parties hereto<br \/>\nis referred to, such  reference  shall be deemed to include the  successors  and<br \/>\npermitted assigns of such party and all covenants,  provisions and agreements by<br \/>\nor on behalf of the Borrower  which are  contained in the Loan  Documents  shall<br \/>\ninure to the benefit of the successors  and permitted  assigns of the Lenders or<br \/>\nany of them.<\/p>\n<p>         11.6.  Expenses.  The Borrower agrees (a) to pay or reimburse the Agent<br \/>\nfor all its reasonable and customary  out-of-pocket  costs and expenses incurred<br \/>\nin  connection  with the  preparation,  negotiation  and  execution  of, and any<br \/>\namendment,  supplement or  modification  to, this  Agreement or any of the other<br \/>\nLoan Documents, and the consummation of the transactions contemplated hereby and<br \/>\nthereby,  including,  without limitation,  the reasonable and customary fees and<br \/>\ndisbursements  of counsel to the Agent,  (b) to pay or reimburse  the Agent and,<br \/>\nafter an Event of  Default,  each  Lender  for all  their  reasonable  costs and<br \/>\nexpenses  incurred in connection  with the  enforcement or  preservation  of any<br \/>\nrights under this Agreement,  including without limitation,  the reasonable fees<br \/>\nand disbursements of their counsel,  (c) to pay, indemnify and hold harmless the<br \/>\nAgent and each Lender from any and all recording and filing fees and any and all<br \/>\nliabilities with respect to, or resulting from any failure of Borrower to pay or<br \/>\ndelay of Borrower <\/p>\n<p>                                       92<\/p>\n<p>in paying,  documentary,  stamp, excise, withholding and other similar taxes, if<br \/>\nany,  which may be payable or determined  to be payable in  connection  with the<br \/>\nexecution  and delivery of, or  consummation  of any  amendment,  supplement  or<br \/>\nmodification  of,  or any  waiver  or  consent  under  or in  respect  of,  this<br \/>\nAgreement, and (d) from and after the occurrence of any Event of Default to pay,<br \/>\nand indemnify and hold harmless the Agent and each Lender from and against,  any<br \/>\nand all other liabilities,  obligations,  losses, damages,  penalties,  actions,<br \/>\njudgments,  suits,  costs,  expenses  or  disbursements  of any  kind or  nature<br \/>\nwhatsoever with respect to the execution, delivery, enforcement, performance and<br \/>\nadministration  of this Agreement or in any respect relating to the transactions<br \/>\ncontemplated  hereby  or  thereby,   (all  the  foregoing,   collectively,   the<br \/>\n&#8220;indemnified  liabilities&#8221;);  provided, however, that the Borrower shall have no<br \/>\nobligation  hereunder with respect to indemnified  liabilities  arising from (i)<br \/>\nthe willful misconduct or negligence of the party seeking indemnification,  (ii)<br \/>\nlegal  proceedings  commenced  against  the Agent or any Lender by any  security<br \/>\nholder or creditor  thereof  arising out of and based upon rights  afforded  any<br \/>\nsuch security holder or creditor solely in its capacity as such, (iii) any taxes<br \/>\nimposed upon the Agent or any Lender other than the documentary,  stamp, excise,<br \/>\nwithholding and similar taxes described in clause (c) above or any tax resulting<br \/>\nfrom any change  described in Section 4.1, which tax would be payable to Lenders<br \/>\nby Borrower pursuant to Article IV, (iv) taxes imposed as a result of a transfer<br \/>\nor  assignment  of any Note,  participation  or  assignment  of a portion of its<br \/>\nrights, (v) any taxes imposed upon any transferee of any Note, or (vi) by reason<br \/>\nof the  failure of the Agent or any Lender to perform  its or their  obligations<br \/>\nunder this  Agreement.  The  agreements  in this  subsection  shall  survive the<br \/>\nFacility Termination Date.<\/p>\n<p>         11.7. Amendments. No amendment, modification or waiver of any provision<br \/>\nof this  Agreement  or any of the other  Loan  Documents  and no  consent by the<br \/>\nLenders to any  departure  therefrom by the Borrower  shall be effective  unless<br \/>\nsuch  amendment,  modification  or waiver  shall be in writing and signed by the<br \/>\nAgent and the Borrower, but only upon having received the written consent of the<br \/>\nRequired  Lenders,  and the same shall then be effective only for the period and<br \/>\non the conditions and for the specific  instances and purposes specified in such<br \/>\nwriting; provided, however, that no such amendment, modification or waiver<\/p>\n<p>                  (i) which changes,  extends or waives any provision of Section<br \/>\n         2.7,  Section  2.11,  Section  3.3(a),  Section  5.1(a),  Section 7.11,<br \/>\n         Section 10.10, Section 11.1(g), this Section 11.7 or Section 11.15, the<br \/>\n         amount of or the due date of any scheduled installment or other payment<br \/>\n         of or the rate of interest or other amounts  payable on or with respect<br \/>\n         to any  Obligation,  which changes the definition of Required  Lenders,<br \/>\n         which  increases  or  extends  the  Commitment  of any  Lender or which<br \/>\n         increases or extends the Revolving  Credit  Termination Date (including<br \/>\n         any  extension  of the  expiry  date of a Letter<\/p>\n<p>                                       93<\/p>\n<p>         of Credit beyond the Revolving Credit  Termination  Date) or the Stated<br \/>\n         Termination  Date or which  waives any  condition  to the making of any<br \/>\n         Loan or the issuance of any Letter of Credit shall be effective  unless<br \/>\n         in writing and signed by each of the Lenders;  provided,  however,  the<br \/>\n         Required  Lenders  may in their sole  discretion  waive any  Default or<br \/>\n         Event of Default  (other than any Event of Default under Section 9.1(a)<br \/>\n         as to which only the Lender  which is the payee of a Note may waive the<br \/>\n         failure to make a payment of principal or interest due on such Note and<br \/>\n         Section  9.1(f)  as to which  all  Lenders  must  waive  such  Event of<br \/>\n         Default);<\/p>\n<p>             (ii)  which   affects  the  rights,   privileges,   immunities   or<br \/>\n         indemnities  of the Agent,  shall be  effective  unless in writing  and<br \/>\n         signed by the Agent.<\/p>\n<p>Notwithstanding  any provision of the other Loan  Documents to the contrary,  as<br \/>\nbetween the Agent and the  Lenders,  execution  by the Agent shall not be deemed<br \/>\nconclusive  evidence  that the Agent has  obtained  the  written  consent of the<br \/>\nRequired  Lenders;  however,  the  Borrower  shall  be  entitled  to rely on the<br \/>\nsignature  of the Agent as evidence  of  consent.  No notice to or demand on the<br \/>\nBorrower in any case shall  entitle the Borrower to any other or further  notice<br \/>\nor demand in similar or other  circumstances,  except as  provided  by law or as<br \/>\notherwise  expressly provided herein. No delay or omission on any Lender&#8217;s,  the<br \/>\nAgent&#8217;s or the Borrower&#8217;s  part in exercising any right,  remedy or option shall<br \/>\noperate  as a waiver  of such or any  other  right,  remedy  or option or of any<br \/>\nDefault or Event of Default.<\/p>\n<p>         11.8.  Counterparts.  This  Agreement  may be executed in any number of<br \/>\ncounterparts,  each of which when so executed and  delivered  shall be deemed an<br \/>\noriginal,  and it shall not be necessary  in making  proof of this  Agreement to<br \/>\nproduce or account for more than one such fully-executed counterpart.<\/p>\n<p>         11.9. Waivers by Borrower.  In any litigation in any court with respect<br \/>\nto, in connection with, or arising out of this Agreement,  the Loans, any of the<br \/>\nNotes, any of the other Loan Documents,  the  Obligations,  or any instrument or<br \/>\ndocument  delivered  pursuant to this  Agreement,  or the validity,  protection,<br \/>\ninterpretation, collection or enforcement thereof, or any other claim or dispute<br \/>\nhowsoever  arising  between  the  Borrower  and the  Lenders or the  Agent,  the<br \/>\nBorrower and each Lender and the Agent hereby waive, to the extent  permitted by<br \/>\nlaw, trial by jury in connection with any such litigation.<\/p>\n<p>         The Borrower,  the Agent and the Lenders believe that, inasmuch as this<br \/>\nAgreement and the  transactions  contemplated  hereby have been entered into and<br \/>\nconsummated  outside  the  State  of  Alabama,   such  transactions   constitute<br \/>\ntransactions  in interstate  commerce,  so that neither the Agent nor any of the<br \/>\nLenders is required, solely by entering into this Agreement and consummating the<\/p>\n<p>                                       94<\/p>\n<p>transactions  contemplated  hereby,  to  qualify  to do  business  as a  foreign<br \/>\ncorporation within the State of Alabama. Notwithstanding the foregoing, however,<br \/>\nthe Borrower hereby  irrevocably waives all rights that it may have to raise, in<br \/>\nany action  brought by any of the  Lenders or the Agent to enforce the rights of<br \/>\nthe Lenders and the Agent hereunder or under any of the other Loan Documents, or<br \/>\nthe  obligations of the Borrower  hereunder or thereunder,  any defense which is<br \/>\nbased  upon the  failure  of any of the  Lenders  or the Agent to  qualify to do<br \/>\nbusiness as a foreign  corporation in the State of Alabama,  including,  but not<br \/>\nlimited to, any defenses based upon ss. 232 of the Alabama Constitution of 1901,<br \/>\nss.  10-2B-15.01  of the Code of  Alabama  (1975) or ss.  40-14-4 of the Code of<br \/>\nAlabama (1975), or any successor provision to any thereof.  The foregoing waiver<br \/>\nis made knowingly and voluntarily and is a material inducement for the Agent and<br \/>\nthe Lenders to enter into the transactions contemplated by this Agreement or any<br \/>\nof the other Loan Documents.<\/p>\n<p>         11.10. Termination.  The termination of this Agreement shall not affect<br \/>\nany rights of the  Borrower,  the Lenders or the Agent or any  obligation of the<br \/>\nBorrower,  the Lenders or the Agent, arising prior to the effective date of such<br \/>\ntermination,  and the  provisions  hereof shall  continue to be fully  operative<br \/>\nuntil all  transactions  entered into or rights created or obligations  incurred<br \/>\nprior to such  termination  have been fully disposed of, concluded or liquidated<br \/>\nand the  Obligations  arising  prior  to or after  such  termination  have  been<br \/>\nirrevocably paid in full. The rights granted to the Agent for the benefit of the<br \/>\nLenders  hereunder  and under the other Loan  Documents  shall  continue in full<br \/>\nforce and effect,  notwithstanding the termination of this Agreement,  until all<br \/>\nof the Obligations  have been paid in full after the  termination  hereof or the<br \/>\nBorrower  has  furnished  the  Lenders  and the  Agent  with an  indemnification<br \/>\nsatisfactory   to  the  Agent  and  each  Lender  with  respect   thereto.   All<br \/>\nrepresentations,  warranties, covenants, waivers and agreements contained herein<br \/>\nshall survive termination hereof until payment in full of the Obligations unless<br \/>\notherwise provided herein.  Notwithstanding  the foregoing,  if after receipt of<br \/>\nany payment of all or any part of the Obligations,  any Lender is for any reason<br \/>\ncompelled  to  surrender  such  payment to any Person  because  such  payment is<br \/>\ndetermined  to be void or  voidable as a  preference,  impermissible  setoff,  a<br \/>\ndiversion of trust funds or for any other reason,  this Agreement shall continue<br \/>\nin full force and the Borrower shall be liable to, and shall  indemnify and hold<br \/>\nsuch Lender  harmless  for,  the amount of such payment  surrendered  until such<br \/>\nLender shall have been finally and  irrevocably  paid in full. The provisions of<br \/>\nthe  foregoing  sentence  shall  be and  remain  effective  notwithstanding  any<br \/>\ncontrary  action which may have been taken by the Lenders in reliance  upon such<br \/>\npayment, and any such contrary action so taken shall be without prejudice to the<br \/>\nLenders&#8217;  rights  under  this  Agreement  and  shall  be  deemed  to  have  been<br \/>\nconditioned upon such payment having become final and irrevocable.<\/p>\n<p>                                       95<\/p>\n<p>         11.11.   Governing  Law.  All  documents   executed   pursuant  to  the<br \/>\ntransactions contemplated herein, including,  without limitation, this Agreement<br \/>\nand each of the other Loan Documents shall be deemed to be contracts made under,<br \/>\nand for all purposes  shall be construed in accordance  with,  the internal laws<br \/>\nand judicial  decisions  of the State of North  Carolina.  The  Borrower  hereby<br \/>\nsubmits to the  jurisdiction  and venue of the state and federal courts of North<br \/>\nCarolina for the purposes of resolving  disputes hereunder or arising out of the<br \/>\ntransaction contemplated hereby or for the purposes of collection.<\/p>\n<p>         11.12. Indemnification.  In consideration of the execution and delivery<br \/>\nof this  Agreement  by the  Agent  and  each  Lender  and the  extension  of the<br \/>\nCommitments,  and  so  long  as the  Agent  and  Lenders  have  fulfilled  their<br \/>\nobligations  hereunder,  the Borrower hereby  indemnifies,  exonerates and holds<br \/>\nfree and  harmless  the  Agent  and  each  Lender  and each of their  respective<br \/>\nofficers,  directors,  employees,  affiliates  and  agents  (collectively,   the<br \/>\n&#8220;Indemnified  Parties&#8221;) from and against any and all actions,  causes of action,<br \/>\nclaims, suits, losses, costs,  liabilities and damages, and expenses incurred in<br \/>\nconnection  therewith  (irrespective of whether any such Indemnified  Party is a<br \/>\nparty to the action for which  indemnification  hereunder is sought),  including<br \/>\nreasonable  attorneys&#8217; fees and  disbursements  (collectively,  the &#8220;Indemnified<br \/>\nLiabilities&#8221;),  incurred by the  Indemnified  Parties or any of them as a result<br \/>\nof, or arising out of, or relating to, any of the following:<\/p>\n<p>                  (a) any transaction  financed or to be financed in whole or in<br \/>\n         part,  directly  or  indirectly,  with  the  proceeds  of any  Loan  or<br \/>\n         supported by any Letter of Credit;<\/p>\n<p>                  (b) the entering into and  performance  of this  Agreement and<br \/>\n         any other Loan Document by any of the Indemnified Parties;<\/p>\n<p>                  (c)  provided  Lenders  have  no  ownership  interest  in real<br \/>\n         property of  Borrower,  any  investigation,  litigation  or  proceeding<br \/>\n         related to any environmental cleanup, audit, compliance or other matter<br \/>\n         relating to the  protection  of the  environment  or the release by the<br \/>\n         Borrower or any of its  Subsidiaries or Controlled  Partnerships of any<br \/>\n         hazardous waste material; or<\/p>\n<p>                  (d)  provided  Lenders  have  no  ownership  interest  in real<br \/>\n         property of Borrower, the presence on or under, or the escape, seepage,<br \/>\n         leakage, spillage,  discharge,  emission,  discharging or releases from<br \/>\n         any real property  owned or operated by the Borrower or any  Subsidiary<br \/>\n         or Controlled  Partnership of any hazardous  waste material  (including<br \/>\n         any losses,  liabilities,  damages, injuries, costs, expenses or claims<br \/>\n         asserted  or  arising  under any  environmental  laws),  regardless  of<br \/>\n         whether  caused by, or within the  control  of,  the  Borrower  or such<br \/>\n         Subsidiary or Controlled Partnerships,<\/p>\n<p>                                       96<\/p>\n<p>         except for any such Indemnified  Liabilities arising for the account of<br \/>\n         a particular  Indemnified  Party by reason of the relevant  Indemnified<br \/>\n         Party&#8217;s negligence or willful misconduct, and if and to the extent that<br \/>\n         the foregoing  undertaking  may be  unenforceable  for any reason,  the<br \/>\n         Borrower hereby agrees to make the maximum  contribution to the payment<br \/>\n         and  satisfaction  of  each of the  Indemnified  Liabilities  which  is<br \/>\n         permissible  under applicable law. The agreements in this Section 11.12<br \/>\n         shall survive the Facility Termination Date.<\/p>\n<p>         11.13.  Agreement  Controls.  In the event  that any term of any of the<br \/>\nLoan  Documents  other  than  this  Agreement  conflicts  with  any term of this<br \/>\nAgreement, the terms and provisions of this Agreement shall control.<\/p>\n<p>         11.14.  Integration.  This  Agreement  and  the  other  Loan  Documents<br \/>\nrepresent  the final  agreement  between the  parties as to the  subject  matter<br \/>\nhereof  or  thereof  and  may  not  be   contradicted   by  evidence  of  prior,<br \/>\ncontemporaneous, or subsequent oral agreements of the parties. There are no oral<br \/>\nagreements between the parties.<\/p>\n<p>         11.15. Successors and Assigns. This Agreement shall be binding upon and<br \/>\nshall inure to the benefit of the parties hereto and their respective successors<br \/>\nand assigns; provided, however, that the Borrower may not assign or transfer its<br \/>\nrights or obligations  hereunder  without the prior written consent of the Agent<br \/>\nand all Lenders. The Agent and the Lenders may assign or transfer their interest<br \/>\nhereunder but only as provided herein.<\/p>\n<p>         11.16.  Severability.  If any provision of this  Agreement or the other<br \/>\nLoan Documents shall be determined to be illegal or invalid as to one or more of<br \/>\nthe parties  hereto,  then such provision shall remain in effect with respect to<br \/>\nall parties,  if any, as to whom such provision is neither  illegal nor invalid,<br \/>\nand in any event all other provisions  hereof shall remain effective and binding<br \/>\non the parties hereto.<\/p>\n<p>         11.17.  Usury  Savings  Clause.  Notwithstanding  any  other  provision<br \/>\nherein,  the aggregate  interest rate charged under any of the Notes,  including<br \/>\nall  charges or fees in  connection  therewith  deemed in the nature of interest<br \/>\nunder North Carolina law, shall not exceed the Highest Lawful Rate (as such term<br \/>\nis defined  below).  If the rate of interest  (determined  without regard to the<br \/>\npreceding  sentence) under this Agreement at any time exceeds the Highest Lawful<br \/>\nRate (as defined  below),  the  outstanding  amount of the Loans made  hereunder<br \/>\nshall  bear  interest  at the  Highest  Lawful  Rate  until the total  amount of<br \/>\ninterest due hereunder  equals the amount of interest  which would have been due<br \/>\nhereunder if the stated rates of interest set forth in this Agreement had at all<br \/>\ntimes been in effect.  In addition,  if when the Loans made hereunder are repaid<br \/>\nin full the total  interest  due  hereunder  (taking  into  account the increase<br \/>\nprovided for above) is less than the total  amount of interest  which would have<br \/>\nbeen due  hereunder if the stated rates of<\/p>\n<p>                                       97<\/p>\n<p>interest set forth in this  Agreement  had at all times been in effect,  then to<br \/>\nthe extent permitted by law, the Borrower shall pay to the Agent an amount equal<br \/>\nto the  difference  between  the amount of the  interest  paid and the amount of<br \/>\ninterest  which would have been paid if the Highest Lawful Rate had at all times<br \/>\nbeen in  effect.  Notwithstanding  the  foregoing,  it is the  intention  of the<br \/>\nLenders and the  Borrower  to conform  strictly  to any  applicable  usury laws.<br \/>\nAccordingly, if any Lender contracts for, charges, or receives any consideration<br \/>\nwhich  constitutes  interest in excess of the Highest Lawful Rate, then any such<br \/>\nexcess shall be canceled  automatically  and, if previously  paid, shall at such<br \/>\nLender&#8217;s option be applied to the outstanding amount of the Loans made hereunder<br \/>\nor be refunded to the  Borrower.  As used in this  paragraph,  the term &#8220;Highest<br \/>\nLawful Rate&#8221; means, as to any Lender,  the maximum lawful interest rate, if any,<br \/>\nthat at any  time  or from  time to time  may be  contracted  for,  charged,  or<br \/>\nreceived under the laws  applicable to such Lender which are presently in effect<br \/>\nor, to the extent allowed by law, under such applicable laws which may hereafter<br \/>\nbe in effect and which allow a higher  maximum  nonusurious  interest  rate than<br \/>\napplicable laws now allow.<\/p>\n<p>                                       98<\/p>\n<p>         IN WITNESS  WHEREOF,  the parties hereto have caused this instrument to<br \/>\nbe made,  executed and delivered by their duly authorized officers as of the day<br \/>\nand year first above written.<\/p>\n<p>                                               HEALTHSOUTH CORPORATION<br \/>\nWITNESS:<\/p>\n<p>\/s\/ WILLIAM W. HORTON<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;                  By:  \/s\/ MICHAEL D. MARTIN<br \/>\n\/s\/ TERRY L. SCAGGS                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;                  Name:  Michael D. Martin<br \/>\n                                               Title: Senior Vice President and<br \/>\n                                                      Treasurer<\/p>\n<p>                                       99<\/p>\n<p>                                               NATIONSBANK N.A.,<br \/>\n                                               as Agent for the Lenders<\/p>\n<p>                                               By:    \/s\/ DOUGLAS E. COLTHARP<br \/>\n                                                 &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                               Name:  Douglas E. Coltharp<br \/>\n                                               Title: Senior Vice President<\/p>\n<p>COMMITMENT:                                    NATIONSBANK, N.A.<br \/>\n$70,000,000<\/p>\n<p>                                               By:    \/s\/ DOUGLAS E. COLTHARP<br \/>\n                                               Name:  Douglas E. Coltharp<br \/>\n                                               Title: Senior Vice President<\/p>\n<p>                                               Lending Office:<br \/>\n                                                 100 South Tryon Street<br \/>\n                                                 Charlotte, North Carolina 28255<\/p>\n<p>                                               Wire Transfer Instructions:<br \/>\n                                                 NationsBank, N.A.<br \/>\n                                                 Charlotte, North Carolina<br \/>\n                                                 ABA #053000196<br \/>\n                                                 Reference: HEALTHSOUTH<br \/>\n                                                      Corporation<br \/>\n                                                 Attention: Agency Services<\/p>\n<p>                                      100<\/p>\n<p>COMMITMENT:                                 THE BANK OF NOVA SCOTIA<br \/>\n$55,000,000<\/p>\n<p>                                               By:    \/s\/ DANA MALONEY<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Name: Dana Maloney<br \/>\n                                               Title: Relationship Manager<\/p>\n<p>                                               Lending Office:<br \/>\n                                                 600 Peachtree Street, N.E.<br \/>\n                                                 Suite 2700<br \/>\n                                                 Atlanta, Georgia 30308<\/p>\n<p>                                               Wire Transfer Instructions:<br \/>\n                                                 The Bank of Nova Scotia<br \/>\n                                                 New York Agency, for further<br \/>\n                                                   credit to BNS-Atlanta Agency<br \/>\n                                                 New York, New York<br \/>\n                                                 ABA #026002532<br \/>\n                                                 Account #0606634<br \/>\n                                                 Attention: Houston-Atlanta Team<br \/>\n                                                 Reference: HEALTHSOUTH<\/p>\n<p>                                      101<\/p>\n<p>COMMITMENT:                                 FIRST UNION NATIONAL BANK OF<br \/>\n$55,000,000                                 NORTH CAROLINA<\/p>\n<p>                                            By:    \/s\/ JOSEPH H. TOWELL<br \/>\n                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Joseph H. Towell<br \/>\n                                            Title: Senior Vice President<\/p>\n<p>                                              Lending Office:<br \/>\n                                               One First Union Plaza<br \/>\n                                               Charlotte, North Carolina 28288<\/p>\n<p>                                               Wire Transfer Instructions:<br \/>\n                                               First Union National Bank of<br \/>\n                                               North Carolina<br \/>\n                                               Charlotte, North Carolina<br \/>\n                                               ABA #053000219<br \/>\n                                               Account #465906 0001802<br \/>\n                                               Reference: HEALTHSOUTH<br \/>\n                                               Attention: Sue Patterson<\/p>\n<p>                                      102<\/p>\n<p>COMMITMENT:                                 TORONTO DOMINION (TEXAS), INC.<br \/>\n$55,000,000<\/p>\n<p>                                                   By:    \/s\/ LISA ALLISON<br \/>\n                                                      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                                   Name: Lisa Allison<br \/>\n                                                   Title: Vice President<\/p>\n<p>                                                     Lending Office:<br \/>\n                                                     909 Fannin Street, 17th<br \/>\n                                                     Floor<br \/>\n                                                     Houston, Texas 77010<\/p>\n<p>                                                     Wire Transfer Instructions:<br \/>\n                                                     The Toronto Dominion Bank<br \/>\n                                                     ABA #0260003243<br \/>\n                                                     Favor: TD Houston<br \/>\n                                                     Account #2159251<br \/>\n                                                     Reference: HEALTHSOUTH<br \/>\n                                                     Attention: Lisa Allison<\/p>\n<p>                                      103<\/p>\n<p>COMMITMENT:                                 WACHOVIA BANK OF GEORGIA, N.A.<br \/>\n$55,000,000<\/p>\n<p>                                                     By:    \/s\/ LEIF MURPHY<br \/>\n                                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     Name: Leif Murphy<br \/>\n                                                     Title: Banking Officer<\/p>\n<p>                                                     Lending Office:<br \/>\n                                                     191 Peachtree Street, N.E.<br \/>\n                                                     Atlanta, Georgia 30303<\/p>\n<p>                                                     Wire Transfer Instructions:<br \/>\n                                                     Wachovia Bank of Georgia<br \/>\n                                                     Atlanta, Georgia<br \/>\n                                                     ABA #061000010<br \/>\n                                                     Account #18-800-621<br \/>\n                                                     Attention: Becky Creel<\/p>\n<p>                                      104<\/p>\n<p>COMMITMENT:                                 AMSOUTH BANK OF ALABAMA<br \/>\n$55,000,000<\/p>\n<p>                                                  By:    \/s\/ WILLIAM P. BARNES<br \/>\n                                                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                                  Name:  William P. Barnes<br \/>\n                                                  Title: Vice President<\/p>\n<p>                                                     Lending Office:<br \/>\n                                                     1900 5th Avenue North<br \/>\n                                                     Birmingham, Alabama 35203<\/p>\n<p>                                                     Wire Transfer Instructions:<br \/>\n                                                     AmSouth Bank of Alabama<br \/>\n                                                     Birmingham, Alabama<br \/>\n                                                     ABA #062000019<br \/>\n                                                     Reference:Account #50214357<br \/>\n                                                     HEALTHSOUTH<br \/>\n                                                     Attention: Jane Dainas<\/p>\n<p>                                      105<\/p>\n<p>COMMITMENT:                                 BANK OF TOKYO-MITSUBISHI LTD.,<br \/>\n$55,000,000                                 ATLANTA AGENCY<\/p>\n<p>                                            By:    \/s\/ NATHANIEL W. LEA<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Nathaniel W. Lea<br \/>\n                                            Title: Banking Officer<\/p>\n<p>                                             Lending Office:<br \/>\n                                              Atlanta Agency<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>                                             Wire Transfer Instructions:<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                               ABA #<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Reference:<br \/>\n                                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                               Attention:<br \/>\n                                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                      106<\/p>\n<p>COMMITMENT:                                 DEUTSCHE BANK AG, NEW YORK AND\/OR<br \/>\n$55,000,000                                 CAYMAN ISLANDS BRANCHES<\/p>\n<p>                                            By:    \/s\/ STEPHEN A. WIEDEMANN<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Stephen A. Weidemann<br \/>\n                                            Title: Vice President<\/p>\n<p>                                            By:    \/s\/ DAPHNE K. LEE<br \/>\n                                                   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                            Name: Daphne K. Lee<br \/>\n                                            Title: Assistant Vice President<\/p>\n<p>                                                 Lending Office:<br \/>\n                                                    31 W. 52nd Street<br \/>\n                                                    New York, New York  10019<\/p>\n<p>                                                  Wire Transfer Instructions:<br \/>\n                                                    Deutsche Bank AG<br \/>\n                                                    New York, New York  10019<br \/>\n                                                    ABA #026003780<br \/>\n                                                    Reference: HEALTHSOUTH<br \/>\n                                                    Account #0479733<\/p>\n<p>                                      107<\/p>\n<p>COMMITMENT:                                 THE INDUSTRIAL BANK OF JAPAN,<br \/>\n$55,000,000                                 LIMITED<\/p>\n<p>                                            By:    \/s\/ JUNRI ODA<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                            Name: Junri Oda<br \/>\n                                            Title: Senior Vice President<br \/>\n                                                   and Senior Manager<\/p>\n<p>                                            Lending Office:<br \/>\n                                              New York Branch<br \/>\n                                              245 Park Avenue<br \/>\n                                              New York, New York 10167<\/p>\n<p>                                            Wire Transfer Instructions:<br \/>\n                                              Industrial Bank of Japan, Limited,<br \/>\n                                              New York Branch<br \/>\n                                              ABA #026008345<br \/>\n                                              Reference: HEALTHSOUTH Corporation<br \/>\n                                              Attention: Credit Administration<\/p>\n<p>                                      108<\/p>\n<p>COMMITMENT:                                 PNC BANK, KENTUCKY, INC.<br \/>\n$55,000,000<\/p>\n<p>                                            By:    \/s\/ TODD D. MUNSON<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name: Todd D. Munson<br \/>\n                                            Title: Vice President<\/p>\n<p>                                               Lending Office:<br \/>\n                                                 500 West Jefferson Street<br \/>\n                                                 Louisville, Kentucky 40202<\/p>\n<p>                                               Wire Transfer Instructions:<br \/>\n                                                 PNC Bank, Kentucky, Inc.<br \/>\n                                                 Louisville, Kentucky<br \/>\n                                                 ABA #083-000-108<br \/>\n                                                 Account #3000990597<br \/>\n                                                 Reference: HEALTHSOUTH<br \/>\n                                                 Attention: Margie Pate<\/p>\n<p>                                      109<\/p>\n<p>COMMITMENT:                                COOPERATIEVE CENTRALE RAIFFEISEN-<br \/>\n$55,000,000                                BOERENLEENBANK B.A.,<br \/>\n                                           &#8220;RABOBANK NEDERLAND&#8221;, NEW YORK BRANCH<\/p>\n<p>                                           By:    \/s\/ TERRELL BOYLE<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                           Name: Terrell Boyle<br \/>\n                                           Title: Vice President<\/p>\n<p>                                           By:    \/s\/ W. JEFFREY VOLLACK<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                           Name:  W. Jeffrey Vollack<br \/>\n                                           Title: Vice President, Manager<\/p>\n<p>                                                 Lending Office:<br \/>\n                                                   245 Park Avenue<br \/>\n                                                   New York, New York 10167<br \/>\n                                                   Attention: Corporate Services<br \/>\n                                                              Dept.<br \/>\n                                                   Telephone: 212-917-7800<br \/>\n                                                   Fax: 212-818-0233<\/p>\n<p>                                                 Wire Transfer Instructions:<br \/>\n                                                   Bank of New York<br \/>\n                                                   New York, New York<br \/>\n                                                   ABA #021000018<br \/>\n                                                   For the account of RaboBank<br \/>\n                                                   Account #8026002533<br \/>\n                                                   Reference: HEALTHSOUTH<\/p>\n<p>                                      110<\/p>\n<p>COMMITMENT:                                 CREDIT LYONNAIS, NEW YORK BRANCH<br \/>\n$55,000,000<\/p>\n<p>                                            By:    \/s\/ FARBOUD TAVANGER<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Farboud Tavanger<br \/>\n                                            Title: Vice President<\/p>\n<p>                                              Lending Office:<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                              Wire Transfer Instructions:<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                               ABA #<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                               Reference:<br \/>\n                                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                               Attention:<br \/>\n                                                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                      111<\/p>\n<p>COMMITMENT:                                 MELLON BANK, N.A.<br \/>\n$55,000,000<\/p>\n<p>                                            By:    \/s\/ MICHAEL R. ZAKSHESKE<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Michael R. Zaksheske<br \/>\n                                            Title: Vice President<\/p>\n<p>                                               Lending Office:<br \/>\n                                                 2 Mellon Bank Center<br \/>\n                                                 Room 152-0270<br \/>\n                                                 Pittsburgh, Pennsylvania 15259<\/p>\n<p>                                               Wire Transfer Instructions:<br \/>\n                                                 Mellon Bank, N.A.<br \/>\n                                                 Pittsburgh, Pennsylvania 15259<br \/>\n                                                 ABA #0430-0026-1<br \/>\n                                                 Account #990873800<br \/>\n                                                 Attention: Christine Bissell<br \/>\n                                                 Reference: HEALTHSOUTH Corp.<\/p>\n<p>                                      112<\/p>\n<p>COMMITMENT:                                 BANKERS TRUST COMPANY<br \/>\n$55,000,000<\/p>\n<p>                                            By:    \/s\/ ROBERT R. TELESCA<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Robert P. Telesca<br \/>\n                                            Title: Assistant Vice President<\/p>\n<p>                                           Lending Office:<br \/>\n                                             1 Bankers Trust Plaza<br \/>\n                                             130 Liberty Street<br \/>\n                                             New York, New York  10006<\/p>\n<p>                                           Wire Transfer Instructions:<br \/>\n                                             Bankers Trust Company<br \/>\n                                             New York, New York  10006<br \/>\n                                             ABA #021-001-033<br \/>\n                                             Reference: HEALTHSOUTH<br \/>\n                                             Attention: Commercial Loan<br \/>\n                                                        Division<\/p>\n<p>                                      113<\/p>\n<p>COMMITMENT:                                 LTCB TRUST COMPANY<br \/>\n$37,500,000<\/p>\n<p>                                            By:    \/s\/ SATORU OTSUBO<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name: Satoru Otsubo<br \/>\n                                            Title: Executive Vice President<\/p>\n<p>                                                Lending Office:<br \/>\n                                                  165 Broadway<br \/>\n                                                  New York, New York 10006<\/p>\n<p>                                                 Wire Transfer Instructions:<br \/>\n                                                   Bankers Trust Company<br \/>\n                                                   ABA #021001033<br \/>\n                                                   Name of Account: LTCB Trust<br \/>\n                                                       Company<br \/>\n                                                   Account #04-203-606<\/p>\n<p>                                      114<\/p>\n<p>COMMITMENT:                                 NATIONAL CITY BANK, KENTUCKY<br \/>\n$37,500,000<\/p>\n<p>                                            By:    \/s\/ RODERIC M. BROWN<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Roderic M. Brown<br \/>\n                                            Title: Vice President<\/p>\n<p>                                               Lending Office:<br \/>\n                                                  101 S. Fifth Street<br \/>\n                                                  Louisville, Kentucky 40202<\/p>\n<p>                                                Wire Transfer Instructions:<br \/>\n                                                  National City Bank, Kentucky<br \/>\n                                                  Louisville, Kentucky<br \/>\n                                                  ABA #0830-0005-6<br \/>\n                                                  Reference: HEALTHSOUTH<br \/>\n                                                  Attention: Sandy Walker<\/p>\n<p>                                      115<\/p>\n<p>COMMITMENT:                                 ABN AMRO BANK N.V., ATLANTA AGENCY<br \/>\n$37,500,000<br \/>\n                                            By: ABN AMRO NORTH AMERICA, INC.,<br \/>\n                                                as Agent<\/p>\n<p>                                            By:    \/s\/ W. PAT FISCHER<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  W. Pat Fischer<br \/>\n                                            Title: Senior Vice President<br \/>\n                                                       and Managing Director<\/p>\n<p>                                            By:    \/s\/ MICHIEL VAN CRANENBURGH<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Michiel Van Cranenburgh<br \/>\n                                            Title: Assistant Vice President<\/p>\n<p>                                            Lending Office:<br \/>\n                                              One Ravinia Drive, Suite 1200<br \/>\n                                              Atlanta, Georgia 30346<\/p>\n<p>                                            Wire Transfer Instructions:<br \/>\n                                              Federal Reserve Bank<br \/>\n                                              New York, New York<br \/>\n                                              ABA #0260-09580<br \/>\n                                              Further credit to: ABN AMRO<br \/>\n                                                   Bank N.V., Atlanta Branch<br \/>\n                                              Account #651-0-010197-41<br \/>\n                                              Reference: HEALTHSOUTH<\/p>\n<p>                                      116<\/p>\n<p>COMMITMENT:                                 FLEET NATIONAL BANK<br \/>\n$37,500,000<\/p>\n<p>                                            By:    \/s\/ GINGER STOLZENTHALER<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Ginger Stolzenthaler<br \/>\n                                            Title: Vice President<\/p>\n<p>                                              Lending Office:<br \/>\n                                                75 State Street<br \/>\n                                                Boston, Massachusetts 02109<\/p>\n<p>                                              Wire Transfer Instructions:<br \/>\n                                                Fleet National Bank<br \/>\n                                                Boston, Massachusetts<br \/>\n                                                ABA #011-000-138<br \/>\n                                                Account #1510351<br \/>\n                                                For credit to Commercial Loan<br \/>\n                                                   Services<br \/>\n                                                Attention: Agent Bank<br \/>\n                                                   Department<\/p>\n<p>                                      117<\/p>\n<p>COMMITMENT:                                 THE BANK OF NEW YORK<br \/>\n$37,500,000<\/p>\n<p>                                            By:    \/s\/ ALAN F. LYSTER, JR.<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Alan F. Lyster, Jr.<br \/>\n                                            Title: Vice President<\/p>\n<p>                                              Lending Office:<br \/>\n                                                One Wall Street, 22nd Floor<br \/>\n                                                New York, New York 10286<\/p>\n<p>                                              Wire Transfer Instructions:<br \/>\n                                                The Bank of New York<br \/>\n                                                Commercial Loan Department<br \/>\n                                                New York, New York<br \/>\n                                                ABA #021000018<br \/>\n                                                CLA #111556<br \/>\n                                                Attention: Lorna O. Alleyne<\/p>\n<p>                                      118<\/p>\n<p>COMMITMENT:                                 THE DAI-ICHI KANGYO BANK, LIMITED,<br \/>\n$37,500,000                                 ATLANTA AGENCY<\/p>\n<p>                                            By:    \/s\/ TOSHIAKI KURIHARA<br \/>\n                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Toshiaki Kurihara<br \/>\n                                            Title: Joint General Manager<\/p>\n<p>                                             Lending Office:<br \/>\n                                               Marquis Two Tower, Suite 2400<br \/>\n                                               285 Peachtree Center Avenue, N.E.<br \/>\n                                               Atlanta, Georgia 30303<\/p>\n<p>                                             Wire Transfer Instructions:<br \/>\n                                               The Dai-Ichi Kangyo Bank, Ltd.<br \/>\n                                               New York, New York<br \/>\n                                               ABA #0260 0430 7<br \/>\n                                               For credit to DKB-Atlanta Agency<br \/>\n                                               Account #H79-740-111250<br \/>\n                                               Reference: HEALTHSOUTH<\/p>\n<p>                                      119<\/p>\n<p>COMMITMENT:                                 UNION BANK OF CALIFORNIA, N.A.<br \/>\n$20,000,000<\/p>\n<p>                                            By:    \/s\/ WILLIAM SWIONTEK<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  William Swiontek<br \/>\n                                            Title: Vice President<\/p>\n<p>                                            Lending Office:<br \/>\n                                              550 S. Hope Street, 3rd Floor<br \/>\n                                              Los Angeles, California  90071<\/p>\n<p>                                            Wire Transfer Instructions:<br \/>\n                                              The Bank of California<br \/>\n                                              Los Angeles, California  90071<br \/>\n                                              ABA #121000015<br \/>\n                                              Reference: HEALTHSOUTH<br \/>\n                                              Account #001 060 235<br \/>\n                                              Attention: Hisaki Sakamoto<\/p>\n<p>                                      120<\/p>\n<p>COMMITMENT:                                CREDITANSTALT CORPORATE FINANCE, INC.<br \/>\n$20,000,000<\/p>\n<p>                                           By:    \/s\/ JOE LONGOSZ<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                           Name:  Joe Longosz<br \/>\n                                           Title: Vice President<\/p>\n<p>                                           By:    \/s\/ SCOTT KRAY<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                           Name:  Scott Kray<br \/>\n                                           Title: Senior Associate<\/p>\n<p>                                             Lending Office:<br \/>\n                                               Two Ravinia Drive, Suite 1680<br \/>\n                                               Atlanta, Georgia 30346<\/p>\n<p>                                           Wire Transfer Instructions:<br \/>\n                                               Chemical Bank<br \/>\n                                               New York, New York<br \/>\n                                               ABA #021000128<br \/>\n                                               Account: Creditanstalt, New York<br \/>\n                                               Account #544-7-73095<\/p>\n<p>                                      121<\/p>\n<p>COMMITMENT:                                 FIRST AMERICAN NATIONAL BANK<br \/>\n$20,000,000<\/p>\n<p>                                           By:    \/s\/ NEDDA M. POLLACK<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                           Name:  Nedda M. Pollack<br \/>\n                                           Title: Senior Vice President<\/p>\n<p>                                             Lending Office:<br \/>\n                                               300 Union Street, 2nd Floor<br \/>\n                                               Nashville, Tennessee  37237-0203<\/p>\n<p>                                             Wire Transfer Instructions:<br \/>\n                                               First American National Bank<br \/>\n                                               Nashville, Tennessee  37237-0203<br \/>\n                                               ABA #064000017<br \/>\n                                               Account #0901256<br \/>\n                                               Attention: Betsy Pylkos<\/p>\n<p>                                      122<\/p>\n<p>COMMITMENT:                            FUJI BANK<br \/>\n$20,000,000<\/p>\n<p>                                       By:    \/s\/ TOSHIHIRO MITSUI<br \/>\n                                             &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                       Name:  Toshihiro Mitsui<br \/>\n                                       Title: Vice President and Manager<\/p>\n<p>                                         Lending Office:<br \/>\n                                           Atlanta Agency<\/p>\n<p>                                         Wire Transfer Instructions:<br \/>\n                                           The Fuji Bank, Limited<br \/>\n                                           New York Agency<br \/>\n                                           ABA #026009700<br \/>\n                                           Account: The Fuji Bank, Ltd., Atlanta<br \/>\n                                           Attention: ____________________<\/p>\n<p>                                      123<\/p>\n<p>COMMITMENT:                                 HIBERNIA NATIONAL BANK<br \/>\n$20,000,000<\/p>\n<p>                                            By:    \/s\/ COLLEEN LACY<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name: Colleen Lacy<br \/>\n                                            Title: Vice President<\/p>\n<p>                                            Lending Office:<br \/>\n                                              313 Carondelet Street<br \/>\n                                              New Orleans, Louisiana 70130<\/p>\n<p>                                            Wire Transfer Instructions:<br \/>\n                                              Hibernia National Bank<br \/>\n                                              New Orleans, Louisiana<br \/>\n                                              ABA #065000090<br \/>\n                                              Account #0520-36615<br \/>\n                                                       National Accounts<br \/>\n                                              Reference: HEALTHSOUTH<br \/>\n                                              Attention: ____________________<\/p>\n<p>                                      124<\/p>\n<p>COMMITMENT:                                 THE SANWA BANK LIMITED, ATLANTA<br \/>\n$20,000,000                                 AGENCY<\/p>\n<p>                                            By:    \/s\/ WILLIAM M. PLOUGH<br \/>\n                                               &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  William M. Plough<br \/>\n                                            Title: Vice President<\/p>\n<p>                                                Lending Office:<br \/>\n                                                  133 Peachtree Street, N.E.<br \/>\n                                                  Suite 4750<br \/>\n                                                  Atlanta, Georgia 30303<\/p>\n<p>                                                Wire Transfer Instructions:<br \/>\n                                                  The Sanwa Bank Limited<br \/>\n                                                  New York, New York<br \/>\n                                                  ABA #026009823<br \/>\n                                                  Account #999669<br \/>\n                                                  For the account of Atlanta<br \/>\n                                                  Reference: HEALTHSOUTH<\/p>\n<p>                                      125<\/p>\n<p>COMMITMENT:                                 THE SUMITOMO BANK, LIMITED<br \/>\n$20,000,000<\/p>\n<p>                                            By:    \/s\/ E. B. BUCHANAN, III<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  E. B. Buchanan, III<br \/>\n                                            Title: Vice President<\/p>\n<p>                                              Lending Office:<br \/>\n                                                303 Peachtree Street, Suite 4420<br \/>\n                                                Atlanta, Georgia 30308<\/p>\n<p>                                              Wire Transfer Instructions:<br \/>\n                                                The Sumitomo Bank, Ltd.<br \/>\n                                                Chicago, Illinois  60606<br \/>\n                                                ABA #071001850<br \/>\n                                                Reference: HEALTHSOUTH<br \/>\n                                                Attention: Maria Martinez<\/p>\n<p>                                      126<\/p>\n<p>COMMITMENT:                                 KREDIETBANK, N.V.<br \/>\n$20,000,000<\/p>\n<p>                                            By:    \/s\/ ROBERT SHAUFFER<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name: Robert Shauffer<br \/>\n                                            Title: Vice President<\/p>\n<p>                                            Lending Office:<br \/>\n                                              1349 W. Peachtree Street<br \/>\n                                              Suite 1750<br \/>\n                                              Atlanta, Georgia 30309<\/p>\n<p>                                            Wire Transfer Instructions:<br \/>\n                                              Bank of New York<br \/>\n                                              New York, New York<br \/>\n                                              ABA #021-000-018<br \/>\n                                              Account #802 301 5618<br \/>\n                                              Account Name: Kredietbank<br \/>\n                                                            New York<br \/>\n                                              Reference: HEALTHSOUTH<br \/>\n                                              Attention: Lynda Resuma,<br \/>\n                                                         Loan Administration<\/p>\n<p>                                      127<\/p>\n<p>COMMITMENT:                                 THE SAKURA BANK, LIMITED<br \/>\n$20,000,000                                 ATLANTA AGENCY<\/p>\n<p>                                            By:    \/s\/ HIROYASU IMANISHI<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Hiroyasu Imanishi<br \/>\n                                            Title: Vice President<br \/>\n                                                   and Senior Manager<\/p>\n<p>                                             Lending Office:<br \/>\n                                               245 Peachtree Center Ave, N.E.<br \/>\n                                               Suite 2703<br \/>\n                                               Atlanta, Georgia 30303<\/p>\n<p>                                             Wire Transfer Instructions:<br \/>\n                                               Morgan Guaranty Trust Co.<br \/>\n                                               of New York<br \/>\n                                               New York, New York<br \/>\n                                               ABA #021 000 238<br \/>\n                                               Account Name: The Sakura Bank,<br \/>\n                                                             Ltd., New York<br \/>\n                                               Account #631-22-624<br \/>\n                                               In favor of MTKB, Atlanta,<br \/>\n                                                           A\/C 8000100-1<\/p>\n<p>                                      128<\/p>\n<p>COMMITMENT:                                 THE SUMITOMO TRUST AND BANKING CO.,<br \/>\n$20,000,000                                 LTD.<\/p>\n<p>                                            By:    \/s\/ SURAJ P. BHATIA<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Suraj P. Bhatia<br \/>\n                                            Title: Senior Vice President<\/p>\n<p>                                               Lending Office:<br \/>\n                                                 527 Madison Avenue<br \/>\n                                                 New York, New York  10022<\/p>\n<p>                                               Wire Transfer Instructions:<br \/>\n                                                 Chase Manhattan Bank<br \/>\n                                                 New York, New York<br \/>\n                                                 ABA #021-000-021<br \/>\n                                                 Account #920-1-061497<br \/>\n                                                 For account of Sumitomo Trust<br \/>\n                                                   and Banking Co., Ltd.<\/p>\n<p>                                      129<\/p>\n<p>COMMITMENT:                                 SUNTRUST BANK, NASHVILLE, N.A.<br \/>\n$20,000,000<\/p>\n<p>                                            By:    \/s\/ KAREN COLE AHERN<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Karen Cole Ahern<br \/>\n                                            Title: Vice President<\/p>\n<p>                                             Lending Office:<br \/>\n                                               201 4th Avenue, North<br \/>\n                                               Nashville, Tennessee  37219<\/p>\n<p>                                             Wire Transfer Instructions:<br \/>\n                                               SunTrust Bank, Nashville, N.A.<br \/>\n                                               Nashville, Tennessee  37219<br \/>\n                                               ABA #064000046<br \/>\n                                               Reference: HEALTHSOUTH<br \/>\n                                               Account #170730-0998<br \/>\n                                               Attention: Leigh Anne Gregory<\/p>\n<p>                                      130<\/p>\n<p>COMMITMENT:                                 THE TOKAI BANK, LTD., ATLANTA AGENCY<br \/>\n$20,000,000<\/p>\n<p>                                            By:    \/s\/ ELICHI FUJIHIRA<br \/>\n                                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                            Name:  Elichi Fujihira<br \/>\n                                            Title: General Manager<\/p>\n<p>                                             Lending Office:<br \/>\n                                               285 Peachtree Center Avenue, N.E.<br \/>\n                                               Marquis II Tower, Suite 2802<br \/>\n                                               Atlanta, Georgia 30303<\/p>\n<p>                                             Wire Transfer Instructions:<br \/>\n                                               The Tokai Bank, Ltd.<br \/>\n                                               New York, New York<br \/>\n                                               ABA #026-004-747<br \/>\n                                               For account of The Tokai<br \/>\n                                                Bank, Ltd., Atlanta Agency<br \/>\n                                               Account #08961<\/p>\n<p>                                      131<\/p>\n<p>                                    EXHIBIT A<\/p>\n<p>                        Applicable Commitment Percentages<\/p>\n<p>Lender                              Revolving        Line of Applicable<br \/>\n&#8212;&#8212;                              Credit           Credit Commitment<br \/>\n                                    Commitment       Commitment Percentage<br \/>\n                                    &#8212;&#8212;&#8212;-       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>NationsBank, National<br \/>\nAssociation                         $  50,400,000       $  19,600,000     5.60%<\/p>\n<p>The Bank of Nova Scotia                39,600,000          15,400,000     4.40<\/p>\n<p>First Union National<br \/>\nBank of North Carolina                 39,600,000          15,400,000     4.40<\/p>\n<p>Toronto Dominion (Texas),<br \/>\nInc.                                   39,600,000          15,400,000     4.40<\/p>\n<p>Wachovia Bank of Georgia,<br \/>\nN.A.                                   39,600,000          15,400,000     4.40<\/p>\n<p>AmSouth Bank of Alabama                39,600,000          15,400,000     4.40<\/p>\n<p>Bank of Tokyo-Mitsubishi<br \/>\nLtd., Atlanta Agency                   39,600,000          15,400,000     4.40<\/p>\n<p>Deutsche Bank AG, New York<br \/>\nand\/or Cayman Islands Branches         39,600,000          15,400,000     4.40<\/p>\n<p>The Industrial Bank of<br \/>\nJapan, Limited                         39,600,000          15,400,000     4.40<\/p>\n<p>PNC Bank, Kentucky,                    39,600,000          15,400,000     4.40<br \/>\nInc.<\/p>\n<p>Cooperatieve Centrale<br \/>\nRaiffeisen-Boerenleenbank<br \/>\nB.A., &#8220;Rabobank Nederland&#8221;,<br \/>\nNew York Branch                        39,600,000          15,400,000     4.40<\/p>\n<p>Credit Lyonnais, New<br \/>\nYork Branch                            39,600,000          15,400,000     4.40<\/p>\n<p>Mellon Bank, N.A.                      39,600,000          15,400,000     4.40<\/p>\n<p>Bankers Trust Company                  39,600,000          15,400,000     4.40<\/p>\n<p>LTCB Trust Company                     27,000,000          10,500,000     3.00<\/p>\n<p>National City Bank,<br \/>\nKentucky                               27,000,000          10,500,000     3.00<\/p>\n<p>                                      A-1<\/p>\n<p>ABN AMRO Bank, N.V.,<br \/>\nAtlanta Agency                         27,000,000          10,500,000     3.00<\/p>\n<p>Fleet National Bank                    27,000,000          10,500,000     3.00<\/p>\n<p>The Bank of New York                   27,000,000          10,500,000     3.00<\/p>\n<p>The Dai-Ichi Kangyo<br \/>\nBank, Limited Atlanta<br \/>\nAgency                                 27,000,000          10,500,000     3.00<\/p>\n<p>Union Bank of California,<br \/>\nN.A.                                   14,400,000           5,600,000     1.60<\/p>\n<p>Creditanstalt Corporate<br \/>\nFinance, Inc.                          14,400,000           5,600,000     1.60<\/p>\n<p>First American National<br \/>\nBank                                   14,400,000           5,600,000     1.60<\/p>\n<p>Fuji Bank                              14,400,000           5,600,000     1.60<\/p>\n<p>Hibernia National Bank                 14,400,000           5,600,000     1.60<\/p>\n<p>The Sanwa Bank Limited,<br \/>\nAtlanta Agency                         14,400,000           5,600,000     1.60<\/p>\n<p>The Sumitomo Bank,<br \/>\nLimited                                14,400,000           5,600,000     1.60<\/p>\n<p>Kredietbank, N.V.                      14,400,000           5,600,000     1.60<\/p>\n<p>The Sakura Bank,<br \/>\nLimited, Atlanta Agency                14,400,000           5,600,000     1.60<\/p>\n<p>The Sumitomo Trust and<br \/>\nBanking Co., Ltd.                      14,400,000           5,600,000     1.60<\/p>\n<p>SunTrust Bank, Nashville,<br \/>\nN.A.                                   14,400,000           5,600,000     1.60<\/p>\n<p>The Tokai Bank, Ltd.,<br \/>\nAtlanta Agency                         14,400,000           5,600,000     1.60<br \/>\n                                    &#8212;&#8212;&#8212;&#8212;&#8211;         &#8212;&#8212;&#8212;&#8212;   &#8212;&#8212;<\/p>\n<p>         TOTALS                      $900,000,000        $350,000,000   100.00%<\/p>\n<p>                                      A-2<\/p>\n<p>                                    EXHIBIT B<\/p>\n<p>                        Form of Assignment and Acceptance<\/p>\n<p>                         DATED               ,<br \/>\n                              &#8212;&#8212;&#8212;&#8212;&#8211;   &#8212;&#8212;-<\/p>\n<p>         Reference is made to the Third  Amended and Restated  Credit  Agreement<br \/>\ndated as of April 18, 1996,  as amended  (the  &#8220;Agreement&#8221;),  among  HEALTHSOUTH<br \/>\nCorporation, a Delaware corporation (the &#8220;Borrower&#8221;), the Lenders (as defined in<br \/>\nthe Agreement), and NationsBank,  National Association, as Agent for the Lenders<br \/>\n(&#8220;Agent&#8221;).  Unless otherwise defined herein,  terms defined in the Agreement are<br \/>\nused herein with the same meanings.<\/p>\n<p>                                        (the &#8220;Assignor&#8221;) and<br \/>\n         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;                      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                (the &#8220;Assignee&#8221;) agree as follows:<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>         1. The  Assignor  hereby  sells and  assigns to the  Assignee,  and the<br \/>\nAssignee hereby purchases and assumes from the Assignor, WITHOUT RECOURSE to the<br \/>\nAssignor,  a  _______%  1 interest  in and to all of the  Assignor&#8217;s  rights and<br \/>\nobligations  under the  Agreement as of the Effective  Date (as defined  below),<br \/>\nincluding,  without  limitation,  such percentage interest in the Loans owing to<br \/>\nthe Assignor on the Effective Date, and evidenced by the Revolving Note and Line<br \/>\nof Credit  Note held by the  Assignor  and in  Participations  and the Letter of<br \/>\nCredit Commitment of the Assignor.<\/p>\n<p>         2. The  Assignor  (i)  represents  and  warrants  that,  as of the date<br \/>\nhereof, (A) the aggregate  outstanding  principal amounts of the Revolving Loans<br \/>\nowing to it (without  giving  effect to  assignments  thereof which have not yet<br \/>\nbecome effective) is $________ under a Revolving Note dated __________,  19__ in<br \/>\nthe principal amount of $_________,  (B) the aggregate  principal amount of Line<br \/>\nof Credit Loans owing to it (without  giving effect to the  assignments  thereof<br \/>\nwhich have not yet become  effective) is $__________ under a Line of Credit Note<br \/>\ndated  ____________,  19__ in the  principal  amount of  $_________  and (C) the<br \/>\naggregate  principal amount of the Participations  purchased by it in Letters of<br \/>\nCredit  (without  giving  effect to the  assignments  thereof which have not yet<br \/>\nbecome  effective) is  $_________;  (ii)  represents and warrants that it is the<br \/>\nlegal and  beneficial  owner of the interest  being assigned by it hereunder and<br \/>\nthat such  interest is free and clear of any adverse  claim created by it; (iii)<br \/>\nmakes no representation  or warranty and assumes no responsibility  with respect<br \/>\nto any statements,  warranties or representations  made in or in connection with<br \/>\nthe  Agreement  or any of the other Loan  Documents or any other  instrument  or<br \/>\ndocument  furnished  pursuant  thereto  or the  execution,  legality,  validity,<br \/>\nenforceability, genuineness, sufficiency or value of the Agreement or any of the<br \/>\nother Loan Documents or any<br \/>\n&#8212;&#8212;&#8211;<br \/>\n     1      Specify percentage in no more than 8 decimal points.<\/p>\n<p>                                      B-1<\/p>\n<p>other  instrument  or  document  furnished  pursuant  thereto;   (iv)  makes  no<br \/>\nrepresentation  or warranty  and assumes no  responsibility  with respect to the<br \/>\nfinancial  condition of the Borrower or any  Subsidiary  or the  performance  or<br \/>\nobservance by the Borrower or any Subsidiary of any of its obligations under any<br \/>\nof the Loan  Documents or any other  instrument or document  furnished  pursuant<br \/>\nthereto and (v) attaches  hereto the Revolving Note and the Line of Credit Note,<br \/>\nas the case may be, referred to in paragraph 1 above and requests that the Agent<br \/>\nexchange such Notes for  replacement  Notes as follows:  a Revolving  Note dated<br \/>\n_____________, 19__ in the principal amount of $________________,  and a Line of<br \/>\nCredit Note dated __________,  19__ in the principal amount of $__________ and a<br \/>\nCompetitive Bid Note dated ____________________, 19__ in the principal amount of<br \/>\n$_______________  each  payable to the order of the  Assignor,  and a  Revolving<br \/>\nNote,   dated   ______________________,   19__,  in  the  principal   amount  of<br \/>\n$_________________  and a Line of Credit  Note dated  _________________________,<br \/>\n19___ in the principal amount of  $_________________  and a Competitive Bid Note<br \/>\ndated _________________,  19___ in the amount of $____________,  each payable to<br \/>\nthe order of the Assignee.<\/p>\n<p>         3.  The  Assignee  (i)  confirms  that  it has  received  a copy of the<br \/>\nAgreement,  together  with  copies of the  financial  statements  referred to in<br \/>\nSection 7.1 thereof and such other  documents and  information  as it has deemed<br \/>\nappropriate  to make its own credit  analysis  and  decision  to enter into this<br \/>\nAssignment and Acceptance;  (ii) agrees that it will,  independently and without<br \/>\nreliance  upon the Agent,  the  Assignor,  or any other Lender and based on such<br \/>\ndocuments and information as it shall deem appropriate at the time,  continue to<br \/>\nmake  its own  credit  decisions  in  taking  or not  taking  action  under  the<br \/>\nAgreement;  (iii)  appoints and authorizes the Agent to take such actions on its<br \/>\nbehalf and to exercise such powers under the Loan  Documents as are delegated to<br \/>\nthe Agent by the terms  thereof,  together  with such  powers as are  reasonably<br \/>\nincidental thereto;  (iv) will perform all of the obligations which by the terms<br \/>\nof the  Agreement  are  required  to be  performed  by it as a  Lender;  and (v)<br \/>\nspecifies  as its address  for notices the office set forth  beneath its name on<br \/>\nthe signature pages hereof.<\/p>\n<p>         4. The  effective  date for this  Assignment  and  Acceptance  shall be<br \/>\n_____________________________ (the &#8220;Effective Date&#8221;). Following the execution of<br \/>\nthis Assignment and Acceptance, it will be delivered to the Agent for acceptance<br \/>\nand recording by the Agent.<\/p>\n<p>         5. Upon such  acceptance and recording,  as of the Effective  Date, (i)<br \/>\nthe Assignee  shall be a party to the Agreement  and, to the extent  provided in<br \/>\nthis  Assignment  and  Acceptance,  have the rights and  obligations of a Lender<br \/>\nthereunder  and under the other Loan Documents and (ii) the Assignor  shall,  to<br \/>\nthe extent provided in this  Assignment and  Acceptance,  relinquish its rights,<br \/>\nother than those set forth in Section 3.2(g), Article IV, Section 11.6<\/p>\n<p>                                       B-2<\/p>\n<p>and Section 11.12 of the Agreement  and be released from its  obligations  under<br \/>\nthe Agreement and the other Loan Documents.<\/p>\n<p>         6. Upon such  acceptance  and  recording,  from and after the Effective<br \/>\nDate, the Agent shall make all payments under the Agreement and Notes in respect<br \/>\nof the interest assigned hereby (including,  without limitation, all payments of<br \/>\nprincipal,  interest,  commitment  fees and letter of credit  fees with  respect<br \/>\nthereto) to the Assignee.  The Assignor and Assignee shall make all  appropriate<br \/>\nadjustments  in payments  under the Agreement and the Notes for periods prior to<br \/>\nthe Effective Date directly between themselves.<\/p>\n<p>         7. This Assignment and Acceptance shall be governed by and construed in<br \/>\naccordance with, the laws of the State of _________.<\/p>\n<p>                                      [NAME OF ASSIGNOR]<\/p>\n<p>                                      By:_______________________________________<br \/>\n                                        Name:___________________________________<br \/>\n                                        Title:__________________________________<\/p>\n<p>                                      Notice Address:<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                      After the Effective Date<br \/>\n                                      Outstanding Revolving Loans:$_____________<br \/>\n                                      Outstanding Linen of Credit<br \/>\n                                        Loan: $___________<br \/>\n                                      Outstanding LC<br \/>\n                                        Participations:             $___________<\/p>\n<p>                                      [NAME OF ASSIGNEE]<\/p>\n<p>                                      By:_______________________________________<br \/>\n                                        Name:___________________________________<br \/>\n                                        Title:__________________________________<\/p>\n<p>                                      Notice Address\/Lending Office<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                      Wire transfer Instructions:<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                                     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>                                      After the Effective Date<br \/>\n                                      Outstanding Revolving Loans:$_____________<br \/>\n                                      Outstanding Line of Credit<br \/>\n                                                       Loans: $__________<\/p>\n<p>                                       B-3<\/p>\n<p>                                      Outstanding LC<br \/>\n                                        Participations: $___________<\/p>\n<p>                                      Accepted this ______ day of ________, 19__<br \/>\n                                      NATIONSBANK, NATIONAL ASSOCIATION,<br \/>\n                                        as Agent<\/p>\n<p>                                      By:_______________________________________<br \/>\n                                        Name:___________________________________<br \/>\n                                        Title:__________________________________<\/p>\n<p>Consented to:<\/p>\n<p>HEALTHSOUTH Corporation<\/p>\n<p>By:____________________________________<br \/>\n   Name:_______________________________<br \/>\n   Title:______________________________<\/p>\n<p>                                       B-4<\/p>\n<p>                                    EXHIBIT C<\/p>\n<p>               Notice of Appointment (or Revocation) of Authorized<br \/>\n                                 Representative<\/p>\n<p>         Reference  is hereby  made to the Third  Amended  and  Restated  Credit<br \/>\nAgreement  dated as of April 18,  1996,  as  amended  (the  &#8220;Agreement&#8221;),  among<br \/>\nHEALTHSOUTH  Corporation,  a Delaware corporation (the &#8220;Borrower&#8221;),  the Lenders<br \/>\n(as defined in the Agreement), and NationsBank,  National Association,  as Agent<br \/>\nfor the Lenders  (&#8220;Agent&#8221;).  Capitalized terms used but not defined herein shall<br \/>\nhave the respective meanings therefor set forth in the Agreement.<\/p>\n<p>         The Borrower hereby nominates, constitutes and appoints each individual<br \/>\nnamed below as an Authorized Representative under the Loan Documents, and hereby<br \/>\nrepresents and warrants that (i) set forth opposite each such  individual&#8217;s name<br \/>\nis a true and  correct  statement  of such  individual&#8217;s  office  (to which such<br \/>\nindividual has been duly elected or appointed),  a genuine specimen signature of<br \/>\nsuch  individual  and an address  for the  giving of notice,  and (ii) each such<br \/>\nindividual  has  been  duly  authorized  by the  Borrower  to act as  Authorized<br \/>\nRepresentative under the Loan Documents:<\/p>\n<p>Name and Address              Office         Specimen Signature<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-    &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>Borrower  hereby revokes  (effective upon receipt hereof by the Agent) the prior<br \/>\nappointment of ________________ as an Authorized Representative.<\/p>\n<p>         This the ___ day of __________________, 19__.<\/p>\n<p>                                                 HEALTHSOUTH Corporation<\/p>\n<p>                                                 By:____________________________<br \/>\n                                                 Name:__________________________<br \/>\n                                                 Title:_________________________<\/p>\n<p>                                       C-1<\/p>\n<p>                                    EXHIBIT D<\/p>\n<p>                            Form of Borrowing Notice<\/p>\n<p>To:      NationsBank, National Association,<br \/>\n         as Agent<br \/>\n         Independence Center, 15th Floor<br \/>\n         NC1-001-15-04<br \/>\n         Charlotte, North Carolina  28255<br \/>\n         Attention: Agency Services<br \/>\n         Telefacsimile:  (704) 386-9923<\/p>\n<p>           Reference  is hereby made to the Third  Amended and  Restated  Credit<br \/>\nAgreement  dated as of April 18,  1996,  as  amended  (the  &#8220;Agreement&#8221;),  among<br \/>\nHEALTHSOUTH  Corporation  (the  &#8220;Borrower&#8221;),  the  Lenders  (as  defined  in the<br \/>\nAgreement),  and  NationsBank,  National  Association,  as Agent for the Lenders<br \/>\n(&#8220;Agent&#8221;).  Capitalized  terms  used  but not  defined  herein  shall  have  the<br \/>\nrespective meanings therefor set forth in the Agreement.<\/p>\n<p>         The Borrower through its Authorized  Representative hereby gives notice<br \/>\nto the Agent that  Loans of the Type and  amount set forth  below be made on the<br \/>\ndate indicated:<\/p>\n<p>Class of Loan        Type Loan       Interest      Aggregate<br \/>\n(check one)         (check one)      Period(1)      Amount(2)    Date of Loan(3)<br \/>\n&#8212;&#8212;&#8212;&#8211;         &#8212;&#8212;&#8212;&#8211;      &#8212;&#8212;&#8212;      &#8212;&#8212;&#8212;    &#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p>Revolving           Base Rate<br \/>\nLoan ___            ___<\/p>\n<p>Line of             Eurodollar<br \/>\nCredit              Rate ___<br \/>\nLoan ___<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>(1)      For any Eurodollar Rate Loan, one, two, three or six months.<br \/>\n(2)      Must be $5,000,000 or if greater an integral multiple of $1,000,000.<br \/>\n(3)      At least three (3) Business Days later if a Eurodollar Rate Loan;<\/p>\n<p>         The Borrower  hereby  requests that the proceeds of Loans  described in<br \/>\nthis  Borrowing  Notice be made  available to the  Borrower as follows:  [insert<br \/>\n                                                                         &#8212;&#8212;-<br \/>\ntransmittal instructions].<br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n         The undersigned hereby certifies that:<\/p>\n<p>         1.     No Default or Event of Default exists either now or after giving<br \/>\neffect to the borrowing described herein; and<\/p>\n<p>                                       D-1<\/p>\n<p>         2. All the  representations  and  warranties set forth in Article VI of<br \/>\nthe Agreement and in the other Loan Documents (other than those expressly stated<br \/>\nto refer to a particular date) are true and correct as of the date hereof except<br \/>\nthat  the  reference  to the  financial  statements  in  Section  6.6(a)  of the<br \/>\nAgreement  are to those  financial  statements  most  recently  delivered to you<br \/>\npursuant to Section 7.1 of the Agreement (it being understood that any financial<br \/>\nstatements  delivered  pursuant  to Section  7.1(b) have not been  certified  by<br \/>\nindependent public accountants).<\/p>\n<p>         3.       All conditions contained in the Agreement to the making of any<br \/>\n Loan requested hereby have been met or satisfied in full .<\/p>\n<p>                                    HEALTHSOUTH CORPORATION<\/p>\n<p>                                    BY: ________________________________________<br \/>\n                                               Authorized Representative<\/p>\n<p>                                    DATE: ______________________________________<\/p>\n<p>                                       D-2<\/p>\n<p>                                    EXHIBIT E<\/p>\n<p>                          Form of Competitive Bid Note<\/p>\n<p>                                 PROMISSORY NOTE<\/p>\n<p>$_____________1                                                   April 18, 1996<\/p>\n<p>         FOR VALUE RECEIVED,  HEALTHSOUTH  CORPORATION,  a Delaware  corporation<br \/>\n(the    &#8220;Borrower&#8221;),    hereby    promises    to   pay   to   the    order    of<br \/>\n____________________________2  (the  &#8220;Lender&#8221;),  for  account of its  Applicable<br \/>\nLending Office  provided for by the Credit  Agreement  referred to below, at the<br \/>\nprincipal office of NationsBank,  N.A., One Independence Center, 101 North Tryon<br \/>\nStreet,  NC1-001-15-04,  Charlotte, North Carolina 28255 (or at such other place<br \/>\nor places as the Agent may  designate  in writing) at the times set forth in the<br \/>\nCredit Agreement (as herein  defined),  the aggregate unpaid principal amount of<br \/>\nthe  Competitive  Bid Loans made by the Lender to the Borrower  under the Credit<br \/>\nAgreement,  in lawful money of the United  States of America and in  immediately<br \/>\navailable  funds,  on the dates and in the  principal  amounts  provided  in the<br \/>\nCredit  Agreement,  and to pay interest on the unpaid  principal  amount of each<br \/>\nsuch  Competitive  Bid Loan,  at such office,  in like money and funds,  for the<br \/>\nperiod  commencing  on  the  date  of  such  Competitive  Bid  Loan  until  such<br \/>\nCompetitive  Bid Loan  shall be paid in full,  at the rates per annum and on the<br \/>\ndates provided in the Credit Agreement.<\/p>\n<p>         The  date,  amount,  Type,  interest  rate  and  maturity  date of each<br \/>\nCompetitive  Bid Loan made by the Lender to the Borrower,  and each payment made<br \/>\non account of the  principal  thereof,  shall be recorded by the Borrower on its<br \/>\nbooks and,  prior to any transfer of this Note,  endorsed by the Borrower on the<br \/>\nschedule attached hereto or any continuation thereof,  provided that the failure<br \/>\nof the Lender to make any such  recordation or endorsement  shall not affect the<br \/>\nobligations of the Borrower to make a payment when due of any amount owing under<br \/>\nthe Credit  Agreement or hereunder in respect of the  Competitive Bid Loans made<br \/>\nby the Lender.<\/p>\n<p>         This Note is one of the  Competitive Bid Notes referred to in the Third<br \/>\nAmended and Restated  Credit  Agreement  dated as of April 18, 1996 (as modified<br \/>\nand supplemented from time to time, the &#8220;Credit  Agreement&#8221;) among the Borrower,<br \/>\nthe Lenders  named  therein  and  NationsBank,  N.A.,  as Agent,  and  evidences<br \/>\nCompetitive Bid Loans made by the Lender thereunder.  Terms used but not defined<br \/>\nin this  Note  have  the  respective  meanings  assigned  to them in the  Credit<br \/>\nAgreement.<\/p>\n<p>&#8212;&#8212;&#8212;-<br \/>\n1  Insert the amount of Lender&#8217;s Revolving Credit Commitment.<br \/>\n2  Insert name of Lender in capital letters.<\/p>\n<p>                                       E-1<\/p>\n<p>         The Credit  Agreement  provides for the acceleration of the maturity of<br \/>\nthis  Note  upon  the  occurrence  of  certain  events  and for  prepayments  of<br \/>\nCompetitive Bid Loans upon the terms and conditions  specified  therein.  In the<br \/>\nevent this Note is not paid when due at any stated or accelerated maturity,  the<br \/>\nBorrower agrees to pay, in addition to the principal and interest,  all costs of<br \/>\ncollection, including reasonable attorney&#8217;s fees.<\/p>\n<p>         Except as permitted by Section 11.1 of the Credit Agreement,  this Note<br \/>\nmay not be assigned by the Lender to any other Person.<\/p>\n<p>         This Note shall be governed by, and construed in accordance  with,  the<br \/>\nlaw of the State of North Carolina.<\/p>\n<p>WITNESS:                                     HEALTHSOUTH CORPORATION<\/p>\n<p>____________________________<br \/>\n                                             By:________________________________<br \/>\n____________________________                 Name:______________________________<br \/>\n                                             Title:_____________________________<\/p>\n<p>                                       E-2<\/p>\n<p>                        SCHEDULE OF COMPETITIVE BID LOANS<\/p>\n<p>         This   Note   evidences   Competitive   Bid   Loans   made   under  the<br \/>\nwithin-described  Credit  Agreement  to  the  Borrower,  on  the  dates,  in the<br \/>\nprincipal amounts,  of the Types,  bearing interest at the rates and maturing on<br \/>\nthe dates set forth below,  subject to the payments and prepayments of principal<br \/>\nset forth below:<\/p>\n<p>       Principal<br \/>\nDate    Amount    Type             Maturity    Amount     Unpaid<br \/>\n of       of       of    Interest    Date of   Paid or   Principal    Notation<br \/>\nLoan     Loan     Loan     Rate       Loan     Prepaid     Amount       Made by<br \/>\n&#8212;-     &#8212;-     &#8212;-     &#8212;-       &#8212;-     &#8212;&#8212;-     &#8212;&#8212;       &#8212;&#8212;-<\/p>\n<p>                                       E-3<\/p>\n<p>                                   EXHIBIT F<\/p>\n<p>                     Form of Interest Rate Selection Notice<\/p>\n<p>To:      NationsBank, National Association<br \/>\n         (Carolinas), as Agent<br \/>\n         Independence Center, 15th Floor<br \/>\n         NC1-001-15-04<br \/>\n         Charlotte, North Carolina  28255<br \/>\n         Attention:  Agency Services<br \/>\n         Telefacsimile:  (704) 386-9923<\/p>\n<p>           Reference  is hereby made to the Third  Amended and  Restated  Credit<br \/>\nAgreement  dated as of April 18,  1996,  as  amended  (the  &#8220;Agreement&#8221;),  among<br \/>\nHEALTHSOUTH  Corporation  (the  &#8220;Borrower&#8221;),  the  Lenders  (as  defined  in the<br \/>\nAgreement),  and  NationsBank,  National  Association,  as Agent for the Lenders<br \/>\n(&#8220;Agent&#8221;).  Capitalized  terms  used  but not  defined  herein  shall  have  the<br \/>\nrespective meanings therefor set forth in the Agreement.<\/p>\n<p>         The Borrower through its Authorized  Representative hereby gives notice<br \/>\nto the  Agent of the  following  selection  of a type of Loan [or  Segment]  and<br \/>\nInterest Period:<\/p>\n<p>Type of Loan             Interest             Aggregate         Date of<br \/>\n(check one)               Period(1)            Amount(2)        Conversion (3)<br \/>\n&#8212;&#8212;&#8212;&#8211;               &#8212;&#8212;&#8212;            &#8212;&#8212;&#8212;        &#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>Revolving Loan<br \/>\nBase Rate Loan ___<\/p>\n<p>Eurodollar Rate<br \/>\nLoan ___<\/p>\n<p>Line of Credit<br \/>\nLoan<br \/>\nBase Rate Loan ___<\/p>\n<p>Eurodollar Rate<br \/>\nLoan ___<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>(1)      For any Eurodollar Rate Loan one, two, three or six months.<br \/>\n(2)      Must be $5,000,000 or if greater an integral multiple of $1,000,000.<br \/>\n(3)      At least  three (3)  Business  Days  later if a  Eurodollar  Rate Loan.<\/p>\n<p>                                            HEALTHSOUTH Corporation<\/p>\n<p>                                            BY: ________________________________<br \/>\n                                                  Authorized Representative<br \/>\n                                            DATE: ______________________________<\/p>\n<p>                                       F-1<\/p>\n<p>                                    EXHIBIT G<\/p>\n<p>                           Form of Line of Credit Note<\/p>\n<p>                                 Promissory Note<br \/>\n                              (Line of Credit Loan)<\/p>\n<p>$&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                                       &#8212;&#8212;&#8212;, &#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                                                  April 18, 1996<\/p>\n<p>         FOR VALUE RECEIVED,  HEALTHSOUTH  Corporation,  a Delaware  corporation<br \/>\nhaving its  principal  place of business  located in  Birmingham,  Alabama  (the<br \/>\n&#8220;Borrower&#8221;), hereby promises to pay to the order of<\/p>\n<p>         _______________________________________________  (the &#8220;Lender&#8221;), in its<br \/>\nindividual  capacity,  at the office of NATIONSBANK,  NATIONAL  ASSOCIATION,  as<br \/>\nagent for the Lenders (the &#8220;Agent&#8221;),  located at One  Independence  Center,  101<br \/>\nNorth Tryon Street,  NC1-001-15-04,  Charlotte, North Carolina 28255 (or at such<br \/>\nother  place or places as the Agent may  designate  in writing) at the times set<br \/>\nforth in the Third Amended and Restated  Credit  Agreement dated as of April 18,<br \/>\n1996 among the Borrower,  the financial  institutions party thereto,  as amended<br \/>\n(collectively,  the &#8220;Lenders&#8221;) and the Agent (the &#8220;Agreement&#8221; &#8212; all capitalized<br \/>\nterms not otherwise defined herein shall have the respective  meanings set forth<br \/>\nin the  Agreement),  in  lawful  money  of the  United  States  of  America,  in<br \/>\nimmediately available funds, the principal amount of<\/p>\n<p>         ________________________________________  DOLLARS  ($__________) or, if<br \/>\nless than such principal  amount,  the aggregate  unpaid principal amount of all<br \/>\nLine of  Credit  Loans  made  by the  Lender  to the  Borrower  pursuant  to the<br \/>\nAgreement,  and to pay  interest  from the date  hereof on the unpaid  principal<br \/>\namount  hereof,  in like money,  at said  office,  on the dates and at the rates<br \/>\nprovided in Article II of the  Agreement.  All or any  portion of the  principal<br \/>\namount of Line of Credit Loans may be prepaid as provided in the Agreement.<\/p>\n<p>         If any amount  payable  under this Note is not paid when due,  the then<br \/>\nremaining  principal  amount and accrued but unpaid interest shall bear interest<br \/>\nwhich shall be payable on demand at the rates per annum set forth in the proviso<br \/>\nto Section 2.3(a) of the Agreement.  Further, in the event of such acceleration,<br \/>\nthis Line of Credit  Note shall  become  immediately  due and  payable,  without<br \/>\npresentment,  demand,  protest  or notice of any kind,  all of which are  hereby<br \/>\nwaived by the Borrower.<\/p>\n<p>         In the  event  this  Line of  Credit  Note is not paid  when due at any<br \/>\nstated or accelerated  maturity,  the Borrower agrees to pay, in addition to the<br \/>\nprincipal and interest, all costs of collection,<\/p>\n<p>                                       G-1<\/p>\n<p>including reasonable  attorneys&#8217; fees, and interest due hereunder thereon at the<br \/>\nrates set forth above.<\/p>\n<p>         Interest hereunder shall be computed as provided in the Agreement.<\/p>\n<p>         This Line of Credit Note is one of the Line of Credit Notes referred to<br \/>\nin the Agreement  and is issued  pursuant to and entitled to the benefits of the<br \/>\nAgreement to which reference is hereby made for a more complete statement of the<br \/>\nterms and conditions upon which the Line of Credit Loans  evidenced  hereby were<br \/>\nor are made and are to be repaid. This Line of Credit Note is subject to certain<br \/>\nrestrictions on transfer or assignment as provided in the Agreement.<\/p>\n<p>         All Persons bound on this obligation,  whether primarily or secondarily<br \/>\nliable as principals, sureties, guarantors, endorsers or otherwise, hereby waive<br \/>\nto the full extent  permitted by law the benefits of all  provisions  of law for<br \/>\nstay or delay of execution or sale of property or other satisfaction of judgment<br \/>\nagainst any of them on account of liability  hereon  until  judgment be obtained<br \/>\nand execution  issues against any other of them and returned  satisfied or until<br \/>\nit can be shown  that the  maker  or any  other  party  hereto  had no  property<br \/>\navailable for the  satisfaction  of the debt  evidenced by this  instrument,  or<br \/>\nuntil any other proceedings can be had against any of them, also their right, if<br \/>\nany,  to require the holder  hereof to hold as security  for this Line of Credit<br \/>\nNote any  collateral  deposited  by any of said  Persons as  security.  Protest,<br \/>\nnotice of  protest,  notice of  dishonor,  diligence,  presentment  or any other<br \/>\nformality are hereby waived by all parties bound hereon.<\/p>\n<p>                                       G-2<\/p>\n<p>         IN WITNESS WHEREOF, the Borrower has caused this Line of Credit Note to<br \/>\nbe made, executed and delivered by its duly authorized  representative as of the<br \/>\ndate and year first above written, all pursuant to authority duly granted.<\/p>\n<p>                             HEALTHSOUTH Corporation<\/p>\n<p>WITNESS:<\/p>\n<p>______________________                     By: _________________________________<br \/>\n______________________<br \/>\n                                           Name: _______________________________<br \/>\n                                           Title: ______________________________<\/p>\n<p>                                       G-3<\/p>\n<p>                                    EXHIBIT H<\/p>\n<p>                                   Investments<\/p>\n<p>                                       H-1<\/p>\n<p>                                    EXHIBIT I<\/p>\n<p>                             Form of Revolving Note<\/p>\n<p>                                 Promissory Note<br \/>\n                                (Revolving Loan)<\/p>\n<p>$&#8212;&#8212;&#8212;&#8212;-                                         &#8212;&#8212;&#8212;, &#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>                                                                  April 18, 1996<\/p>\n<p>         FOR VALUE RECEIVED,  HEALTHSOUTH  Corporation,  a Delaware  corporation<br \/>\nhaving its  principal  place of business  located in  Birmingham,  Alabama  (the<br \/>\n&#8220;Borrower&#8221;), hereby promises to pay to the order of<\/p>\n<p>         _______________________________________________  (the &#8220;Lender&#8221;), in its<br \/>\nindividual  capacity,  at the office of NATIONSBANK,  NATIONAL  ASSOCIATION,  as<br \/>\nagent for the Lenders (the &#8220;Agent&#8221;),  located at One  Independence  Center,  101<br \/>\nNorth Tryon Street,  NC1-001-15-04,  Charlotte, North Carolina 28255 (or at such<br \/>\nother  place or places as the Agent may  designate  in writing) at the times set<br \/>\nforth in the Third Amended and Restated  Credit  Agreement dated as of April 18,<br \/>\n1996 among the Borrower,  the financial  institutions party thereto,  as amended<br \/>\n(collectively,  the &#8220;Lenders&#8221;) and the Agent (the &#8220;Agreement&#8221; &#8212; all capitalized<br \/>\nterms not otherwise defined herein shall have the respective  meanings set forth<br \/>\nin the  Agreement),  in  lawful  money  of the  United  States  of  America,  in<br \/>\nimmediately available funds, the principal amount of<br \/>\n         ________________________________________  DOLLARS  ($__________) or, if<br \/>\nless than such principal  amount,  the aggregate  unpaid principal amount of all<br \/>\nRevolving  Loans made by the Lender to the Borrower  pursuant to the  Agreement,<br \/>\nand to pay interest from the date hereof on the unpaid  principal amount hereof,<br \/>\nin like money, at said office, on the dates and at the rates provided in Article<br \/>\nII of the  Agreement.  All or any portion of the  principal  amount of Revolving<br \/>\nLoans may be prepaid as provided in the Agreement.<\/p>\n<p>         If any amount  payable  under this Note is not paid when due,  the then<br \/>\nremaining  principal  amount and accrued but unpaid interest shall bear interest<br \/>\nwhich shall be payable on demand at the rates per annum set forth in the proviso<br \/>\nto Section 2.3(a) of the Agreement.  Further, in the event of such acceleration,<br \/>\nthis  Revolving  Note  shall  become   immediately  due  and  payable,   without<br \/>\npresentment,  demand,  protest  or notice of any kind,  all of which are  hereby<br \/>\nwaived by the Borrower.<\/p>\n<p>         In the event this  Revolving Note is not paid when due at any stated or<br \/>\naccelerated  maturity,  the Borrower agrees to pay, in addition to the principal<br \/>\nand interest, all costs of collection, including reasonable attorneys&#8217; fees, and<br \/>\ninterest due hereunder thereon at the rates set forth above.<\/p>\n<p>                                       I-1<\/p>\n<p>         Interest hereunder shall be computed as provided in the Agreement.<\/p>\n<p>         This  Revolving  Note is one of the Revolving  Notes referred to in the<br \/>\nAgreement  and is  issued  pursuant  to and  entitled  to  the  benefits  of the<br \/>\nAgreement to which reference is hereby made for a more complete statement of the<br \/>\nterms and conditions upon which the Revolving Loans evidenced hereby were or are<br \/>\nmade  and  are  to  be  repaid.  This  Revolving  Note  is  subject  to  certain<br \/>\nrestrictions on transfer or assignment as provided in the Agreement.<\/p>\n<p>         All Persons bound on this obligation,  whether primarily or secondarily<br \/>\nliable as principals, sureties, guarantors, endorsers or otherwise, hereby waive<br \/>\nto the full extent  permitted by law the benefits of all  provisions  of law for<br \/>\nstay or delay of execution or sale of property or other satisfaction of judgment<br \/>\nagainst any of them on account of liability  hereon  until  judgment be obtained<br \/>\nand execution  issues against any other of them and returned  satisfied or until<br \/>\nit can be shown  that the  maker  or any  other  party  hereto  had no  property<br \/>\navailable for the  satisfaction  of the debt  evidenced by this  instrument,  or<br \/>\nuntil any other proceedings can be had against any of them, also their right, if<br \/>\nany, to require the holder  hereof to hold as security for this  Revolving  Note<br \/>\nany collateral deposited by any of said Persons as security.  Protest, notice of<br \/>\nprotest, notice of dishonor,  diligence,  presentment or any other formality are<br \/>\nhereby waived by all parties bound hereon.<\/p>\n<p>                                       I-2<\/p>\n<p>         IN WITNESS  WHEREOF,  the Borrower has caused this Revolving Note to be<br \/>\nmade,  executed and delivered by its duly  authorized  representative  as of the<br \/>\ndate and year first above written, all pursuant to authority duly granted.<\/p>\n<p>                             HEALTHSOUTH Corporation<\/p>\n<p>WITNESS:<\/p>\n<p>______________________                      By: ________________________________<br \/>\n______________________<br \/>\n                                            Name: ______________________________<br \/>\n                                            Title: ____________________________<br \/>\n_<\/p>\n<p>                                       I-3<\/p>\n<p>                                    EXHIBIT J<\/p>\n<p>                      Form of Competitive Bid Quote Request<\/p>\n<p>                                     [Date]<\/p>\n<p>To:               NationsBank, N.A.<\/p>\n<p>From:             HEALTHSOUTH Corporation<\/p>\n<p>Re:               Competitive Bid Quote Request<\/p>\n<p>         Pursuant  to  Section  2.2 of the Third  Amended  and  Restated  Credit<br \/>\nAgreement dated as of April 18, 1996 (as modified and supplemented  from time to<br \/>\ntime, the &#8220;Credit Agreement&#8221;) among HEALTHSOUTH  Corporation,  the lenders named<br \/>\ntherein and  NationsBank,  N.A. as agent,  we hereby give notice that we request<br \/>\nCompetitive Bid Quotes for the following proposed Competitive Bid Borrowing(s):<\/p>\n<p>Borrowing              Quotation                                     Interest<br \/>\n   Date                  Date   1        Amount  2       Type   3     Period   4<br \/>\n   &#8212;-                  &#8212;&#8212;&#8211;        &#8212;&#8212;&#8212;       &#8212;&#8212;&#8211;     &#8212;&#8212;&#8212;-<\/p>\n<p>         Terms used  herein  have the  meanings  assigned  to them in the Credit<br \/>\nAgreement.<\/p>\n<p>                                             HEALTHSOUTH CORPORATION<\/p>\n<p>                                             By:________________________________<br \/>\n                                                Title:  <\/p>\n<p>&#8212;&#8212;&#8211;  <\/p>\n<p>         1 For use if an Absolute  Rate in an Absolute Rate Auction is requested<br \/>\nto be submitted before the Borrowing Date.<br \/>\n         2 Each  amount must be  $10,000,000  or a larger  integral  multiple of<br \/>\n$1,000,000.<br \/>\n         3 Insert either  &#8220;Eurodollar  Margin&#8221; (in the case of Eurodollar Market<br \/>\nLoans) or &#8220;Absolute Rate&#8221; (in the case of Absolute Rate Loans).<br \/>\n         4 One, two three or six months, in the case of a Eurodollar Market Loan<br \/>\nor, in the case of an Absolute  Rate Loan,  a period of up to 180 days after the<br \/>\nmaking of such Absolute Rate Loan and ending on a Business Day.<\/p>\n<p>                                       J-1<\/p>\n<p>                                    EXHIBIT K<\/p>\n<p>                          Form of Competitive Bid Quote<\/p>\n<p>To:                        NationsBank, N.A., as Agent<\/p>\n<p>Attention:<\/p>\n<p>Re:                        Competitive Bid Quote to HEALTHSOUTH Corporation<br \/>\n                           (the &#8220;Borrower&#8221;)<\/p>\n<p>         This  Competitive  Bid Quote is given in accordance with Section 2.2(c)<br \/>\nof the Third Amended and Restated  Credit  Agreement  dated as of April 18, 1996<br \/>\n(as modified and supplemented  from time to time, the &#8220;Credit  Agreement&#8221;) among<br \/>\nHEALTHSOUTH  Corporation,  the lenders named therein and  NationsBank,  N.A., as<br \/>\nagent. Terms defined in the Credit Agreement are used herein as defined therein.<\/p>\n<p>         In response to the Borrower&#8217;s  invitation  dated  __________, 199__, we<br \/>\nhereby make the following Competitive Bid Quote(s) on the following terms:<\/p>\n<p>                  1.       Quoting Bank:<\/p>\n<p>                  2.       Person to contact at Quoting Bank:<\/p>\n<p>                  3.       We hereby offer to make Competitive Bid Loan(s) in<br \/>\n         the following principal amount[s], for the following Interest<br \/>\n         Period(s) and at the following rate(s):<\/p>\n<p>    Borrowing      Quotation                                          Interest<\/p>\n<p>                                       K-1<\/p>\n<p>      Date            Date    1      Amount2     Type3     Period  4       Rate5<br \/>\n      &#8212;-            &#8212;-    &#8211;      &#8212;&#8212;-     &#8212;&#8211;     &#8212;&#8212;  &#8211;       &#8212;&#8211;<\/p>\n<p>         We understand  and agree that the offer(s) set forth above,  subject to<br \/>\nthe satisfaction of the applicable conditions set forth in the Credit Agreement,<br \/>\nirrevocably  obligate[s]  us to make the  Competitive  Bid Loan(s) for which any<br \/>\noffer(s) (is\/are)  accepted,  in whole or in part (subject to the third sentence<br \/>\nof Section 2.2(e) of the Credit Agreement).<\/p>\n<p>                                             Very truly yours,<\/p>\n<p>                                             [NAME OF BANK]<\/p>\n<p>                                             By:________________________________<br \/>\n                                                Authorized Officer<\/p>\n<p>Dated:  __________, ____<\/p>\n<p>&#8212;&#8212;&#8211;<\/p>\n<p>         1 As specified in the related Competitive Bid Quote Request.<br \/>\n         2 The principal  amount bid for each Interest Period may not exceed the<br \/>\nprincipal  amount  requested.  Bids  must be made for at least  $5,000,000  or a<br \/>\nlarger integral multiple of $1,000,000.<br \/>\n         3 Indicate &#8220;Eurodollar Margin&#8221; (in the case of Eurodollar Market Loans)<br \/>\nor &#8220;Absolute Rate&#8221; (in the case of Absolute Rate Loans).<br \/>\n         4 One,  two,  three or six months,  in the case of a Eurodollar  Market<br \/>\nLoan or, in the case of an Absolute  Rate Loan, a period of up to 180 days after<br \/>\nthe making of such Absolute Rate Loan and ending on a Business Day, as specified<br \/>\nin the related Competitive Bid Quote Request.<br \/>\n         5 For a  Eurodollar  Market  Loan,  specify  margin  over or under  the<br \/>\nInterbank Offered Rate adjusted for the Eurodollar Reserve Percentage determined<br \/>\nfor the applicable  Interest Period.  Specify percentage (rounded to the nearest<br \/>\n1\/10,000 of 1%) and specify  whether  &#8220;PLUS&#8221; or  &#8220;MINUS&#8221;.  For an Absolute  Rate<br \/>\nLoan,  specify  rate of interest per annum  (rounded to the nearest  1\/10,000 of<br \/>\n1%).<\/p>\n<p>                                       K-2<\/p>\n<p>                                    EXHIBIT L<\/p>\n<p>                      Form of Opinion of Borrower&#8217;s Counsel<\/p>\n<p>                                  See attached.<\/p>\n<p>                                       L-1<\/p>\n<p>                                    EXHIBIT M<\/p>\n<p>                             Compliance Certificate<\/p>\n<p>NationsBank, National Association,<br \/>\nas Agent<br \/>\nIndependence Center, 15th Floor<br \/>\nNC1-001-15-04<br \/>\nCharlotte, North Carolina  28255<br \/>\nAttention: Agency Services<br \/>\nTelefacsimile:  (704) 386-9923<\/p>\n<p>NationsBank, National Association,<br \/>\nas Agent<br \/>\n_____________________________________<br \/>\nAttention: __________________________<br \/>\nTelefacsimile: (___) ___-____<\/p>\n<p>         Reference  is hereby  made to the Third  Amended  and  Restated  Credit<br \/>\nAgreement  dated as of April 18,  1996,  as  amended  (the  &#8220;Agreement&#8221;),  among<br \/>\nHEALTHSOUTH  Corporation  (the  &#8220;Borrower&#8221;),  the  Lenders  (as  defined  in the<br \/>\nAgreement)  and  NationsBank,  National  Association,  as Agent for the  Lenders<br \/>\n(&#8220;Agent&#8221;).  Capitalized  terms used but not otherwise  defined herein shall have<br \/>\nthe respective meanings therefor set forth in the Agreement. The undersigned,  a<br \/>\nduly authorized and acting Authorized Representative, hereby certifies to you as<br \/>\nof __________ (the &#8220;Determination Date&#8221;) as follows:<\/p>\n<p>I.       Calculations:<\/p>\n<p>         1.  Consolidated Net Worth                             <\/p>\n<p>             A.    Consolidated Net Worth at<br \/>\n                   Determination Date                           $___________<\/p>\n<p>             B.    Consolidated Net Worth Required<\/p>\n<p>                   a)       At Closing Date                     $917,711,000<br \/>\n                   b)       Consolidated Net Income for<br \/>\n                            successive fiscal quarters<br \/>\n                            x 50%                                ___________<br \/>\n                   c)       Net proceeds of any sale of<br \/>\n                            Capital Stock                        ___________<br \/>\n                   d)       Additions resulting from<br \/>\n                            &#8220;pooling of interests&#8221;               ___________<br \/>\n                   e)       (a) + (b) + (c) + (d) (Required)    $___________<\/p>\n<p>                                       M-1<\/p>\n<p>         2.       Consolidated EBITDA to Consolidated<br \/>\n                  Interest Expense<\/p>\n<p>                  A.  Consolidated Net Income                   ___________<br \/>\n                  B.  Consolidated Interest Expense             ___________<br \/>\n                  C.  Consolidated Income Tax Expense           ___________<br \/>\n                  D.  Consolidated Amortization Expense         ___________<br \/>\n                  E.  Consolidated Depreciation Expense         ___________<br \/>\n                  F.  Minority Interest in Consolidated<br \/>\n                      Entities                                  ___________<br \/>\n                  G.  2A + 2B + 2C + 2D + 2E + 2F               ___________<br \/>\n                  H.  Ratio of 2G to 2B                        ____ to 1.00<\/p>\n<p>                  Required:  Not less than 2.50 to 1.00<\/p>\n<p>         3.       Consolidated Indebtedness to Consolidated<br \/>\n                  Total Capital<\/p>\n<p>                  A.  Consolidated Indebtedness                 ___________<br \/>\n                  B.  Consolidated Total Capital                ___________<br \/>\n                  C.  Ratio of 3A to 3B                        ____ to 1.00<\/p>\n<p>                  Required:  Not to exceed .65 to 1.00<\/p>\n<p>II.      No Default<\/p>\n<p>                           A.  Since  __________  (the date of the last  similar<br \/>\n                  certification),  (a) the  Borrower  has not  defaulted  in the<br \/>\n                  keeping,   observance,   performance  or  fulfillment  of  its<br \/>\n                  obligations pursuant to any of the Loan Documents;  and (b) no<br \/>\n                  Default or Event of Default has occurred and is continuing.<\/p>\n<p>                           B. If a  Default  or Event of  Default  has  occurred<br \/>\n                  since __________ (the date of the last similar certification),<br \/>\n                  the  Borrower  proposes  to take  the  following  action  with<br \/>\n                  respect to such Default or Event of Default:__________________<br \/>\n                  ______________________________________________________________<br \/>\n                  ______________________________________________________________<br \/>\n                  ______________________________________________________________<br \/>\n                         (Note,   if  no  Default  or  Event  of  Default  has<br \/>\n                          occurred, insert &#8220;Not Applicable&#8221;).<\/p>\n<p>         The  Determination  Date is the  date of the  last  required  financial<br \/>\nstatements  submitted  to the  Lenders in  accordance  with  Section  9.1 of the<br \/>\nAgreement.<\/p>\n<p>                                       M-2<\/p>\n<p>IN  WITNESS  WHEREOF,  I  have  executed  this  Certificate  this  _____  day of<br \/>\n__________, 19___.<\/p>\n<p>                                             By:________________________________<br \/>\n                                                Authorized Representative<br \/>\n                                             Name:______________________________<br \/>\n                                             Title:_____________________________<\/p>\n<p>                                       M-3<\/p>\n<p>                                    EXHIBIT N<\/p>\n<p>                               Executive Officers<\/p>\n<p>                                       N-1<\/p>\n<p>                                  Schedule 6.4<\/p>\n<p>                                  Subsidiaries<\/p>\n<p>                                       S-1<\/p>\n<p>                                  Schedule 6.19<\/p>\n<p>                               Employment Matters<\/p>\n<p>                                       S-1<\/p>\n<p>                                  Schedule 8.3<\/p>\n<p>                        Existing Subsidiary Indebtedness<\/p>\n<p>                                       S-2<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6550,6694,6846,6852,7545,7751,7772,8182,8287,8542,8973,9279],"corporate_contracts_industries":[9415,9438],"corporate_contracts_types":[9561,9560],"class_list":["post-40964","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-abn-amro-holding-nv","corporate_contracts_companies-amsouth-bancorporation","corporate_contracts_companies-bank-of-america-corp","corporate_contracts_companies-bankers-trust-corp","corporate_contracts_companies-fleetboston-financial-corp","corporate_contracts_companies-healthsouth-corp","corporate_contracts_companies-hibernia-corp","corporate_contracts_companies-mellon-financial-corp","corporate_contracts_companies-national-city-corp","corporate_contracts_companies-pnc-financial-services-group-inc","corporate_contracts_companies-suntrust-banks-inc","corporate_contracts_companies-wachovia-corp","corporate_contracts_industries-financial__banks","corporate_contracts_industries-health__misc","corporate_contracts_types-finance__credit","corporate_contracts_types-finance"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/40964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=40964"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=40964"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=40964"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=40964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}